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ABSTRACT 
Micro- and nanoparticles are being widely investigated for pharmaceutical purposes and 
are beginning to see application in clinical practice. There are numerous techniques to 
produce such therapeutic particles, including emulsion-based techniques and spray 
drying, each with their advantages. Electrospraying provides an alternative technique 
for preparing drug-loaded particles in the micro-scale with a good control of important 
particle characteristics, such as size and shape. In this work, electrospraying was used to 
investigate its potential for producing microparticles intended for oral administration of 
low solubility drugs. Different processing parameters including flow rate, solute 
concentration, drug loading and type of solvent and their influence on particle 
characteristics and drug release were studied using Celecoxib as a model drug and 
poly(lactic-co-glycolic acid) as a carrier material. The role of solvent mixtures were 
studied in detail with respect to particle characteristics and drug release kinetics and 
additional studies were performed for microparticles prepared with Celecoxib and the 
polymer Hypromellose Acetate Succinate.  
The electrosprayed particles were then compared with particles prepared with spray 
drying using similar experimental conditions and their performance was tested.  
Electrosprayed microparticles were prepared with diameters between 2-8 m and a 
near-monodisperse size distribution was obtained in most cases. The morphology of the 
particles ranged from smooth and spherical to rough and non-spherical depending on 
parameters used and were mainly attributed the evaporation rate and solubility of solute 
in the solvents. They are different from the spray dried particles which were all smooth, 
spherical and with a broader size distribution. Electrosprayed particles also showed 
more porosity and a different drug distribution compared with spray dried particles. The 
drug molecules were in an amorphous form in particles prepared using both techniques 
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and remained stable after 8 months of storage. Drug release studies showed differences 
in release profiles depending on the parametric values. The drug release rates were 
directly related to the particle size, morphology, porosity and drug distribution observed 
and hence influenced by the studied process parameters. Spray dried particles generally 
had a slower drug release rate compared with electrosprayed particles attributed to 
differences in the particles characteristics observed. 
The results indicated that electrospraying is an attractive technique for producing drug 
loaded microparticles that can be tailored towards an intended drug delivery application. 
Compared with the more conventional spray drying process it provides better control of 
particle characteristics and demonstrated its suitability for preparing particle-based solid 
dispersion formulations in which the drug is molecularly dispersed and is released in a 
sustained manner to potentially improve oral bioavailability of low solubility drugs. 
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Chapter 1  
Introduction 
 
This chapter introduces to the background of the project and the importance of the 
subject within the life sciences and engineering fields. The chapter also presents the 
aims and objectives of this PhD project and outlines the content of the different chapters 
in this thesis.  
1.1 Background 
Advances in health sciences have led to an ever increasing number of pharmaceutical 
treatments available to treat diseases and improve quality of life. However, 
pharmaceutical innovation is an expensive affair, and it has recently been estimated that 
the development and marketing of a new drug compound on average costs more than $1 
billion [Adams and Brantner 2006, Adams and Brantner 2010]. On the other hand, 
developing new delivery methods for existing drug compounds typically costs 
substantially less and may result in both improved efficacy and bioavailability and a 
reduction in side effects. This strategy can maximize the economic potential of a new 
drug during its early stage and lead to an extension in patent life [Yang et al. 2000]. 
Yet, despite progress in technologies and several successful drug delivery product on 
the market, preparation of clinically effective drug delivery systems still represents a 
significant on-going challenge for many drug delivery applications [Allison 2012].  
Oral drug administration is generally regarded the optimal route of administration as it 
is easy to perform, allows various types of dosage forms, avoids pain and is often 
inexpensive to manufacture. An oral dosage form can be categorized as being either 
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liquid or solid of which the solid dosages offer certain advantages compared with liquid 
dosages including their greater stability and lower manufacturing costs [Sastry et al. 
2000, Vasconcelos et al. 2007]. Notwithstanding, the oral administration route is also 
challenging for drugs that have either low aqueous solubility or low permeability across 
the intestinal wall. Indeed, there is a broad consensus within the pharmaceutical 
community that poor water-soluble active pharmaceutical ingredients (API) have 
become more prevalent in the last decades with an estimated 70% of all new drugs 
classified as being poorly soluble. This is considered a great challenge which needs to 
be overcome due to the cost and inconvenience of systemic administration of these 
drugs via intravenous injection [Lipinski 2002]. New drug candidates for oral delivery 
are becoming increasingly insoluble due to their tendency to increase in molecular 
weight, number of H-bond acceptors and lipophilicity, all of which are parameters 
associated with poor solubility. This tendency is based on the increasing complexity of 
new drug compounds as well as a large fraction of new drug targets being in the lipid-
based cell membrane [Lipinski 2000]. Many of these drugs, however, have an intestinal 
permeability ranging from reasonable to good and thus their main issue is their poor 
solubility [Saharan et al. 2009].   
The poor solubility of drugs poses a significant problem for the therapeutic performance 
of these drugs since with oral delivery the drug must first dissolve in the gastrointestinal 
tract (GI tract) before it can pass across the intestinal membrane. A slow and incomplete 
dissolution often results in low and erratic drug absorption during the relatively short 
absorption window of the digestive system and the consequence is suboptimal clinical 
efficacy of these drugs [Panchagnula and Thomas 2000]. Yet, an increase in the 
bioavailability is often demonstrated by improving the solubility or dissolution rate of 
these drugs. Further, it is believed that by controlling the drug dissolution to take place 
over several hours one may enhance the pharmacokinetics and prevent high variability 
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in the plasma concentration. Such extended drug release combined with good drug 
solubility/dissolution would result in high bioavailability and therapeutically relevant 
drug concentrations over an extended time [Nyholm et al. 2003, Tanaka et al. 2006]. 
There have been many attempts to deal with the poor oral bioavailability of low 
solubility drugs, which is evident from the numerous strategies available, and while 
excellent in vitro results are often shown, the results typically cannot be reproduced 
clinically [Emami 2006].   
Some of the factors determining the success of drug delivery systems are better control 
of size, morphology and surface characteristics of the delivery vehicles used. Micro- 
and nanoparticles are small and flexible and can have different functions useful for 
producing effective formulations and delivery vehicles [Chow et al. 2007, Liversidge 
and Cundy 1995]. The large surface area to volume ratio of these drug carrier particles 
may be used as an advantage as it allows a greater area for interaction with cells and 
tissue and further increases the drug dissolution rate [Kohane 2007]. However, as 
particles decrease in size, beyond a certain range, they may become more unstable and 
difficult to work with. Also, the maximal encapsulated payload per volume of particles 
decreases as the surface to volume ratio increases, limiting the drug loading capacity of 
particles. Thus, it is not necessarily desirable to have particles in the nanoscale unless it 
is crucial for their function or application, i.e. cell uptake of particles but rather have 
particles in the lower micro-range [Kohane 2007, Wendorf et al. 2008]. 
Microparticles are seen used in many type of dosage forms including powders and 
aerosols for nasal and pulmonary delivery, compressed tablets or capsules for oral 
delivery and liquid suspensions for systemic delivery [Vehring 2008]. Until recently, 
the microparticles were mainly seen as a carrier for protecting and releasing drugs 
without any additional functions and attributes. New strategies focus on carefully 
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engineering these microparticles for superior performance with enhanced functionality 
and with better biological interaction [Chew et al. 2005]. This includes the engineering 
of particle shape and surface characteristics as well as engineering of size, size 
distribution and inner structure of the particles. Several studies have indicated that a 
narrow particle size distribution gives better control of drug release and better 
therapeutic effect of the drug [Ding et al. 2005, Valo et al. 2009]. Techniques that allow 
production of microparticles of different size, morphology and surface characteristics 
with an inexpensive process could thus be suitable for developing oral formulations of 
poorly soluble drugs. Such techniques include spray drying and electrospraying (also 
known as electrohydrodynamic spraying) and they may be used to produce 
microparticles that can further enhance dissolution of the drugs. Spray drying is the 
most developed and commonly used of the mentioned techniques and it is used in many 
commercial processes including pharmaceutical applications. Spray drying has also 
been used to produce microparticles intended for oral formulations of low solubility 
drugs [Janssens et al. 2008, Mu and Feng 2001]. 
Electrospraying has mostly been used for processes such as coating and painting, and 
most notably it is used for ionization purposes in many mass spectrometer setups 
[Gorovoi et al. 1969, Takáts et al. 2004]. However, recently the electrospraying 
technique has attracted the attention of many researchers for biomedical applications 
and for development of drug delivery carriers. Electrospraying is a process based on the 
formation, control and breaking up of a liquid jet under the influence of a strong 
electrical field. It is an inexpensive, one-step process that is compatible with a broad 
range of liquids and materials. Compared with spray drying, electrospraying can 
produce more monodisperse particles which are also well dispersed, and the process can 
be performed under ambient conditions [Jaworek 2008, Peltonen et al. 2010]. 
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The suitability of electrospraying for particle engineering purposes has be demonstrated 
by several researchers and it has been observed that by adjusting the process parameters 
some particle properties can be controlled. Although many aspects of the technique and 
its applications have been studied, there are still a number of aspects related to drug 
formulation, particle formation and influences on particle characteristics that have yet to 
be fully examined. Further, the drug release kinetics and cellular uptake of drug from 
microparticles prepared using electrosprayed have only been touched briefly and should 
be explored in more detail [Chang et al. 2010, Enayati et al. 2009, Xie et al. 2006b]. By 
gaining more insight into the particle formation process, control of particle 
characteristics and drug release behaviour, electrospraying may provide improved 
formulation of low solubility drugs and allow development of better treatments. 
1.2 Aims and objectives of this research 
1.2.1 General aims 
The aim of this project is to investigate the preparation of drug-loaded microparticles 
that provides enhanced oral bioavailability of drugs that have low water solubility and 
hence poor oral bioavailability. This is done by investigating the two technologies, 
electrospraying and spray drying, for producing microparticle-based solid dispersions 
with the main focus on electrospraying, a novel method for producing solid dispersions. 
The processing parameters influencing particle formation and characteristics as well as 
drug release behaviour from the particles are studied for electrospraying to gain better 
understanding of the technique. Two different polymers are studied using the same 
model drug to examine differences in particles properties and drug release kinetics. 
Then the electrospraying system is investigated from a particle engineering view point 
by studying particle formation mechanisms specifically with focus on the solvent 
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system used. Then electrospraying is compared with spray drying with regards to their 
differences in particle formation process, particle characteristics and drug release.  
1.2.2 Specific aims 
 Evaluation and validation of electrospraying for preparing solid dispersions and 
drug loaded microparticles 
 Assessment of the adjustable parameters with electrospraying and exploration of 
the influence of these parameters on particle characteristics and drug release and 
the control of these attributes.   
 Investigation of the role of solvent systems on the particles formation and 
resulting characteristics including drug distribution using electrospraying 
 Evaluation of spray drying for the preparation of solid dispersion microparticles 
and the influence of solvent mixtures on particle formation 
 Comparison of spray drying and electrospraying and their resulting products  
1.3 Outline of the report 
This report describes research performed during the project by introducing to the basic 
concepts of the research done, explaining present scientific knowledge in the areas 
covered in a literature review, describing the experimental setup and the analytical 
methods applied and by going through and discussing the results obtained so far in the 
project.   
Chapter 1 briefly introduces to the background of this research. The aims and 
objectives of the research are presented and the scope of this work is defined. 
Chapter 2 is a literature review that covers and explains the different concepts 
necessary to understand the later sections of the report. This review will go through 
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pharmaceutical and technological aspects of the research as well as a combination of the 
two, and further bring the reader up to date with the current research and findings within 
the specific field of this project. 
Chapter 3 explains the materials and methods used in the investigation carried out. The 
different materials and the experimental setup used for microparticle production are 
described, and the different analytical and characterization methods used are explained.  
Chapter 4 presents and discusses the results from the studies concerning 
characterization of spraying solutions and assessment of the electrospraying equipment, 
initial studies on electrosprayed celecoxib-loaded PLGA microparticles and the results 
from studying different electrospraying processing parameters and their influence on 
particle characteristics and drug release are shown and discussed.  
Chapter 5 presents and discusses the results and discussion on the study of different 
solvents systems for preparing particles using electrospraying with focus on particle 
formation, characteristics, drug distribution and drug release. A system composed from 
HPMCAS is also discussed in this chapter. 
Chapter 6 presents and discusses the results and discussion from the studies on 
celecoxib-loaded PLGA microparticles prepared with spray drying using different 
solvent systems and further compares and discusses the data obtained with spray drying 
and electrospraying. 
Chapter 7 summarises the report and outlines the main findings and conclusions 
presented in chapters 4, 5 and 6 and the project in general and gives insight on the 
future perspectives of this project. 
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Chapter 2  
Literature Review  
 
This chapter provides a detailed literature review on the scientific concepts and prior 
research findings important for the understanding of the subsequent chapters. 
Formulation strategies for poorly soluble drugs with particular focus on solid 
dispersions as well as the theory and application of techniques electrospraying and 
spray drying will be reviewed. 
2.1 Strategies to improve oral formulations of poorly soluble drugs 
2.1.1 Introduction to strategies 
The bioavailability of a drug-carrier system describes the rate and extent at which the 
active pharmaceutical ingredient is absorbed by the body from the administered dosage 
and becomes available in the blood circulation. The oral bioavailability is mainly linked 
to the permeability and solubility of a drug. Formulation plays a crucial role on the 
bioavailability of poorly soluble drug compounds and it is often a challenging task to 
develop oral formulations for such drugs [Amidon et al. 1988]. This is primarily due to 
their low aqueous solubility and their poor capacity to dissolve in the gastrointestinal 
fluid within a relevant window of absorption. Thus, drug dissolution is considered the 
main limitation for these drugs and in order to obtain adequate bioavailability, it is 
necessary to understand the mechanisms of dissolution and how it can be improved for 
immediate release purposes [Amidon et al. 1988, Fahr and Liu 2007].     
Although oral formulations mainly aim at obtaining a high dissolution rate, in order to 
achieve supersaturation and quick absorption of the drug, there are also certain 
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advantages with an extended release formulation. Extended release formulations not 
only consider the net bioavailability but are also designed to provide increased patient 
compliance by reducing the dosing frequency as well as reducing fluctuations in the 
drug plasma concentration. They must, however, still provide sufficient drug dissolution 
rate over an extended time interval via one of another strategy [Riis et al. 2007].  
In the following, the concept of dissolution rate is initially explained and subsequently 
different strategies for increasing the dissolution rate, and thereby bioavailability, will 
be discussed. 
2.1.2 Dissolution rate 
Dissolution is the process in which one or several substances go from the solid state into 
solution. The rate at which this process takes place is referred to as the dissolution rate. 
There is a direct proportionality between the solubility and the dissolution rate of a 
substance in a specific solvent and this relationship is described by the Noyes-Whitney 
equation (see equation 2.1) [Noyes and Whitney 1897]: 
  
  
 
           
   
 (Equation 2.1) 
where D is the diffusion coefficient, A is the surface area of drug exposed to the 
dissolution media, Cs is the saturation solubility of the drug, Ct is the drug concentration 
at time, t, h is the thickness of the surface boundary layer and v is the volume of the 
dissolution media. An increase in the drug dissolution rate in a given medium can 
therefore take place either by an increase in drug solubility, an increase in the surface 
area exposed to the medium or a reduction in the diffusion layer thickness, assuming a 
constant volume of the medium. Several properties of the drug and drug-carrier system 
are tied to the parameters influencing the dissolution, and the dissolution rate of the 
drug can be improved by altering these properties. Formulation and drug design 
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strategies have been developed to improve the dissolution rate of poorly soluble drugs 
using the principles of the Noyes-Whitney equation and are typically based on physical 
modifications, chemical modifications or formulation strategies. These different 
strategies are briefly explained in sections 2.1.3-2.1.5. 
2.1.3 Physical strategies 
There are many dissolution enhancing strategies that make use of physical approaches, 
here among approaches where the surface area available for dissolution is maximized, 
solubility is enhanced via modifications in the solid state form of the drug, and lipid 
based formulations.  
Increase in surface area 
The surface area available for dissolution is increased via reduction in the drug particle 
size and is a very common approach for improving the dissolution rate [Gursoy and 
Benita 2004]. This is done either with a top-down approach or a bottom-up approach.   
Top-down approach:  
This involves breaking down large drug crystals into smaller crystals and is typically 
done via a milling process, referred to as micronization or nanonization depending on 
the final crystal size obtained. Micronization is a simple way to reduce particle size 
using various types of mills. Yet it does not provide good control of particle 
characteristics and produces drug particles around 2-5 µm, which are not small enough 
to allow significant enhancement of the dissolution rate [Chaumeil 1998, Rasenack and 
Müller 2004]. With nanonization using for instance Elan‟s NanoCrystal technology 
[Elan 2006], a wet milling process or high pressure homogenization particle sizes can 
be reduced down to 100-250 nm resulting in a significant improvement in dissolution 
rate. However, post processing is typically necessary for these processes, using 
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stabilizing agents in order to avoid aggregation/agglomeration [Merisko-Liversidge and 
Liversidge 2011]. 
Bottom-up approach:  
This involves generating drug nanocrystals from a liquid medium via a controlled 
precipitation/crystallization process. The drug is typically dissolved in a solvent and an 
anti-solvent is then added resulting in precipitation of the drug [Keck and Müller 2006]. 
As the crystals begin precipitating a suspension is obtained, which is stabilized using 
surfactants or polymers and used as a suspension, or later made into a solid dosage via 
granulation or pelletization. Nanocrystals below 100 nm have been produced using this 
approach leading to significant dissolution enhancement. A challenge with this 
technology is the large amount of organic solvent used in the process, which makes it 
costly and cumbersome for large scale production [Shegokar and Müller 2010].  
Solid state modifications 
Solid state modifications of the drug can also lead to improved dissolution. The 
amorphous state is a metastable state in which the material exhibits short-range order 
only over a few molecular dimensions and thus possesses different physical properties 
compared with its corresponding crystalline state. It is associated with higher internal 
energy and specific volume than the ordered crystalline state, which can be favourable 
for pharmaceutical purposes because of their enhanced solubility. The solubility of the 
amorphous form is in the order of 10 to 1600 fold higher than that of the most stable 
crystalline form thus resulting in higher dissolution rate of the drug [Hancock and Parks 
2000]. A drug in the amorphous form allows increased dissolution in a supersaturated 
solution, where it over time precipitates as the drug relaxes into a crystalline form. 
[Müllertz et al. 2010]. Amorphous drugs can be achieved in many ways including 
quench-cooling of a melt, rapid drying of a solution and condensation from vapour 
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state, where quench-cooling and spray drying are some of the more common methods. 
The amorphous state is, however, a non-equilibrium state and the drug has a strong 
tendency to crystallize over time to form a more stable crystalline polymorph. Different 
stabilizers have been used for amorphous formulations acting in order to prevent 
recrystallization characterized by Ostwald‟s step rule but stability still presents an issue 
with these formulations [Lindfors et al. 2007]. Recently, there has been some interest in 
the use of co-amorphous systems, where essentially two poorly soluble drug compounds 
are melted together and subsequently forms a co-amorphous system, one compound 
with good glass forming ability and one with poor glass forming ability. Such co-
amorphous systems have been shown to enhance both dissolution rate and stabilization 
of the amorphous form [Löbmann et al. 2011]. 
2.1.4 Chemical strategies  
Depending on the drug‟s ability to ionize different chemical approaches have also been 
developed to overcome the low dissolution rates of poorly soluble drugs. Ionisable 
drugs have been employed using salt formation while synthesis of prodrugs is another 
popular approach for different classes of drugs.  
The solubility of basic and acidic drugs can often be improved by forming salts of the 
drug. This approach is commonly used for liquid parenteral dosage forms, but it has 
also been shown to increase the dissolution rate of solid dosage forms for oral use. Salts 
are formed using salt-forming agents which are typically acids for basic drugs and bases 
for acidic drugs. Salt formation is useful for some drugs, notably those which are basic 
or acidic, but for many drug compounds this method is not practical due to their 
physicochemical properties. Also, with some drugs salt formation does not improve 
dissolution rate and hence bioavailability [Serajuddin 2007, Sweetana and Akers 1996].   
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Soluble produgs have also been used for oral delivery by forming a reversible chemical 
derivative of an active drug. The prodrug approach aims at increasing the solubility of 
the drug by reducing the intermolecular hydrogen bonding. Reconversion into the 
original drug structure may take place at the intestinal mucosa via enzymatic cleavage 
and has good permeability across the intestinal wall. In addition to solubility 
enhancement, prodrugs may also provide some organ or tissue specific targeting. 
Typical progroups used to enhance the solubility of poorly soluble drugs include esters 
such as phosphate esters, amino acid esters choline esters, or carbonyls and acetates 
[Rautio et al. 2008, Testa 2009]. 
Multi-component crystalline systems are another approach where the dissolution rate of 
drugs in some cases can be improved with crystal pseudo-polymorphs such as solvates. 
Solvates are crystal structures where the unit cell consists of host drug molecules 
accompanied by guest liquid molecules. In the special case where the guest molecule is 
water, they are referred to as hydrates. Solvates occur by crystallization from a solution 
and occasionally have the potential to enhance the drug dissolution rate, as shown for 
some drugs [ odr  guez-Spong et al. 2004]. It has previously been reported, that the 
solubility of solvates can be about four times higher than the solubility of the drug in the 
most stable crystalline state [Hancock and Parks 2000]. Hydrates are the most common 
solvate and many drugs are capable of forming hydrates due to their small size and the 
multidirectional bonding capability of water molecules [Aaltonen et al. 2009]. Solvent 
levels in solvates using organic solvents may be at concentrations that are above the 
tolerated levels with toxicological consequences. Such solvates are thus typically 
avoided for pharmaceutical applications [Blagden et al. 2007].  
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2.1.5 Formulation strategies 
Solubilizing agents 
Cyclodextrins:  
Cyclodextrins are a class of molecules that form inclusion complexes with other 
molecules such as small drug molecules. Inclusion of drugs in different cyclodextrin 
channels may take place through milling or non-covalent interactions. Cyclodextrins 
have different functions such as acting as stabilizers, solubility enhancement and taste 
and odour masking. They typically have a low absorption across the intestinal 
membrane. However, they may have a negative impact on membrane integrity at higher 
doses. Further, they can be difficult to scale up [Del Valle 2003].  
Wetting agents:  
Wettability is referred to as the ability of a liquid to maintain in contact with a solid 
surface via interactions. An increase in the wettability of the drug leads to an increase in 
dissolution rate, as it allows more interaction with the surrounding medium and thus 
enables more penetration into and around the solid surface. The wettability of a drug in 
a given medium can be determined either by the structure of the drug or by the contact 
angle at the liquid/solid interface. A low contact angle indicates that wetting is 
favourable, and hence that the solid drug is wettable. Poorly soluble drugs typically 
have poor wettability due to their high free surface energy from their inherent 
hydrophobicity. A non-wetting material can be made more wettable using surfactants, 
which lower the excess free energy at the solid surface, decreasing the surface tension 
and increasing wettability. Yet, surfactants result in alterations in the barrier functions 
of the intestinal epithelial.    
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Lipid formulations 
Lipid-based formulations comprise a large group of approaches which share similar 
characteristics, mainly the lipophilic nature of the formulations. These formulations 
include oils, self-emulsifying formulations, emulsions and liposomes each with their 
specific advantages and limitations. However, in most cases they involve incorporating 
a lipophilic drug into an inert lipid-based vehicle. Currently, the most popular of the 
lipid formulations for oral delivery are the self-emulsifying drug delivery systems 
(SEDDS), which are essentially mixtures of oils, surfactants and/or solvents. SEDDS 
form emulsions or microemulsions loaded with lipophilic drug upon agitation and are 
considered good candidates for oral delivery [Gershanik and Benita 2000, Pouton 
2000]. 
Lipid-based formulations enhance oral bioavailability by reducing particle size and thus 
increasing dissolution rate, decreasing gastric emptying rate, increasing solubility in the 
intestinal fluid and promoting absorption via intrinsic lipid pathways. [Saharan et al. 
2009]. However, most lipid-based formulations are used in the liquid form, except for a 
few that are solid at room temperature such as solid lipid nanoparticles (SLN). These 
are lipid “nanoparticles” in the size range of 50-1000 nm and combine the advantages of 
conventional lipid formulations with that of nanoparticles. They have further been 
shown to improve oral bioavailability. SLNs are prepared via high pressure 
homogenization, microemulsion techniques, nanopellets or solvent evaporation 
precipitation. These formulations are, however, often influenced by food intake due to 
their lipophilic properties [Hu et al. 2004, Müller et al. 2000]. Although some lipophilic 
nanoparticles have been demonstrated to penetrate the intestinal mucosa without 
releasing their payload, it is not known whether they travel into to the bloodstream 
undigested. Lipid-based formulations seem to be a useful strategy, yet they are mainly 
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limited to highly lipophilic drugs and thus exclude many drugs [Gershanik and Benita 
2000].   
2.1.6 Solid dispersions 
Solid dispersions are a different strategy for modifying the dissolution rate of low 
solubility drugs which combines the effect of several parameters in the Noyes-Whitney 
equation (see section 2.1.2). Solid dispersions are defined as solid dosages composed of 
a minimum of two components, the drug compound and a matrix material, which keeps 
the drug dispersed in a solid form as the name suggests. Solid dispersions were first 
described by Sekiguchi and Obi in 1961 [Sekiguchi 1964]. They showed that by 
forming a eutectic mixture consisting of a poorly soluble drug and urea, a water soluble 
carrier material, the drug dissolution rate was improved hence improving the drug 
bioavailability. An improvement in dissolution rate was found to essentially result from 
the small drug particle size and the increased wettability of the system [Chiou and 
Riegelman 1971].  
There are many methods for reducing the drug particle size, as described in the previous 
sections, hence improving the dissolution rate. Yet, with solid dispersions, given the 
fine dispersion of drug in the carrier matrix, the drug particle size is arguably reduced to 
the molecular level, the smallest building blocks, and thus provides the largest possible 
surface area available for dissolution. Therefore, the release of drug would take place in 
the molecular form and dissolution would be quicker relative to its crystalline 
counterpart, forming a supersaturated solution [Leuner and Dressman 2000]. The drug 
is therefore considered to be amorphous due to the molecular dispersion within the 
carrier matrix and its lack of long-range order and provides similar solubility 
enhancement as the amorphous systems discussed in section 2.1.3.  
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Solid dispersions also provide improvement in wettability which in turn results in 
further increase of dissolution rate. Wettability is carrier dependent, and the highest 
wettability is observed for carriers or additives with high surface energy such as 
surfactants. Yet, an increase in wettability is also observed for materials without high 
surface activity, through close contact between drug and carrier and by decrease in 
crystallinity [Juppo et al. 2003].    
2.2 Preparation of solid dispersions 
2.2.1 Introduction to solid dispersions 
In the beginning, solid dispersions were prepared with crystalline carrier materials such 
as sugars in which the drug was dispersed [Kanig 1964]. Solid dispersions formed from 
crystalline carriers have high thermodynamic stability, yet, their resulting drug 
dissolution rate is relatively low compared with that of other carrier materials used for 
preparing solid dispersions [Vippagunta et al. 2007]. A shift was then made towards 
using amorphous polymeric carriers, currently the most commonly used carriers for 
preparing solid dispersions. The most frequently reported amorphous polymeric carriers 
include cellulose-derived polymers such as hydroxypropyl methyl cellulose (HPMC), 
polymethacrylates, starch-derivatives, polyethylene glycols (PEG) and polyvinyl 
pyrrolidone (PVP) [Serajuddin 1999, Vasconcelos et al. 2007]. These carriers lead to 
drug dispersions either in the form of amorphous or crystalline clusters (solid 
suspension) or as molecular dispersions (glass solution) or a combination of the two 
[Van Drooge et al. 2006].  
Solid suspensions typically form for drugs with a high melting point and a low 
solubility in the polymer phase while glass solutions typically arise when the drug is 
soluble or fully miscible in the polymer phase. Amorphous solid suspensions can be 
difficult to distinguish from glass solutions, but the suspensions tend to exhibit two 
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glass transition temperatures, Tg, one for the amorphous drug phase and one for the 
polymer phase. The glass solutions on the other hand only show one Tg, somewhere in 
between the Tg values of the drug and the polymer [Leuner and Dressman 2000]. 
Although amorphous polymeric carriers provide good enhancement in dissolution rate 
on their own, they are also often been used together with solubility enhancers such as 
surfactants in order to achieve further improvements in bioavailability [Müllertz et al. 
2010, Wong et al. 2006]. These solubility enhancers including gelucire and poloxamer 
have also been used alone, together with the drug, to prepare solid dispersion 
formulations [Majerik et al. 2007, Yüksel et al. 2003].  
2.2.2 Extended release solid dispersions 
Set aside from the dissolution-based improvements in bioavailability, there has in the 
recent years also been a substantial amount of research directed towards solid 
dispersions for extended release applications. Despite not being as well explored as 
conventional immediate release applications such extended or sustained release solid 
dispersions seem to have a lot to offer. Extended release solid dispersions provide drug 
release after administration over a period of several hours at a pre-defined rate. They 
have several advantages over immediate release formulations including the fewer doses 
required each day, higher efficacy of each dose, and smaller variations in the drug 
plasma levels and fewer side effects experienced  [Cui et al. 2003]. Yet, they have 
previously been associated with the risk of dose dumping, a premature and rapid release 
of drug in a short period of time, in the case of failure in the release system. Further, 
extended release formulations have also been associated with low in vivo predictability 
due to their complexity and dependence on environmental factors [Huang and Brazel 
2001].   
Chapter 2. Literature Review 
19 
 
Extended release can be achieved in a variety of ways, but for solid dispersions they are 
generally prepared using a carrier material that has controlled disintegration or 
degradation properties and include materials such as cellulose-derived polymers, 
biodegradable polymers and waxes etc. The properties of the carriers as well as the 
preparation method determine the release mechanism of the drug from the solid 
dispersion. Currently however, there are different challenges to be overcome for 
optimizing the performance of extended release solid dispersions including finding a 
desirable method for producing the formulations with specific physicochemical 
characteristics with high reproducibility and ultimately at a commercial scale. Further 
the stability of the formulations is a matter of concern and may make it challenging to 
use solid dispersion as a method for preparing extended release dosages [Ohara et al. 
2005, Tanaka et al. 2006].  
2.2.3 Methods for preparing solid dispersions   
Solid dispersions can be prepared using a number of different techniques and these are 
typically divided into melting methods and solvent evaporation methods. Melting 
methods include extrusion methods such as hot-stage extrusion and melt extrusion as 
well as melt agglomeration, while the common solvent evaporation methods are 
supercritical fluids technology, spray drying and freeze drying. Some of the main 
preparation methods will be explained briefly and the methods, spray drying and 
electrospraying, will be discussed in further details.   
Melt extrusion:  
Melt extrusion is widely used to prepare solid dispersions and is a useful technique as it 
produces solid dispersions in a single step process, without the need for any solvents, 
and therefore does not require lengthy drying times. This process consists of three parts, 
a conveyer system that moves the material through the die, which is typically either a 
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turning screw or a moving ram, a dye that forms the required shape and a cooling device 
to cool down the melt [Crowley et al. 2007]. The drug and carrier are initially mixed 
and are then heated by the extruder until it softens, and the conveyer system then pushes 
the mixture out through the die. The melt is then cooled down to obtain a solid product, 
in which the drug is dispersed within the carrier matrix, and can then be milled to 
reduce their size. Typically, granules or pellets are prepared from the process and can 
then be further processes into tablets or other dosages. The materials used for melt 
extrusion must have good thermal stability since the process takes place at high 
temperatures [Breitenbach 2002, Crowley et al. 2007]. 
Supercritical fluids technology:  
Supercritical fluids are liquids and gases at temperatures and pressures above their 
critical point, a phase area in the liquid:gas pressure curve. These fluids have lower 
viscosities and higher diffusivities of solutes than liquids [York 1999]. The drug 
compound is filled into a vessel together with the carrier material and a gas is then 
added into the vessel. The gas is pressurized via a compressor before entering the vessel 
and becomes a supercritical fluid, which dissolves the drug and carrier within the vessel. 
Particles are then formed from the dissolved mixtures and are collected on a filter, at the 
outlet of the vessel, until the system is de-pressurized and the powder can be collected. 
With supercritical fluids technology non-volatile solvents can also be dissolved and 
carbon dioxide (CO2) is the most widely used supercritical fluid, due to its low critical 
temperature and pressure (Tcritical = 31.1 ºC, Pcritical = 73.8 bar) [Sethia and Squillante 
2004]. CO2 is further inexpensive, non-toxic and non-flammable compared with organic 
solvent and is hence suitable for pharmaceutical processing. Supercritical fluids 
technology results in particles that are relatively small (0.5-10µm) and has been used as 
an alternative to milling [Van Nijlen et al. 2003].  
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Spray freeze-drying:  
Spray freeze-drying is another solvent-based method where a solvent is removed to 
form a solid dispersion and is a combination of spray drying and freeze drying. In 
freeze-drying, the drug and carrier are dissolved and the solution is first frozen and the 
solvent is then removed through sublimation by applying a vacuum. This process would 
result in solid dispersion powders formed of porous particles with approximately the 
original size of droplets formed by the atomizing nozzle. With spray freeze drying the 
solution containing drug and carrier is atomized from a nozzle into a stream of cold air 
(around -60 ºC) at atmospheric pressure. The small droplets produced quickly freeze 
and then their solvent sublimates in the cold air stream resulting in dry particles in the 
collection chamber [Leuenberger 2002]. 
Spray drying  
Spray drying is a widely used liquid atomization process that evaporates the solvent off 
a solution or suspension to produce a dry powder in one rapid step. It produces particles 
in the micro-scale while at the same time it can be used to prepare solid dispersions. 
Rapid drying takes place as a result of the small droplets formed with high surface to 
volume ratio. Spray drying is one of the most commonly used techniques for producing 
microparticles as well as for preparing solid dispersions and the process takes place as 
follows: Briefly, the liquid is fed into a nozzle and atomized, the droplets are mixed 
with the drying gas, the solvent of the droplets is evaporated and finally the particles are 
separated from the drying gas. Most of the components in a spray drying setup are 
similar from setup to setup, although different types of atomizers exist and make use of 
different atomization forces. Commonly used atomizers starting with the most common 
include, pneumatic nozzles, rotary atomizers, pressure nozzles and ultrasonic nozzles. 
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For more details on the construction and components of a spray dryer please refer to the 
excellent review by Cal and Sollohub [Cal and Sollohub 2010]. 
Electro-spray/electro-spinning  
Electrospraying and electrospinning both belong to the class of electrohydrodynamic 
atomization techniques and are essentially based on the same physical principles. Both 
techniques make use of a strong electrical potential to drive the atomization of a liquid 
into either small droplets or fibres respectively. The droplets and fibres produced then 
solidify as the solvent evaporates, typically without the use of an active drying process, 
and result in products of size ranging between nano- and micro scale. The 
electrospraying and electrospinning setups are relatively simple and can be assembled in 
a laboratory setting using custom parts and the two techniques can practically be 
performed on the same device. The main distinction between the two processes is the 
range in viscosity of the polymer feed solution that is atomized. The principles and 
theories for each of these techniques will be explained to some detail in the following 
section. However, the detailed physical theories and governing equations of 
electrospraying and electrospinning are explained in more depth in other reviews 
[Cloupeau and Prunet-Foch 1989, Jaworek and Sobczyk 2008, Luo et al. 2012, Reneker 
and Chun 1996]. 
2.2.4 Particulate solid dispersions and particle engineering  
Many of the preparation methods for solid dispersions described in Section 2.2.3 
produce microparticle-based formulations, where each microparticle is composed of a 
carrier matrix with the drug dispersed. This applies for both the solvent based 
atomization techniques, where the solid dispersion precipitates from the atomized 
solution, and the melting techniques, where larger structures are formed but can 
subsequently be milled into microparticles. Microparticulate solid dispersions provide 
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quicker drug release compared with more bulky products, due to shorter diffusion 
distances, but this is less significant for systems composed of water soluble carriers. 
Further, microparticles may be better suited for processing or filling into tablets or 
capsules and are likely to provide better re-dispersion or disintegration upon wetting. 
The latter can be an important factor for achieving a desirable dissolution profile. 
Particle-based solid dispersions could also be useful in controlling specific qualitative 
features of solid dispersions including stability, by optimizing the spatial distribution of 
drug molecules in the matrix or by preventing phase separation between the drug and 
carrier. Progress in development of solid dispersion formulations have mainly focused 
on using different carrier materials and additives and a combination of these to achieve 
better bioavailability via dissolution enhancement [Van Eerdenbrugh and Taylor 2010]. 
Yet, with the conventional approaches to preparing and developing solid dispersions, 
there has been little or no attention on the particle aspect of formulations and its 
influence on the product performance [Vasconcelos et al. 2007, Yu et al. 2009].  
Recent progress in nanotechnology as well as particle engineering have introduced new 
tools for preparation of particles providing better control of their attributes and thus 
allowing the design of particles with desirable characteristics. Although still in 
development, advanced nano processing techniques such as lithographical techniques 
and nano impregnation may allow precise control of particle size, shape and drug dose 
with triggered drug release [Guan et al. 2006, Lu and Chen 2004]. However, these 
techniques are typically expensive to operate and must be conducted in a clean room 
environment using several processing steps. Cheaper and less advanced technology such 
as atomization techniques seems to provide a more viable option at the present and still 
allow substantial control of particle characteristics. For example, the size, surface 
morphology and porosity can be controlled to some degree, thus the total surface area 
can be increased by preparing particles with a rough surface and a porous inner structure 
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[Iskandar et al. 2003, Yao et al. 2008]. Control of these and other particle characteristics 
can be used to optimize current drug formulations and seems be very promising. For 
this purpose, the techniques spray drying and electrospraying have proven interesting 
and suitable, since they allow inexpensive production of microparticles which can be 
done in a simple one-step process. Further, certain particle characteristics can be 
modified to improve their in vivo drug delivery performance.       
Solid dispersions composed mainly from water-soluble carriers may not necessarily 
benefit from such a particle engineering approach, as they mainly rely on rapid 
dissolution. Even for bulky solid dispersions the drug release typically takes place very 
fast due to rapid dissolution of the matrix. There could, however, be a stability related 
benefit for these formulations, although this has not yet been demonstrated. For solid 
dispersions composed from non-water-soluble carriers intended for extended or 
sustained release it is important to be able to control the drug release profile. It is first of 
all desirable to have small particles where drug can be released within a relevant time 
span, due to the short diffusional distances for the drug molecules. Further, the particles 
may be tailored to provide better release kinetics and less agglomeration. 
2.3 Spray drying 
2.3.1 Principles of the spray drying process 
Spray drying is a commercial manufacturing process capable of producing a solid 
product from a liquid in the form of a solution or a suspension, and has been used for a 
wide variety of applications ranging from manufacturing of foods to pharmaceutical 
products. The first spray dryer is considered to have been invented in 1872 with the 
registration of the first patent [Percy 1872]. Since then significant improvement have 
been made on the technology per se, concerning the process as well as hardware which 
is compatible with industrial level applications. Set aside its widespread use, there has 
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recently been an interest in gaining further understanding on the underlying mechanisms 
of particle formation using spray drying in order to better control the resulting particle 
characteristics.  
The general spray drying process consists of three major subprocesses; atomization of 
the liquid feed, drying of the atomized droplets into solid particles and separation of 
particle from the drying gas with subsequent collection into a container. Each of these 
subprocesses have an impact on the resulting characteristics of the end product and are 
important to understand and control [Masters 2002]. A spray dryer consists of the 
following major components, sketched in Figure 2.1: A pump that drives the liquid feed 
(1) into the atomization nozzle at a constant flow rate, an atomizer which uses a certain 
driving force (2) to disrupt the liquid into small filaments at the nozzle tip (3), a drying 
chamber (4) where the droplets are exposed to a heated gas, a cyclone (5) which 
separates the dried particles from the drying gas and a collection vial which is used to 
collect the spray dried product (6) [Cal and Sollohub 2010]. 
 
Figure 2.1 General spray drying setup and jetting process. 
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Interest in better control of particle characteristics has led to several reports discussing 
how to control different characteristics using principles from particle formation theory 
and models. In the following sections the different models describing the particle 
formation process and mechanisms in spray drying, the properties of the molecular 
dispersion obtained and their advantages for spray drying will be discussed.  
2.3.2 Particle formation models for the spray drying process  
Much effort has been put into investigating the particle formation process with spray 
drying, and several types of models have been developed to explain the separate steps 
involved in the process. Further, there has specifically been focus on the evaporation 
stage, which is a critical stage where most of the droplet mass is evaporated to form dry 
particles. The models include both theoretical and experimental models, yet most of 
these models are simplifications, since there are many intervariate parameters that 
complicate the process from being fully simulated.   
Experimental methods that have been used to increase the knowledge on particle 
formation include methods in which the solutes of a solution are analysed during 
evaporation of the solvent and methods in which droplets are observed in their transition 
from droplets to particles. For example, Lin and Gentry monitored the morphological 
characteristics of a single droplet hanging from a capillary filament using a device they 
built [Lin and Gentry 2003]. In this study, the steady state drying of the droplet was 
monitored, although taking place at a larger geometric scale, and similar methods have 
been used by others to understand the solidification process [Walton and Mumford 
1999]. Aerodynamic levitators, acoustic levitators as well as concave hot plates have 
been used to hold a droplet in the air while observing the process with a CCD camera or 
a high speed camera. The two types of methods used to study the evaporation of a single 
droplet differ since the levitation methods allow free rotational motion of the droplet, 
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resulting in better approximation of the heat and mass transfer taking place [Adhikari et 
al. 2000, Schiffter and Lee 2007, Tsapis et al. 2005]. Levitation techniques have also 
been coupled with spectroscopic methods such as infrared spectroscopy to continuously 
measure precipitation during drying of the droplet [Biedasek et al. 2007, Santesson et 
al. 2003, Tuckermann et al. 2009]. 
The main limitation with these methods is that they are based on droplets larger than 
170 µm that solidify over much longer time and under different conditions than in the 
spray drying process [Vehring et al. 2007]. They therefore are not fully representative 
of the actual process.  
Another more common strategy to explain the particle formation process is to analyse 
the prepared particles and retrospectively elucidate the particle formation mechanisms 
using the observations. This approach has been performed by correlating properties 
such as particle size, porosity and morphology with mechanisms in the particle 
formation [I Ré 1998, Iskandar et al. 2003].  
Purely numerical approaches to describe the droplet evaporation process for spray 
drying also exist. The constant rate model is one of such models and is based on Fick‟s 
second low of diffusion under a set of assumptions [Feng et al. 2011, Vehring et al. 
2007]. The evaporation rate, 𝜅 is then defined as: 
         
      (Equation 2.2) 
where d is the droplet diameter, d0 is the initial droplet diameter and t is time.  
Further, the Peclet number, a dimensionless number, describes the radial distribution of 
solutes in the drying droplet. It has been used to describe particle formation and to 
predict particle characteristics for given formulation and processing conditions. A 
simplified version of the Peclet number is given as: 
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   (Equation 2.3) 
where Pei is the Peclet number and Di is the diffusion constant of a solute   in the liquid 
phase of the droplet. Further, various models have been developed to simulate particle 
formation using Monte Carlo simulations to rank different parameters used in spray 
drying, thus identifying the factors playing the greatest role in particle formation [Ivey 
and Vehring 2010]. These and other numerical models are mainly based on the drying 
kinetics of droplets containing solids in still air and are not fully representative of the 
droplet drying process in spray drying, yet they can be used to make predictions on the 
characteristics of the resulting particles, given a set of parameters.  
2.3.3 Particle formation in spray drying 
The spray drying process starts with the atomization of droplets and is then followed by 
droplet evaporation until solid particles are formed (see Figure 2.1). Initially, the feed 
solution (1) and the atomization gas (2) are fed into separate inputs of an atomization 
device (rotary, pneumatic, hydraulic or ultrasonic) and the liquid stream is atomized at 
the tip of the nozzle (3) resulting in liquid filaments which develop into fine droplets. 
The droplets in the drying chamber then come in contact with a drying gas of a certain 
temperature and the solvent component of the droplets evaporates until a solid product 
is formed (4). Finally, the dried particles are separated from the drying gas in a cyclone 
(5) and collected in a receiving container (6) [Cal and Sollohub 2010, Dravid et al. 
2006]. 
The sub-processes in spray drying all have an influence on the product yield and 
different relevant particle characteristics, but the droplet drying stage is considered the 
most essential sub-process. In this stage the transition from droplet to dry particles takes 
place and determines a large part of the particle characteristics. This transition is a 
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coupled heat and mass transfer phenomenon, which is driven by the difference between 
the partial pressure of the gas phase and the vapour pressure of the solvent and is often 
described by the solvent evaporation and solute diffusion processes [Masters 2002, 
Vehring et al. 2007]. Depending on the number of solvents and solutes used the process 
becomes more complex to analyse and control, and the simplest system with a solute 
and one solvent is thus often used to study the process mechanisms.  
The evaporation of a droplet to form a dry particle can be divided into three main stages 
which are not only specific to spray drying but also take place in other solvent 
evaporation processes. First, the heating of the droplet initiates shrinking due to 
evaporation of solvent from the droplet surface. Simultaneously, the solutes become 
more concentrated around the surface of the droplet and resulting in a concentration 
gradient of solutes radially in the droplet. The solutes thus move along this 
concentration gradient from the surface towards the centre of the droplet in order to 
balance out the gradient. This unidirectional movement of molecules can be explained 
by Fick‟s first law and the diffusion is dependent on the molecular mobility of the 
solutes or the viscosity, molecular size and temperature as explained in the Stokes-
Einstein equation. Often the diffusion of solutes cannot follow with the radial shrinking 
as a result of solvent evaporation and the solute molecules start depositing and 
eventually cover the droplet surface like a shell trapping the remaining liquid inside.  
From the point where a shell is formed, the particles volume stays fixed and solvent 
continues to evaporate at the surface until it is more or less dry. Then the evaporation 
continues, but now from inside the shell where solutes are still dissolved [Chen and Xie 
1997, Farid 2003]. The shell thickens as solvent evaporates from the interior and 
increases the resistance to mass transfer of solvent across the shell, resulting in a 
reduction in the evaporation rate. This resistance prevents heat transfer across the shell 
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and instead promotes a rise in temperature inside the shell, resulting in increased 
internal pressure. The pressure accumulates until it is finally released together with the 
remaining solvent by inflation, cracking or explosion, depending on the 
strength/thickness and permeability of the shell at this stage [Nešić and Vodnik 1991]. 
Figure 2.2, modified from [Farid 2003], indicates the different stages in the transition 
from droplet to particle. 
 
Figure 2.2 The drying stages of a liquid droplet with single solute and single solvent. 
The drying process of droplets and later the characteristics of particles is dependent on 
the solvent as well as the solute used, which influence the evaporation rate of the 
droplet, molecular mobility of the solute and precipitation of the solutes. Several studies 
have looked into the relationship between evaporation rate and diffusional motion of 
solutes during the particle formation process for systems of a single solvent with a 
single solute, typically a polymer [Okuyama et al. 2006, Weiler et al. 2010]. Here the 
relationship between evaporation rate and solute diffusion is described using the Peclet 
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number (Pe) (see equation 2.3). When Pei < 1 the diffusional motion of the solute is 
faster than the recession rate of the droplet surface due to evaporation, and diffusion can 
thus keep up with droplet shrinkage. In this case, precipitation of the solute takes place 
homogenously, late in the drying process, and results in solid particles without a 
pronounced shell/core structure. When Pei > 1 the diffusional motion of the solute is 
slower than the recession rate at the droplet surface and thus the solutes cannot keep up 
with droplet shrinkage, which results in earlier precipitation at the droplet surface and 
hence shell formation. In this case, there will be a density gradient within the particles, 
and depending on the Pe number there may be voids inside the particles resulting from 
low, local solute concentration during particle formation. The Pe number thus gives an 
indication of the radial concentration profile of the particles prepared [Vehring 2008, 
Vehring et al. 2007]. 
In the case where more than one solute is used, the differences in molecular mobility 
between the solutes as well as differences in solubility in the solvent will influence the 
drying process and the final distribution of the two solute components within the 
particles. The same applies for systems with two or more solvents, where differences in 
evaporation rate and solvent power may result in an inhomogeneous distribution among 
solutes or result in other events [Iskandar et al. 2003, Okuyama et al. 2006]. In both 
cases the dimensionless number Pe can be applied but it would be necessary to expand 
the model with a time dependent function for the varying evaporation rates of the 
solvent mixture and the varying diffusion constants of the solutes using differential 
equations. Further, interactions between the solutes as well as differences in solubility 
and mobility of the solutes may need to be considered in order to determine the 
distribution of solutes. 
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2.3.4 Parameters influencing particle properties in the spray drying process 
In the spray drying process a range of processing parameters can be adjusted to control 
the drying process and the final particle characteristics. The most important parameters 
include inlet and outlet temperature (Tinlet and Toutlet), the atomising gas flow rate 
(atomising pressure), the liquid flow rate, the viscosity of the liquid and finally the 
properties of the materials in the liquid [Masters 2002]. Tinlet and Toutlet are important 
parameters for functional monitoring of the process and it has been stated by several 
researchers that the ratio between Tinlet and Toutlet influences the particle characteristics 
as well as the system yield [Baldinger et al. 2012]. Further, the drying gas flow does not 
seem to have any direct effect on the particle characteristics, but it is recommended to 
keep it at the maximum as it has an influence on Tinlet and Toutlet [Cal and Sollohub 
2010]. The effect of both the formulation and operation conditions on particle properties 
have been elucidated by Maa et al as well as Cal and Sollohub, who have performed a 
large study on these effects [Cal and Sollohub 2010, Maa et al. 1997]. In their review 
article, Cal and Sollohub present a table of the spray drying process parameters that 
influence the resulting particle properties. However, they do not discuss the influence of 
process and formulation parameters on the density and shape of particles and on the 
surface and molecular distribution of drug in particles prepared with spray drying.  
2.4 Electrospraying 
2.4.1 Principles of the electrospraying process  
Electrohydrodynamic spraying (or simply electrospraying) is a technology for 
producing particles in the nano- and micro scale which has been used in a variety of 
application, also recently including pharmaceutical applications [Chakraborty et al. 
2009, Pareta and Edirisinghe 2006, Xie et al. 2006b]. Electrospraying is based on the 
phenomenon where a liquid is passed through a concentric nozzle, at a controlled flow 
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rate, to which a strong electric potential of several kilovolts is applied. As the liquid 
passing through is exposed to this electric potential the surface tension of the liquid is 
reduced at the tip of the needle and small, charged droplets form (see Figure 2.3). The 
basis of this technology has been known since 1879, when Lord Rayleigh discovered 
that a sufficiently strong electric force could cancel out the surface tension and create 
instability of a drop at the tip of a nozzle [Rayleigh 1882]. The electric charge limit at 
which a droplet exposed to an electric force is no longer stable is called the Rayleigh 
limit and is given as: 
            
       (Equation 2.4) 
where QR is electric charge, is γ the surface tension at the liquid-gas interface, ε0 is the 
liquid to vacuum permittivity ratio and r is the radius of the drop. Some years later, 
Zeleny carried out experimental studies with electrospraying based on findings made by 
Rayleigh and discovered several different modes in which spraying could be performed, 
which he also quantitatively described [Zeleny 1917]. Since then, the electrospraying 
process has been employed and described by many either via numerical descriptions or 
experimentally [Cloupeau and Prunet-Foch 1989, Taylor 1964]. However, there are still 
areas of electrospraying that remain relatively unexplored, including the detailed 
particle formation process from droplet to particle, the use of electrosprayed particles 
for pharmaceutical applications and the commercialization of electrospraying.   
2.4.2 Cone-jet and spraying modes 
There are various modes by which the jet can form from the nozzle tip in 
electrospraying. These modes are typically defined by the geometrical form of the liquid 
at the nozzle tip and the behaviour and disintegration of the jet into droplets (see Figure 
2.3). These different modes are of interest because each of these modes has different 
stability and gives rise to droplets of different size, size distribution and shape 
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[Cloupeau and Prunet-Foch 1990]. Based on these definitions the spraying modes can 
be divided into two major groups; those in which small fragments of the liquid are 
ejected from the nozzle and those that produce a long continuous jet, which 
disintegrates further downstream of the jet [Jaworek and Krupa 1999]. The first group 
includes micro-dripping, spindles and ramified-meniscus modes and the latter includes 
cone-jet, multi-jet, oscillating-jet, ramified-jet and precession mode (see Figure 2.3). 
Additionally, a corona discharge may also be present and can also affect the jetting 
behaviour and the resulting particles. These modes of atomization are obtained by 
adjusting the operation parameters such as flow rate and applied voltage or by changing 
the liquid composition or the electric field distribution [Cloupeau and Prunet-Foch 
1994].  
    
Figure 2.3 Overview of electrospraying atomization modes (A) adapted from [Jaworek 
and Krupa 1999] and illustration of cone-jet mode captured with CCTV camera (B). 
Of all the different jetting modes the cone-jet mode is the one of particular interest to 
most people using electrospraying. In this mode the liquid meniscus takes the form of a 
cone leading on to a thin, long jet, which eventually breaks up into small, charged 
droplets (see Figure 2.4). The cone-jet mode was first discovered by Zeleny, but has 
A        B 
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since been described and used by many others [Zeleny 1915]. Studies done by Taylor 
demonstrated that the diameter of the jet achieved in the cone-jet mode could be very 
small compared with the capillary diameter. He also showed theoretically that a cone-
like interface between two liquids can exist in equilibrium in an electric field when the 
angle at the apex of the cone is 49.3º. The critical voltage applied to transform a 
spherical drop to a cone-shape at the tip of a concentric nozzle was predicted based on 
the angle of 49.3. This was also demonstrated experimentally where angles during a 
stable cone-jet were very close to 49.3º. The cone-jet formed at this angle is known as 
the Taylor cone-jet and has also been shown to be a material-dependent value [Taylor 
1964]. 
 
Figure 2.4 General electrospraying setup with droplet formation, where i indicates the 
direction of the electric current, which is in the nA range, and HV is the high voltage 
power source with an electric potential, U, of several kV. 
The cone-jet forms a jet at its tip and as long as the jet does not have too high a charge, 
the jet will break up into droplets. This break-up takes place into a number of main, 
primary droplets and secondary droplets. The distance between the breaks in the jet, λ, 
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(see Figure 2.4) is likely to be the diameter of the jet, Ø, multiplied with a constant, κ, 
which is influenced by the solution viscosity [Cloupeau and Prunet-Foch 1994, Gomez 
and Tang 1994]. The cone-jet mode is attractive because it is stable and can produce 
small particles down to the nano-scale, and it is able to produce near-monodisperse 
droplets. The monodispersity is, however, considered superior in the dripping and 
microdripping modes but these modes result in much larger droplets [Jaworek and 
Krupa 1999]. 
2.4.3 Electrospraying setup 
Electrospraying equipment is generally customized and can vary a lot from one setup to 
another, depending on the applications it is used for, with some setups being more 
advanced than others. In general, an electrospraying setup consists of a syringe pump 
that feeds the liquid into the atomization nozzle(s) at low but constant flow rates (< 6 
mL/h per nozzle for the cone-jet mode), a flat-ended capillary nozzle for uniform drop 
formation and a high voltage power source to drive the atomization process. As with 
spray drying it provides several operation parameters that can be adjusted to control the 
process and the output. Some of the essential parameters include the voltage, the flow 
rate of the liquid feed, humidity and temperature, the collection conditions and the 
properties of the liquid. Of these the most commonly described parameters used to 
monitor and manipulate the process are the applied voltage and liquid flow rate.  
The particles produced are also highly influenced by the method of collection, and since 
most electrospraying setups are custom built or assembled the particle collection 
method especially varies. It is important that the method for collection results in a good 
yield, due to a low output from a single nozzle in the cone-jet mode. It is most common 
to collect the particles directly onto a substrate, for instance onto a glass plate/container 
or onto a filter [Valo et al. 2009]. A ground electrode can be used to facilitate this 
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process by changing the geometry of the electric field present between the nozzle and 
the ground electrode. This would focus the deposition of particles onto a given substrate 
[Pareta and Edirisinghe 2006]. Some have collected particles in a liquid either by 
dispersing the droplets in the gaseous phase above the liquid or collected  directly into a 
continuous liquid phase [Jaworek 2008] or around its surface. Particles collected into 
liquid are subsequently washed, filtered or centrifuged, and dried to obtain a dry powder 
or otherwise simply used as a liquid suspension [Xu and Hanna 2006]. However, when 
collected into a liquid it is most likely that the drug that is on or near the particle surface 
is released in the liquid and thus results in a reduced drug load and a change in release 
kinetics compared with particles collected on a dry surface [Bock et al. 2011]. 
2.4.4 Particle formation models for the electrospraying process  
Although electrospraying is considered a suitable technique for obtaining particles with 
a near-monodisperse size distribution, it is neither easy to operate the process nor to 
control the particle characteristics, and the conditions may differ for each set of 
materials used. Compared with spray drying, it is necessary with electrospraying to also 
consider the electrical properties of the spraying feed, the electrical field architecture 
and its influence on particle attributes. In order to produce particles with better control 
of characteristics it is important to gain further understanding on the particle formation 
as well as find clearer definitions of the effect of inter-dependent parameters through 
multivariate analysis. In section 2.6.3 a brief overview of the efforts in this area is 
described.  
Compared with spray drying there are not many reports on experimental models 
describing the particle formation process with electrospraying. This is believed to be 
partly because the drying process with electrospraying is a passive process in most 
experimental setups and therefore not easy to control and influence by the external 
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environment. Also, the drop models used for spray drying cannot be used to model 
particle formation with electrospraying, since the effect of the electric charge is not 
taken into account and does not correlate to particles at the micro level.  
There are, however, several numerical models that have been developed to explain the 
particle formation process. These include theoretical models that determine the size and 
frequency of electrosprayed droplets from parameters such as viscosity, electrical 
conductivity, voltage applied to nozzle, jet diameter etc. [Jaworek 2007]. A frequently 
used model is the expression for droplet size developed by Gañan-Calvo (see Equation 
2.5), which has been experimentally confirmed by several others:  
   (
    
     
)
   
 (Equation 2.5) 
Where   is a constant, φ is the liquid flow rate,  is the liquid permittivity,  is the 
liquid density,  is the electrical conductivity and   is the surface tension [Gañán-Calvo 
1999]. The charge on each droplet has been calculated and the relationship between 
charge and droplet size was studied by [Chen et al. 1995]. There are also several models 
and simulations concerning the break-up of the jet into droplets but not many 
mathematical models explain the mechanisms taking place from droplet to dry particle 
[Gañan-Calvo 1997, Lastow and Balachandran 2006, López-Jerrera and Gañan-Calvo 
2004].    
2.4.5 Particle formation mechanisms with electrospraying 
There are three continuous processes involved in the particle formation using the cone-
jet mode of electrospraying. First a jet is formed from the liquid meniscus at the nozzle 
tip, then the jet becomes unstable and breaks up into droplets and finally the droplets 
dry out into particles. 
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1: Jet acceleration: The cone-jet forms when the outward stress of the liquid meniscus 
resulting from the applied electric field balances the inward stress from the surface 
tension of the liquid. This corresponds to outbalancing the surface tension of the liquid 
to air interface so that a narrow jet can be formed (see Figure 2.5A). The electric force 
imposed on the liquid cone results in free charge in the liquid and due to the direction of 
the electric field the ions in the liquid are accelerated towards the apex of the cone. The 
ions help forming a thin jet by accelerating the surrounding liquid at the apex of the 
cone [Hartman et al. 1999b, Hartman et al. 2000]. 
2: Jet break-up: When a liquid is ejected from the cone it stays a thin, straight jet for 
some length, typically until surface instabilities occur. At this point, the jet breaks up 
into small, charged droplets as a result of axisymmetric instabilities (see Figure 2.5B). 
Lateral instabilities (see Figure 2.5C) may also occur when the surface charge of the jet 
increases and would result in a broader size distribution of the particles, an often 
undesirable property [Cloupeau and Prunet-Foch 1989].       
      
 
Figure 2.5 Schematic representation of forces in the liquid cone (A) (adapted from 
[Hartman et al. 1999b]) and axisymmetric (B) and lateral (C) instabilities of the 
liquid jet (adapted from [Cloupeau and Prunet-Foch 1994]).      
A                                B  C 
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3: Particle formation from charged droplets: Similar to spray drying, the particle 
formation from droplets in electrospraying takes place through different stages of 
solvent evaporation (see Figure 2.6). Generally, particle formation with electrospraying 
can be divided into the following steps. 
I) The liquid jet is broken up into small electrically charged droplets that repel each 
other and disperse. Solvent evaporation takes place at the droplet surface as the droplets 
are gravitated down in the electric field and the droplet shrinks [Yao et al. 2008].  
II) The net electric charge of the individual droplet remains constant during droplet 
shrinkage and hence the charge becomes more concentrated, until it reaches the 
Rayleigh limit. At this point the droplet cannot hold further charge due to the balance 
between electric stress and surface tension and undergo a so-called Coulomb fission to 
form smaller droplets and may then continue to shrink again [Smith et al. 2002].  
III) The shrinking of the droplet results in a gradual increase in the concentration of 
solutes until the point where the solutes begin to dry out or precipitate on the droplet 
surface. Eventually, the entire surface dries out, a shell is formed just as with spray 
drying, and the particle volume remains constant from this point onwards [Okuzono et 
al. 2006].  
 
Figure 2.6 Particle formation stages of droplets composed of a single solute and a 
single solvent, during electrospraying. 
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IV) Solvent evaporation continues from inside the shell until the particle is dry. 
Diffusion of solutes within the droplet takes place continuously during solvent 
evaporation and depending on the balance between evaporation rate and polymer 
diffusion rate different particle characteristics will be obtained [Xue et al. 2010]. 
Further, there is likelihood that the electric field as well as the electric charge carried by 
the droplets has an influence on the particle formation process and on the distribution 
solutes in the particle although this has not yet been elucidated. 
2.4.6 Parameters influencing jet stability and particle properties  
The electrospraying process is governed by numerous process parameters, which have 
varying degree of influence on the final particle characteristics. The extent of variables 
that can be altered and the interdependent effect of different parameters make it very 
difficult to predict the particle outcome without experimental testing. Generally, these 
parameters can be categorized as being either process operation parameters or liquid 
formulation parameters. Some of the main parameters for jet stability and particle 
characteristics will be discussed in the following. 
Nozzle dimensions 
One can argue that the atomization nozzle is the main component of the electrospraying 
setup and that the geometry and dimension of the nozzle will have influence on its 
output. There are mixed opinions on the role and importance of the nozzle dimensions, 
where some claim that it largely influences the spraying jet, while other say that it has 
no influence on the particle formed but only on the stability of the jet [Jaworek and 
Sobczyk 2008]. Most studies on nozzle dimensions discuss the role of the nozzle 
diameter of a concentric nozzle. Cloupeau and Prunet-Foch studied different aspects of 
the electrospraying setup and mechanisms and noted that the liquid flow rate varies as 
the nozzle diameter changes [Cloupeau and Prunet-Foch 1990]. Tang and Gomez also 
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studied the role of nozzle diameter but reported that it had no influence on the particles. 
They found that the stable region of flow rate and voltage was reduced and shifted 
downwards [Tang and Gomez 1996]. 
The needle thickness, commonly expressed as the needle gauge, is different for each 
setup and can vary to a large extent, typically ranging between 0.33-2.38 mm in outer 
diameter and 0.18-1.77 mm in inner diameter [Cloupeau and Prunet-Foch 1990, Xie et 
al. 2006a]. Generally the needles are flat at the droplet end but there are also angled tips 
and narrowing tips. The needle dimensions do not seem to have a primary role on the 
particle characteristics, although some authors have claimed that particle size 
distribution and jet stability change with needle gauge [Tang and Gomez 1996]. 
Nozzle configurations 
There are also different nozzle configurations that have been used in electrospraying 
where the most simple is the single nozzle setup. With the single nozzle setup generally 
a single liquid containing one or several substances is atomized into particles consisting 
of a mixture of the substances that are sprayed. Another common configuration is the 
co-axial nozzle setup where two nozzles are arranged co-axially with the purpose to 
fully encapsulate one material inside another one as a core-shell structure (see Figure 
2.7 A) [Loscertales et al. 2002]. If the inner material is a gas, hollow particles can be 
prepared using the co-axial setup [Chang et al. 2010]. The same co-axial principle can 
also be used with more than two co-axially arranged nozzles where a similar 
encapsulation effect has been observed [Ahmad et al. 2008].  
Further, another method is to have two capillaries with different liquids merge into one 
nozzle and form a bi-phasic jet, which can result in Janus particles (see Figure 2.7 B) 
[Roh et al. 2005]. Examples of particles formed using the mentioned configurations are 
shown in Figure 2.7 C. Other configurations exist but are not mentioned here. The 
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single nozzle setup is the most apparent and simple setup for producing solid 
dispersions because the drug and carrier are mixed together in the spraying feed.  
 
                  
 
Applied voltage  
The strength of the electric field between the capillary and a ground electrode placed at 
the collection site is mainly controlled by adjusting the applied voltage. The atomization 
process in electrospraying takes place because electrical forces counteract the surface 
tension at the liquid–air boundary. An increase in the applied voltage results in an 
increase in the field strength and hence a stronger atomization effect on the liquid. The 
cone-jet mode is only obtained in a narrow voltage range, where the meniscus of liquid 
is conical and stationary. Below this range the meniscus may be conical but will be 
Figure 2.7 Encapsulation via Co-axial spraying (A) (adapted from [Jaworek 2008]), 
biphasic jetting via dual capillary (B) (adapted from [Roh et al. 2005]) and sketch of 
particles ideally formed by single (a), co-axial (b) and bi-phasic jet (c). 
A              B                     C 
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b 
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unstable and pulsate together with the jet. Above the cone-jet range an unstable multi-jet 
or another type of unstable jet is formed [Ganan-Calvo et al. 1997]. This voltage is thus 
a key variable in establishing a stable cone-jet. Yet, it is important to know that the 
voltage range depends on other factors such as the liquid flow rate.  
Another influence of the applied voltage within the cone-jet region is its influence on 
droplet size and hence particle size. It has been demonstrated that droplet size decreases 
when the voltage is increased within the stable cone-jet range [Jayasinghe and 
Edirisinghe 2004]. However, when highly conductive liquids and highly viscous liquid 
were used the effect of applied voltage on droplet size was shown to be minimal [Ku 
and Kim 2002]. 
Liquid flow rate  
The liquid flow rate is one of the main operation parameters of any liquid atomization 
technique and this is also the case with electrospraying. This flow rate can be controlled 
in a broad range using a high precision syringe pump but a stable cone-jet is only 
established in a certain range. The width and position of this range is dependent on the 
properties of the liquid as well as other factors. At the minimum flow rate necessary to 
establish a cone-jet for a given liquid, the jet break-up happens due to varicose 
instabilities and results in a very narrow particle size distribution. At higher flow rates 
the surface charge on the jet increases and kink instabilities become more influential on 
the jet break-up. This results in a broader particle size distribution when the flow rate is 
increased [Hartman et al. 2000; Jayasinghe and Edirisinghe 2004]. 
Another effect of the flow rate which has been observed by several groups is its 
influence on the mean particle size. When increasing the flow rate within the stable 
cone-jet range an increase in particle size was also observed [Enayati et al. 2009]. 
Chapter 2. Literature Review 
45 
 
Viscosity of liquid 
The viscosity of a spraying liquid plays an important role in the electrohydrodynamic 
process and distinguishes whether the liquid is sprayed into particles or spun into fibres. 
With electrospraying, the viscosity also has great influence on the break-up of the jet 
and the size of the droplets produced. It has been demonstrated by Jayasinghe and 
Edirisinghe (2002) that an increase in viscosity over three orders of magnitudes leads to 
a dramatic increase in particle size. This observation has also been confirmed by several 
others [Jayasinghe and Edirisinghe 2002]. 
Surface tension 
The surface tension of a spraying liquid may be important for the stability of the cone-
jet and must be overcome by the electrical stresses. A liquid with a high surface tension 
needs equally high electric field strength to overcome its surface tension so that small 
droplets can be formed. However, there is a certain limit at which the electric field 
necessary to outbalance the surface tension is so large that a stable jet cannot be formed 
because it results in a breakdown of the gas surrounding the cone. This is typically seen 
as the presence of sparking and results in polydisperse particles or no particles output. 
An example of a liquid with a high surface tension is water, which can only be sprayed 
by lowering its surface tension or by changing the gas surrounding the jet into a gas 
with higher electrical breakdown strength. The surface tension can for instance be 
lowered by adding surfactants to the liquid and an example of a gas with higher 
electrical breakdown strength than atmospheric air is CO2 [Smith 1986; Tang and 
Gomez 1995]. 
Electrical conductivity 
The electrical conductivity of the spraying liquid is also among the important 
parameters when staying in the cone-jet mode, both for establishing a stable cone-jet 
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and also for controlling the size of the droplets produced. Liquids that either have too 
high or too low conductivity cannot reach a stable cone-jet and thereby cannot carry out 
their desired function. The conductivity range, which allows the formation of a stable 
cone-jet, has been reported by Jones and Thong, and Mutoh et al to be between 10
-5
 and 
10
-3
 S/m [Jones and 1971; Mutoh et al. 1979]. If the electrical conductivity is higher 
than this range, cone-jet cannot be established due to electrical discharge. When the 
electrical conductivity is lower than the given range, a stable cone-jet cannot be 
established due to the insufficient charge building up in the liquid and hence a lack of 
tangential stress. Yet, in this case the liquid can still potentially be used by increasing 
the conductivity via addition of salts or other conductivity enhancers [Cloupeau and 
Prunet-Foch 1989; Hartman et al. 1999b]. 
Moreover, the value of electrical conductivity within the stable cone-jet window also 
influences the properties of the droplets generated, most notably their size. A spraying 
solution with a high electrical conductivity has been demonstrated to give rise to smaller 
particles than a solution with low electrical conductivity [Ganan-Calvo et al. 1997; 
Lopez-Herrera et al. 2003]. 
Particle size is one of the most studied particle characteristics and is closely linked to 
the size of the droplets formed and the Peclet number of the feed solution. Equation 2.5 
which describes the droplet size indicates the parameters influencing particle size such 
as flow rate, viscosity, surface tension and electric conductivity. Also, the Peclet 
number (see section 2.3.2) is linked to the particle diameter as the ratio between the 
evaporation rate and solute diffusion determines when the solutes begin to precipite. 
Studies have shown that a decrease in evaporation rate allows longer diffusion time for 
the solutes and leads to smaller particles. However, this may also be associated with a 
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higher solubility of solutes in the solvent resulting in higher polymer mobility [Park and 
Lee 2009]. 
The applied voltage may be adjusted to influence particle size but typically also alters 
the stability and shape of the jet. Increasing the voltage imposes more electric charge on 
the droplets and is seen to alter the shape of the particles, leading to more elongated 
particles and even fibres given the right solution conditions [Enayati et al. 2009]. The 
mode of particle collection obviously has an influence on evaporation time and the 
resulting particle characteristics and the distance of collection can be controlled to give 
optimal conditions as sufficient drying is necessary to obtain non-collapsed particles. 
The particles prepared with electrospraying are very sensitive to changes in the liquid 
properties but also to temperature, humidity and other external factors. 
2.4.7 Advantages and disadvantages of electrospraying 
Although electrospraying is currently not as developed as some conventional techniques 
such as spray drying and freeze drying there are definitely some advantages with 
electrospraying. The most apparent advantages of electrospraying when compared with 
other atomization technologies are: 
1. Due to the exposure to an electrical potential the droplets produced are electrically 
charged, repelling each other and are thus self-dispersing. This acts to prevent 
aggregation of particles [Jaworek 2007]. 
2. Smaller droplets can be produced with atomization using electrospraying, partly due 
to the lowering of surface tension and the electrical charge-related droplet fission 
process. Small droplets will naturally result in small particles [Peltonen et al. 2010]. 
3. Due to the fragmentation mechanism of liquid filaments from the jet during cone-jet 
mode, a very homogenous distribution of particles can be achieved without post-
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processing such as filtering. Good stability of the jet (e.g. cone-jet mode) results in near-
monodisperse particles [Chen et al. 1995].   
4. The deposition of particles onto a substrate can be controlled by modifying the 
electric field limiting particle loss and narrowing the deposition area to a specific region 
[Jaworek and Sobczyk 2008].    
The main disadvantage of particle production with electrospraying is its low throughput, 
which is typically a fraction of a gram of dry weight per hour for a single nozzle setup. 
This is much lower compared with the throughput of a laboratory scale spray dryer and 
is far from sufficient for production in accordance with good manufacturing practice 
(GMP) guidelines. However, efforts have been made in upscaling electrospraying 
devices by using multiple nozzles placed in one plane [Almekinders and Jones 1999, 
Regele et al. 2002] or by spraying through uniform holes in a plate [Bocanegra et al. 
2005, Deng et al. 2009] (see section 2.6.5). 
2.5 Challenges in formulating solid dispersions 
2.5.1 Stability of solid dispersion 
Although solid dispersions provide great improvements in drug dissolution rate and 
other favourable properties, they suffer from both physical and chemical instability. In 
solid dispersions the drug is amorphous or partially amorphous within the polymer 
matrix and is thus not stable from a thermodynamical point of view, eventually resulting 
in devitrification, the process in which an amorphous phase converts into crystalline 
phases. However, such devitrification ideally does not happen for several years if 
careful considerations are made during formulation [Van den Mooter et al. 2001]. 
Nonetheless, due to the properties and characteristics of solid dispersion instability of 
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the solid dispersions may occur during processing as well as during storage, most 
notably leading to crystallization of the drug.  
The stability of solid dispersions can be evaluated using different analytical tools 
including X-ray powder diffraction and differential scanning calorimetry, which are 
often used in combination to determine the physical state of a material, including the 
percentage of crystallinity present [Leuner and Dressman 2000]. Recently, the advance 
of process analytical technology (PAT) has shifted the direction more towards fast, non-
destructive methods in particular vibrational spectroscopy such as Raman, Near infra-
red and Fourier Transformed infra-red spectroscopy in combination with chemometrics 
to identify the solid-phase of these dosage forms [Qian et al. 2010, Strachan et al. 
2007].  
Molecular mobility and drug-polymer interactions   
Molecular mobility is considered one of the key determinants governing the physical 
stability of amorphous phases such as the case with solid dispersions. The molecular 
mobility is related to the number of collisions of the molecules per unit time and is 
representative to some degree of how fast recrystallization takes place. The molecular 
mobility of a material undergoes a remarkable change as the temperature is increased 
above the Tg, and the Tg is known to give an indication of the degree of molecular 
mobility of the system [Zhou et al. 2007]. Molecular mobility in solid dispersions can 
be reduced by selecting a polymer with a high glass transition temperature (Tg), which 
thereby increases the Tg of the whole amorphous system and implies a reduction in 
molecular mobility. This reduces the crystallization at given storage conditions 
[Hancock et al. 1995]. Although mobility is reduced and storage is performed under the 
Tg of the systems, there may still be enough mobility for recrystallization to take place 
over pharmaceutically relevant time scale. However, molecular mobility was reported to 
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become insignificant when the storage takes place 50 K below the Tg. Amorphous drugs 
with a low Tg also benefit from the a high Tg of the polymer, which can lead to an 
antiplasticising effect [Gunawan et al. 2006]. Also, the molecular mobility not only 
depends on the properties of the drug and carrier used but also on the processing method 
used to prepare the solid dispersion.   
The physical stability also depends on the miscibility of the drug in the polymer and is 
ideally molecularly miscible in the polymer. It has been demonstrated that the drug has 
a lower chemical potential when mixed with a polymer, from a thermodynamics 
viewpoint, and thus a reduction in crystallization process is experienced. Further, such 
miscibility will also be influenced by the degree of interaction between the drug and the 
polymer. Several types of such interactions may form and those frequently observed 
include intermolecular hydrogen bonds, van der Waals, and electrostatic interactions.  
A majority of poorly water soluble drugs contain hydrogen bonding sites and by 
formation of bonds between the drug and the polymer hydrogen bonding otherwise 
characteristic to the crystal structure is disrupted, thus promoting stability [Qian et al. 
2010, Taylor and Zografi 1997]. The strength of the molecular interactions formed 
between the polymer and the drug is of high importance for the physicochemical 
properties and physical stability of the system. Some polymers exhibit stronger 
hydrogen bonds to a specific drug than other polymers and for instance PVP has been 
observed to form stronger hydrogen bonds than PEG does, with their interaction 
energies estimated at 30-36kJ/mol and 19-21 kJ/mol for PEG and PVP respectively for 
this specific system [Teberekidis and Sigalas 2007].  
The polymers can act as either intermolecular hydrogen bond donors or acceptors and 
some polymers such as HPMC have both hydrogen bond donating and accepting 
groups, which from a stability stand point could be advantageous for interactions with 
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both a drug and a excipient with hydrogen bonding properties [Bee 2010]. It is, 
however, important to match the properties of the carrier with the drug in order to 
achieve enhanced interaction between them and restrict molecular mobility and thus 
obtain better stability. In addition to hydrogen bonding other types of bonds may also 
enhance stability. It has for instance been shown that Eudragit E100 can stabilize the 
amorphous drug by forming ionic interactions. Such interactions are stronger than 
intermolecular hydrogen bonding and thus may provide further advantage in the 
physical stability compared with systems where hydrogen bonds are formed 
[Moustafine et al. 2005]. Ideally, a combination of these stabilizing strategies would be 
desirable to obtain optimal hindrance of recrystallization.  
A study by Ke et al. has further shown that the physical stability of solid dispersions is 
process dependent and by testing three processes, spray drying, melt quenching and ball 
milling to prepare solid dispersions, it was found that ball milled dispersions were the 
least stable while surface relaxation time was highest for spray dried samples and 
molecular mobility was lowest for melt quenched samples [Ke et al. 2012]. 
Storage considerations 
The formulation, processing method and material selection have all been reported to 
have an influence on the physical stability of solid dispersions. Yet, the storage 
conditions of samples also has a significant impact on the stability and shelf life of the 
samples, and can be optimized to compensate for tendencies of instability from the 
formulation and improvement of already stable formulations. It is in particular the 
temperature and humidity during storage that seems to have a considerable effect on 
physical stability. Studies have been performed on different polymers and humidity 
conditions to observe the influence on stability of amorphous solid dispersions.  
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Comparing PVP, HPMC and HPMCAS at 5-95% relative humidity at 10% intervals it 
was found that all polymers absorbed more water relative to the drug thereby increasing 
the moisture content of the systems. Yet, the crystallinity tendencies were limited 
although in particular PVP was more prone to recrystallization, probably due to the 
hygroscopicity of PVP [Rumondor et al. 2009]. However, it is also seen that moisture 
may lead to phase separation, crystal growth and transformation of polymorphs, all of 
which would lead to a decrease in dissolution rate and thus a critical diversion from the 
intended effect [Van den Mooter et al. 2006].  
It seems clear that solid dispersions often have a vulnerability to storage conditions, 
partly due to the hygroscopicity of many hydrophilic polymers. Thus, it is important to 
thoroughly test the influence of storage conditions on each formulation and develop a 
set of guidelines for packaging, handling and storage of these products, both in order to 
optimize the shelf life and the performance of the products.  
2.5.2 Dissolution and in vivo correlation of solid dispersions 
Although solid dispersions have proven effective in increasing the bioavailability of 
poorly soluble drugs the mechanisms governing the dissolution are still not completely 
understood. There are many parameters dictating the dissolution mechanisms of the 
drug and this also largely depends on the carriers materials used in the formulation. The 
release of drug has been suggested either being controlled via disintegration of the 
polymer or via drug diffusion [Craig 2002]. For solid dispersions composed of a water-
soluble polymer the dissolution mechanism of the system and dissolution rate of the 
drug has been shown to be dependent on the drug loading. At high drug loadings the 
polymer dissolved quicker than the drug leaving behind a drug rich phase, possibly in 
an amorphous form, which regulated the dissolution rate of the remaining solid. At low 
drug loadings the drug dissolution rate was higher and the polymer and drug essentially 
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dissolved simultaneously making the drug dissolution dependent on polymer 
disintegration [Simonelli et al. 1969]. Drug dissolution has in such drug loading 
dependent manner been suggested described via the following equation [Alonzo et al. 
2011]: 
   
     
  
          (Equation 2.6) 
where GD is the dissolution rate of the drug, GC is the dissolution rate of the carrier, CD 
is the component concentration of drug and CC is the component concentration of the 
carrier. Further studies have shown that the physical stability and the crystallization 
behaviour upon contact with dissolution media and the precipitation kinetics of the 
supersaturated drug are both important factors for the drug concentration profile 
[Alonzo et al. 2010]. Often studies on dissolution mechanism have focused on the drug-
carrier interactions and the composition of the solid dispersions and less on the 
supersaturation properties. Yet, much indicates that the ability of the drug to remain 
supersaturated for longer times under non-sink conditions via properties of the drug or 
precipitation inhibition properties of the carriers may provide considerable 
improvements in the in vivo performance of the formulation [Curatolo et al. 2009].    
Solid dispersions have traditionally been thought to increase the release of poorly 
soluble drugs in vitro and in vivo, compared with conventional dosage forms, resulting 
in enhanced bioavailability. Although enhanced in vitro dissolution rates and enhanced 
absorption rates have been demonstrated and in many studies there is often not a 
straightforward correlation between the in vitro and in vivo data [Craig 2002]. Different 
studies are used to try to predict the in vivo performance of these solid dispersions but 
this can often be a challenging task given the complexity of the GI tract biology and the 
variation between species and even among humans. By examining the in vitro / in vivo 
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correlation of a formulation it is observed whether dissolution of the drug is the rate 
limiting step and hence the formulation may be optimized to allow more precise dosing 
or a better pharmacokinetic profile. In order to assess the in vitro / in vivo correlation of 
drug formulations the Cmax (or AUC0 
 
infinity) and the drug dissolution (% dissolved) 
values are typically plotted in an XY-plot and a linear regression is performed. In this 
case a linear relationship between the pharmacokinetic parameters and the dissolution 
profile represents a good correlation [Zerrouk et al. 2001]. 
Emara et al [Emara et al. 2002] prepared solid dispersions of PEG6000 and Nifedipine 
using the fusion method, solvent evaporation and freeze drying and compared the in 
vitro and in vivo behaviour obtained with these three preparation methods. They found 
that the samples prepared with solvent evaporation and freeze drying had faster 
dissolution compared with those prepared with fusion method. However, the in vivo 
data was contradictory to the dissolution data indicating higher bioavailability for the 
samples prepared with the fusion method despite a good correlation generally between 
the dissolved and absorbed amount of drug. Good in vitro / in vivo correlation was 
observed for extended release formulations in dogs by Tanaka et al [Tanaka et al. 2006] 
One of the major considerations for oral formulations is the effect of the gastro-
intestinal environment on the drug release, due to varying milieus such as pH and 
variations due to food intake. These factors and often have a major impact on the drug 
dissolution demonstrated by the divergence in the in vitro / in vivo correlation 
[Dokoumetzidis and Macheras 2006]. Variation between the subjects studied also lead 
to significant divergence. Better understanding on the mechanisms of the GI tract as 
well as its influence on drug is believed to provide better prediction of the in vivo 
performance of drug formulations. 
Chapter 2. Literature Review 
55 
 
2.5.3 Molecular dispersions, homogeneity and drug distribution  
As previously mentioned solid dispersions in which the drug is molecularly dispersed in 
the carrier matrix generally provide the best barrier against crystallization and are thus 
desirable to obtain. In addition to the form of dispersion it is also important to have 
some knowledge on the homogeneity of the dispersion and whether there are some areas 
or local phases with a higher drug concentration. Finally, it is important to know more 
about the spatial distribution of drug in cases where the drug is not present as a 
homogeneous, molecular distribution as this would most likely influence the release 
kinetics and the physical stability [Urbanetz and Lippold 2005].  
There are several analytical methods to determine the characteristics of the drug 
dispersion and these are often used in combination to describe the molecular properties 
of the solid dispersion.  
Nuclear magnetic resonance (NMR) has been used to study polymer mobility and drug 
migration in solid dispersion formulations. Both 2D and 3D images can be obtained 
with NMR, yet with the current spatial resolution available the technique seems more 
suitable for looking at the microstructure of tablets [Dahlberg et al. 2010]. Dahlberg et 
al, however, used the technique to study the drug diffusion process from solid 
dispersions.  
X-ray photoelectron spectroscopy (XPS) has been used in several studies to examine the 
chemical composition of the outer surface layer (~5 nm) of solid dispersions and can 
give an estimate of the concentration of drug in the measured area. XPS has been used 
to study the surface drug concentration in order to examine the possible tendency for 
drug molecules to migrate towards the surface of spray dried powders [Dahlberg et al. 
2008].  
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Time-of-flight secondary ion mass spectroscopy (ToF-SIMS) has also been used to 
investigate the surface chemical composition of solid dispersions but with this method a 
thickness of approximately 1-2nm is examined [Scoutaris et al. 2012]. Scoutaris et al 
used this technique to study the chemical composition of solid dispersion particle 
surfaces and prepared 2D images by generating a chemical map from the ToF-SIMS 
data. In this way it was demonstrated that the drug was homogeneously distributed on 
the particle surface. 
Confocal Raman spectroscopy has been used to determine the physical state of the drug 
in a solid dispersion and it has in some cases also been used to examine the 
homogeneity of the drug distribution [Breitenbach et al. 1999]. In a study by 
Breitenbach et al. an area of 45 × 25 µm
2
 was studied via 200 measurements in the area 
using Confocal Raman spectroscopy. They demonstrated that the homogeneity of the 
sample could be mapped relatively well with a resolution of 2 µm
3
 using a scale for 
drug concentration obtained by setting up a correlation with HPLC measurements 
[Breitenbach et al. 1999]. Although this may be useful for detecting the presence of 
larger drug aggregates or to determine the general homogeneity of melt extrudates or 
other larger samples, the resolution is not sufficient to look at the drug distribution in 
small microparticles prepared with spray drying and electrospraying.  
Fourier Transformed Infrared (FTIR) imaging uses an array of infrared detectors to 
gain information on spatial differences in the concentration of compounds and 
interactions between them. FTIR imaging  has also been used to examine the 
distribution of drugs in solid dispersions [Chan and Kazarian 2004]. In a study by Chan 
and Kazarian a detector setup with a pixel size of around 60 µm was used to study a 
Nifidipine/PEG formulation with 5-20% drug loading as the formulation came into 
contact with water. They observed a relatively homogeneous drug distribution before 
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dissolution and could locate the formation of drug crystals in the matrix as the PEG 
progressively dissolved, and this observation was more prominent for higher drug 
loading.  
Phase separation between the drug and carrier material is an event that could occur in 
solid dispersions. Such phase separation has been studied using methods including 
micro-thermal analysis (µ-TA), which is essentially an AFM technique where the 
cantilever is substituted with a Wollaston wire thermistor. With this technique the 
thermal conductivity in different areas of the sample is mapped in the microscopic scale 
[Six et al. 2003]. In solid dispersion extrudate samples it was demonstrated that phase 
separation took place between the drug, Itraconazole, and polymer, Eudragit. When 
studying phase separation it is interesting to investigate the influence of different 
solvent systems on the drug distribution in the polymer matrix. For binary solvent 
systems phase separation may occur when the solutes have different degrees of 
solubility in the two solvent phases.  
It seems that by combining two or more techniques it is possible to gain some 
understanding of the drug distribution and possible phase separations and crystallization 
processes in amorphous solid dispersions. Currently, one of the better methods to obtain 
information on the radial drug distribution in amorphous solid dispersions would be 
XPS or ToF-SIMS where the exact drug concentration within a specific surface area can 
be determined. There does not seem to be any methods for specifically measuring the 
drug concentration or molecular drug distribution in the deeper areas of particles. It 
should, however, be possible to make cross sections through particles using FIB/SEM 
and subsequently use Energy Dispersive X-ray (EDX) spectroscopy to obtain a 
spectrum of the elements present in the uncovered area of the particle, which may be 
quantified using Monte Carlo simulations. Yet, also simpler or less time consuming 
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methods may appear in the near future. Techniques such as Confocal Raman 
spectroscopy and FTIR imaging may become more useful for studying the general 
homogeneity of solid dispersion samples and for visually detecting phase separation and 
presence of crystals in the samples. NMR may also be used for such purposes and can 
additionally provide 3D images of the samples, but it seems that the spatial resolution is 
currently still too low for this type of application.  
It is well known for liquid atomization processes that solvent selection has an influence 
on the particle characteristics and it has further been reported that the properties of the 
solvent have an influence on the drug distribution in the prepared particles [Vehring et 
al. 2007]. Based on a binary solid dispersion system of drug and polymer the 
characteristics and drug release kinetics of solid dispersions prepared with spray drying 
have previously been correlated to solvents and mixture of solvents used to prepare the 
solid dispersions [Rizi 2011]. The drug and polymer component of a solid dispersion 
can be very different in both size and solubility in a given solvent and may thus result in 
a non-homogenous dispersion and even phase separation during solvent evaporation and 
solute diffusion.  
Properties of the solvent that may influence the drug distribution include in particular 
volatility and solvent power for dissolving the solute components as these properties 
govern the mobility of the solutes in the solvent and the time in which diffusion of 
solutes is allowed. Further, by using a mixture of solvents the solute components may 
have different solubility in each solvent resulting in additional differences in the 
architecture of the dispersion. There have even been cases where an improvement in in 
vitro performance was observed for solid dispersions prepared with a solvent mixture 
compared with single solvents [Paudel and Van den Mooter 2012]. Although, there is 
evidence for the importance of solvents and solvent mixtures on the solid state 
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properties of solid dispersions, there is still no detailed account on the exact impact of 
solvent chemistry on the phase behaviour and resulting drug release kinetics of solid 
dispersions. 
2.6 Applications of spray drying and electrospraying  
Spray drying has been widely applied for preparing solid dispersions and remains one of 
the main methods for preparing solid dispersions. A wide range of drugs and carriers 
may be used with spray drying due to the relatively mild processing conditions, 
including thermolabile materials and polymers with a high melting point. Also with 
electrospraying a wide range of drugs and carriers can be used, although the technique 
is much less explored compared with spray drying, especially for solid dispersions 
purposes. In the following, different formulation strategies currently used for solid 
dispersions are introduced and examples of applications, where solid dispersions are 
produced using spray drying and electrospraying, are provided. The formulation 
approaches for spray drying are relatively similar to those that can be used for 
electrospraying applications. 
2.6.1 Formulation strategies for solid dispersions 
A variety of carrier–drug combinations has been studied using spray drying. The 
carriers have mainly been polymeric and generally have been selected based on their 
physicochemical properties, including their Tg, solubility properties, ionization constant, 
hydrogen bond forming profile as well as suitability with a specific drug compound 
[Janssens and Van den Mooter 2009]. Most polymers used are hydrophilic, increase the 
drug dissolution rate and act as crystallization inhibitors, due to their anti-plasticing 
effect.  
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In order to spray dry a solid dispersion both the drug and the carrier must be soluble in 
the common solvent used. Since poorly soluble drugs do not readily dissolve in water at 
useful concentrations, an organic solvent or a mixture of solvents are typically used for 
solvent based spray dried solid dispersions [Bee 2010]. There are however applications 
where a melt is spray dried to form a dry solid dispersion powder without the use of 
solvents such as with spray cooling/spray congealing [Serajuddin 1999]. In any case it 
is important that the drug and carrier components are dissolved or very well mixed since 
suspensions tend to give rise to phase separation and instability of the formulation. 
Binary solid dispersions are still commonly used, yet ternary or higher degree mixtures 
combining solubilizers, fillers, binders, stabilizers or disintegrants are also becoming 
more common as they often provide further improvement of the dissolution rate and 
better stability.  
Polyvinylpyrrolidone (PVP) is one of the most studied polymers for solid dispersions 
and continues to be popular for binary and multi-component systems. Some grades of 
PVP have a high Tg above 120 ºC and thus act as a good anti-plasticizers lowering 
molecular mobility. PVP is soluble in water as well as several organic solvents 
including ethanol and acetone which makes it is easy to use for spray drying and 
possibly electrospraying applications [Rowe 2009]. A notable concern of using PVP is 
the relatively high hygroscopicity, which lowers the physical stability of the 
formulations at elevated humidity conditions, although appropriate storage conditions 
may help prevent drug re-crystallization [Patterson et al. 2007].  
Polyethylene glycol (PEG) is a widely studied polymer for pharmaceutical applications 
in general but also for solid dispersions. These polymers range from being liquid to 
solid at room temperature depending on their molecular weight. PEG is typically 
semicrystalline with a relatively low Tg 58-63 º C for 3400-20000 MW [Craig 1995]. It 
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is soluble in water as well as many organic solvents which makes it simple to prepare 
solid dispersions using spray drying and possibly electrospraying [Fouad et al. 2011]. 
Solid dispersions formed with PEG generally have the drug molecules dispersed in the 
polymer in an amorphous form or partly crystalline state within the amorphous and 
crystalline sections of the polymer [Weuts et al. 2005, Zhu et al. 2012]. Although, PEG-
based solid dispersions result in an increase in dissolution rate, unless combined with 
other excipients they typically have poor physical stability and result in recrystallization 
of the drug at elevated temperature or humidity [Weuts et al. 2005]. 
Polymethacrylates are synthetic polymers mainly marketed by Evonik under the name 
Eudragit® and come in a variety grades and monomer ratios. These polymers can show 
pH dependent solubility and are thus often used as enteric coating materials for tablets 
and other dosage forms. They are soluble in several organic solvents making them 
suitable for processing via spray drying and possibly also electrospraying [Six et al. 
2004]. Polymethacrylates carry hydrogen bond accepting groups and are therefore 
suitable for drugs with hydrogen bond donating drugs. In addition to hydrogen bonds 
cationic methacrylates provide ionic interactions which are believed to further improve 
the physical stability of the solid dispersions [Bee 2010]. 
Cellulose derivatives include hydroxypropyl methyl cellulose (HPMC), hydroxypropyl 
cellulose (HPC), HPMC-phthalate (HPMC-P) and HPMC-acetyl-succinate (HPMC-
AS). This group of polymers has become the most used polymers for preparing solid 
dispersions. HPMC is a water-soluble polymer and is insoluble in most commonly used 
organic solvents and necessitates hydroalcoholic solvents or a mixture of methanol and 
DCM depending on the polymer grade [Bee 2010]. It has a high Tg above 170º C but its 
hygroscopicity makes the solid dispersions sensitive to humidity [Rowe 2009]. 
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However, it has been reported to provide improvement in dissolution rate resulting from 
increased wettability and its anti-plasticizing effect [Boghra et al. 2011].  
HPMCP and HPMC-AS are both polymers with pH dependent solubility and are 
typically used as enteric coating materials for tablets and granules because they are 
insoluble in gastric fluid but dissolve in the intestine at a pH above 5-6.5 depending on 
the polymer grade [Bee 2010]. HPMC-AS is soluble in several organic solvents, which 
makes it suitable for spray drying while HPMCP is mainly soluble in mixture of 
solvents such as DCM and acetone and are thus slightly more difficult to use for spray 
drying applications. Both polymers have a high Tg above 120 ºC and are relatively 
stable during storage [Rowe 2009]. In a study by Friesen et al solid dispersions of 
HPMC-AS were prepared with 9 different poorly soluble drug compounds using spray 
drying and it was observed that the drugs remained amorphous during a storage time of 
more than two years [Friesen et al. 2008]. 
In addition to their dissolution enhancing and stabilizing properties, the cellulose 
derivates and in particular HPMC and HPMC-AS are known as effective precipitation 
inhibitors prolonging the supersaturation of drugs for many hours after dissolution (see 
Figure 2.8). The pronounced effect observed with HPMC-AS is explained by the 
formation of a reservoir of nanosized amorphous drug-polymer aggregates resulting 
from ionized state and from hydrophobic interactions [Curatolo et al. 2009]. These 
nanosized aggregates result in a drug precipitation process resembling a parachute 
landing where the drug molecules precipitate slowly from the supersaturated state. In 
comparison, the conventional solid dispersion systems using water-soluble polymers 
typically result in a drug precipitation process resembling the behaviour of a spring with 
the drug molecules rapidly precipitating from the supersaturated state (see Figure 2.8).  
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For more information on precipitation inhibition the reader is referred to the review by 
Warren et al [Warren et al. 2010]. 
 
Figure 2.8 Representation of supersaturation in different systems, aqueous drug 
concentration versus time profile. 1: dissolution of pure crystalline drug, 2: dissolution 
of amorphous solid dispersion and 3: dissolution of amorphous solid dispersion under 
presence of precipitation inhibitor(s) (from [Warren et al. 2010]).  
The combination of more than two excipients is also widely applied for preparing solid 
dispersions in order to improve the stability, dissolution rate, powder properties etc. of 
the dispersions [Saharan et al. 2009]. Surfactants are commonly added to increase 
wettability and solubility of the formulation and include poloxamer, a co-polymer of 
poly(ethylene oxide) and poly(propylene oxide), sodium lauryl sulphate and poly vinyl 
alcohol. Acids such as maleic, citric acid and tartaric acid have been used for pH 
modification of the systems and to allow better solubility [Paudel et al.]. Yet, the 
addition of excipients other than the main carrier material may in turn make the 
formulation more complex and result in destabilization of the dispersion or result in 
unexpected dissolution results.       
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2.6.2 Particle-based solid dispersions using spray drying  
There are many examples of applications where spray drying has been used to prepare 
particle-based solid dispersions using a poorly soluble drug together with one or another 
combination of the carrier materials described above. Generally, a powder of 
microparticles is formed and for hydrophilic carriers the results show increased 
dissolution rate of the drug compared with the spray dried drug alone and physical 
mixture of the drug and carrier. For extended release application diffusion controlled 
release of the drug is observed.  
Griseofulvin was spray dried with Poloxamer 407 using a laboratory scale spray drier. It 
was demonstrated that both solubility and bioavailability increased compared with a 
control formulation of griseofulvin alone [Wong et al. 2006]. Solid dispersions with 
ibuprofen, HPMC and poloxamer were prepared and resulted in increased dissolution 
rate and bioavailability compared with crystalline ibuprofen [Park et al. 2009]. PVP has 
been co-spraydried with many different API‟s to form solid dispersion and generally 
results in good dissolution and bioavailability. PVP is typically present in an amorphous 
form in the solid dispersion and reduces the mobility of API in the polymer matrix 
reducing crystallization of drug post drying [Paradkar et al. 2004].  
A comparative study by Qian et al of solid dispersions of polyvinylpyrrolidone-vinyl 
acetate (PVP-VA, a PVP variant with less moisture absorption) and a poorly soluble 
API with solid dispersions of HPMC-AS and the same API showed significantly greater 
bioavailability with HPMC-AS than with PVP-VA. HPMC-AS showed slow dissolution 
with long supersaturation of the drug while the fast dissolution with PVP-VA resulted in 
drug recrystallization before dissolution was completed thus affecting in vivo 
performance [Qian et al. 2012]. Friesen et al have prepared solid dispersions of HPMC-
AS with various poorly soluble drugs and have reported high dissolution rates compared 
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with the crystalline form of the drug and high concentrations of the drug were observed 
for long time periods due to the precipitation inhibiting effect of HPMC-AS. Further, 
significant enhancement in oral absorption and hence enhanced bioavailability of the 
drugs was observed and good stability was obtained with shelf lives of more than 2 
years [Friesen et al. 2008]. Examples of spray dried particles are shown in Figure 2.9.  
     
Figure 2.9 Example of spray dried particulate solid dispersions prepared using 
Netilmicin sulphate (A) [Vehring et al. 2007] and HPMC-AS with AMG 517 (B) 
[Kennedy et al. 2008].  
Further, the influence of process parameters on the prepared solid dispersions and their 
solubility and physical stability have also been studied by a few researchers. Kojima et 
al used a Büchi B-290 laboratory scale spray drier to prepare solid dispersions from 
HPMC together with the drugs nilvadipine and nifedilipine at a constant drug:polymer 
ratio while altering the nitrogen flow rate, feed rate and solute concentration [Kojima et 
al.]. They showed that the dissolution profiles as well as the glass transition temperature 
of the systems changed as a function of these parameters and their results indicated that 
although the particles were similar in size and morphology, microstructural phase 
separation could occur.  
A 
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The effect of the process parameters are, however, not easy to isolate and use for 
controlling particle characteristics and dissolution behaviour due to the numerous 
interactions between the parameters and their dependence on the individual 
formulations parameters. In such a scenario it may be more advantageous to utilize 
multivariate data analysis to evaluate the influence of a collective set of parameters on 
specific characteristics. With such strategies one could gain more comprehensive 
understanding on the interaction between process parameters and for instance how to 
better control and optimize particle and formulation characteristics for better 
performance [Baldinger et al. 2012, Dobry et al. 2009]. High throughput screening 
studies can also help set up a more generalized model for influence of process variables 
and control of characteristics [Gibson et al. 2011].   
2.6.3 Control of particle characteristics with spray drying 
There are numerous reports on the application of spray drying for producing solid 
dispersions but only few reports focus on the resulting particle characteristics and even 
less focus on controlling particle characteristics to improve formulation properties. Yet, 
spray drying is not only a suitable process for industrial scale production of solid 
dispersion formulations but also for tailoring microparticles with desirable attributes. 
Studies on such particle engineering approach is in its early phase but has demonstrated 
its importance in several studies [Chow et al. 2007, Kennedy et al. 2008].  
The control of particle morphology using spray drying has been studied by different 
researchers and several different morphologies have been demonstrated and presented in 
the following reviews [Nandiyanto and Okuyama 2011, Vehring 2008]. Generally 
spherical morphologies are obtained as they are energetically most favourable during 
drying of the droplet and have maximum structural stability. The distinction of 
producing solid or hollow spherical particles depends on the mass and heat transfer 
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mechanisms during drying. It is a balance between solute diffusion and evaporation rate 
and can be controlled using these parameters [Okuyama et al. 2006]. Also, different 
particle shapes such as doughnut shape and disc shape have been obtained via 
controlled collapsing of the particles during formation and may be tailored further 
through understanding of their structural stability [Iskandar et al. 2003].  
Particles can also be made from precursor nanoparticles where these are assembled 
during the spray drying process to form relatively complex microstructures with the 
nanoparticles as their building blocks [Tsapis et al. 2002]. The porosity of such 
structures has been controlled by preparing composite particles consisting of different 
phases or materials and by later removing one of the materials to obtain a controlled 
pore size [Nandiyanto and Okuyama 2011].  
Studies have demonstrated the control of several fundamental characteristics such as 
particle size, to some part morphology, surface topology and porosity. Currently, much 
of this is based on processing of a single material or at the most two materials. When 
two or more materials are spray dried together the interactions and mechanisms become 
more complex. For solid dispersions in which there are at least two components it is 
important to understand the phase structure and drug distribution within the matrix. 
There are currently no studies explaining in detail the influence of process variables on 
drug distribution within the matrix, however, some studied have reported varying 
degrees of drug deposition onto the particle surface [Dahlberg et al. 2008].  
2.6.4 Electrosprayed solid dispersions 
Electrospraying is still a relatively novel method for pharmaceutical applications and 
currently not many reports exist on the preparation of solid dispersions using these 
methods. The few existing reports are presented and discussed in the following. 
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In a majority of electrospraying studies organic solvents are used due to their often 
faster evaporation rate and lower surface tension compared with aqueous solvents. Also, 
many studies make use of particle collection in an aqueous phase or another liquid 
phase thus necessitating solidification before collection. Due to such considerations 
materials used for electrospraying have typically been non-water soluble polymers such 
as PLGA, poly-lactic acid (PLA), polycaprolactone (PCL), although there are some 
examples where water soluble polymers have been used. Natural polymers such as 
elastine-like peptide (ELP) [Wu et al. 2008] and chitosan [Arya et al. 2009] have been 
used. The existing electrosprayed solid dispersions have not necessarily been prepared 
with considerations towards enhancing the physical stability and dissolution rate, but 
instead the studies have mainly focused on the release behaviour and particle 
characteristics.   
The solvents used for electrospraying are mainly organic solvents with acetone [Xu and 
Hanna 2006], dichloromethane [Ranganath et al. 2009], ethanol [Valo et al. 2009], 
chloroform [Hong et al. 2008], N,N-dimethylformamide, dimethyl acetamide [Enayati 
et al. 2010] and methanol [Enayati et al. 2012] being most frequently reported in 
literature. Important consideration for selecting the appropriate solvent include 
sufficient volatility for drying of droplets as well as their electric conductivity, surface 
tension and viscosity being important in allowing formation of a cone-jet and suitable 
resulting characteristics of the particles.  
Pure drug particles have been prepared without excipients using the drugs 
beclomethasone dipropionate and methylparahydroxybenzoate, and led to particles with 
a narrow size distribution, but stability was not tested although they are presumably not 
stable [Ijsebaert et al. 2001]. For solid dispersions Arya et al [Arya et al. 2009] used 
electrospraying to prepare chitosan particles loaded with ampicillin and obtained 
Chapter 2. Literature Review 
69 
 
particles around 520 nm that released most of their payload within 20 hours in 
phosphate buffer (pH 7.4). Hong et al [Hong et al. 2008] prepared solid dispersions of 
PLGA with rifampicin and produced particles around 3-7 µm and further showed 40 % 
drug release in phosphate buffer after 10 days, a relatively slow release rate.   
In a study by Yu et al [Yu et al. 2011] solid dispersions were prepared with tristearin, a 
lipophilic excipient and the drug naproxen and resulted in particles with a mean size of 
376 nm and a narrow size distribution. A sustained release was achieved here, lasting 
over 24 hours. PLGA has also been used to prepare particles loaded with the drugs 
doxorubicin [Almería et al. 2011] and paclitaxel (see Figure 2.10) resulting in 65-73 % 
drug release over 50 hours and 60 % drug release in 30 days, respectively, when 
dissolution studies were performed in phosphate buffer [Kumar Naraharisetti et al. 
2007]. Xie et al studied PLA/PLGA and PLA for preparing particles loaded with 
cisplatin and particles around 5µm were obtained. In this study a burst release as high as 
40-70 % was observed in the first 15min. Further, a surface drug loading of < 25 % of 
drug was measured on the particle surface [Xie et al. 2008]. Solid dispersions of 
budesonide with polycaprolactone were prepared and resulted in small particles around 
100-200 nm and a drug release taking place within 10 days [Midhun 2011]. Another 
study using polycaprolactone with paclitaxel resulted in particles of 4-32 µm and a drug 
release over several days in phosphate buffer [Ding et al. 2005]. Moreover, 
poly(amidoamines)-cholesterol particles were prepared with Tamoxifen and indicated 
that the drug was amorphous and resulted in 26 % release in 6 hours in phosphate buffer 
[Cavalli et al. 2011]. Currently, there is very little in vivo data available in literature 
using electrospraying even for applications other than solid dispersions and possible 
improvements in bioavailability from electrosprayed solid dispersions have not been 
investigated. 
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Figure 2.10 Electrosprayed particles prepared with PCL (A) and PLGA (B) loaded with 
paclitaxel indicating different morphology [Xie et al. 2006b]. 
Application with electrospinning 
There have also been some studies where polymers were electrospun with poorly 
soluble drugs to form solid dispersions with the purpose of achieving immediate release. 
Verreck et al [Verreck et al. 2003] prepared electrospun fibres containing the poorly 
soluble drug itraconazole in HPMC 2910. The electrospun fibre mesh was milled 
subsequently to obtain fibre fragments of approx. 27 µm and with a diameter of 0.5-3 
µm and these fibres were compared with Melt Extruded samples prepared using a co-
rotating screw extruder. Dissolution studies performed in 0.1N HCl showed complete 
drug release after 240 min of dissolution. The study further demonstrated using thermal 
analysis that itraconazole was amorphous with some residual crystallinity possibly 
resulting from the milling process. Studies by Yu et al reported the preparation of 
electrospun solid dispersions from PVP K30 with the drugs ibuprofen [Yu et al. 2009], 
ketoprofen [Yu et al. 2010a], ferulic acid [Yu et al. 2010c] as well as PVP K90 with 
acetaminophen [Yu et al. 2010b] in ethanol (see Figure 2.11). The studies using 
ibuprofen indicated that the drug was in an amorphous form, observed via DSC and 
XRPD. Further, FTIR data suggested interaction between the polymer and the drug 
Chapter 2. Literature Review 
71 
 
through intermolecular hydrogen bonding. Dissolution studies performed in water 
showed that all drug was dissolved in less than 1 min.   
   
Figure 2.11 High and low magnification SEM images of electrospun solid dispersion 
fibres composed from PVP K30 and ibuprofen (from [Yu et al. 2009].  
Electrospinning requires less solvent per gram dry weight of fibre/particle produced 
compared with both electrospraying and spray drying, which makes the technique more 
cost-effective, especially when using organic solvents. However, electrospraying 
provides more possibility for tailoring the characteristics of the product, which may be 
of special interest for particle engineering purposes and for optimizing the drug release 
behaviour for sustained release purposes. 
2.6.5 Preparation of the final dosage form  
Particle-based solid dispersion formulations are attractive as they may provide enhanced 
performance, but they may be difficult to process into a useful dosage forms. 
Downstream post processing may disrupt or destroy the beneficial characteristics of the 
particles via mechanical or thermal stress. This could prevent the re-dispersion of the 
particles and thus alter both the release kinetics of the drug and the physical stability of 
the formulation making it less desirable than otherwise expected. 
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Compression and tableting 
The development of dosage forms from solid dispersion systems has not been widely 
studied but nevertheless is an important aspect of bringing more solid dispersion 
formulations onto the market. Processing steps that take place after formation of the 
actual solid dispersion may have an influence on several properties of the formulation, 
including the structure of the dispersion, physical stability and the dissolution kinetics.    
There are many ways in which solid dosage forms can be produced from particle-based 
solid dispersions including granulation or compression and later tableting or capsule 
filling. However, for particle-based solid dispersions such as those prepared with spray 
drying or electrospraying it is desirable to retain the engineered particle attributes which 
may be damaged during compression or granulation and compaction which are 
necessary for making tablets. Thus, these particles are more suitable for gentle methods 
such as capsule filling, where the particles would be exposed to mechanical stresses.  
Several studies have reported on the tableting behaviour of the spray dried powders, yet 
such studies seem to be conducted more in industry and results are thus not as widely 
available. Moretti et al showed that microparticles in the size range of 5-10 µm formed 
with HPMCP, cellulose acetate butyrate and Ketoprofen using spray drying could be 
loaded into hard gelatin capsules or compressed into tablets via direct compression 
together with maltose or HPMC. They did not report any significant changes to the 
particle morphology as a consequence of tablet compression or capsule filling [Moretti 
et al. 2001]. It has also been reported in other studies that microparticles could be 
compressed into tablets and remain intact without merging with each other or rupturing 
[Soppimath et al. 2001, Xu et al. 2008]. Although the morphology of the particles may 
not have changed significantly the compression process could still have an influence on 
the properties of the solid dispersion and the physical form of the drug dispersed. 
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Compression of the particle could for instance lead to polymer-drug de-mixing at the 
microscopic level, making subsequent relaxation processes more probable [Ayenew et 
al 2012].  
For now it appears that the compression of particles can be performed to produce tablets 
from the particle formulations without severe concerns. Yet, for particles engineered 
with fine surface attributes this may different. The post-processing of particle powders 
should be studied more carefully, to make sure that particles can be re-dispersed into 
their original form with and without the use of dispersing agents. It is especially 
important that such re-dispersion can take place in vivo to provide the intended purposes 
of the particles. 
One method of making tableting available for these particle-based solid dispersions 
techniques is to combine the atomization process with a fluidized bed coating system in 
which the solid dispersion is directly sprayed onto the granular surface of excipients 
such as sugars so that the formulation is immediately ready for tableting immediately 
after, and hence even less damage may be caused on the particles [Beten et al. 1995]. 
This has both been done with organic solvents and without organic solvent where a hot 
melt process was used [Kennedy and Niebergall 1996]. 
A recent study by Leane et al 2012 [Leane et al.] has looked into the effect of tableting 
and coating processes and subsequent storage of solid dispersions prepared from PVP 
K-30, SLS and ibipinabant using spray drying. Tablets were prepared using either 
microcrystalline cellulose or mannitol. The study demonstrated that the physical 
stability and release profile are dependent on the filler and coating materials used.  
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Scale-up of the system 
Often processing techniques are not feasible for commercial scale production and may 
thus fail in their translation into industrial application. Indeed there are numerous cases 
where a technology could not be further developed due to too high costs associated with 
production. Spray drying has long been known as a commercially viable technology and 
is used to produce pharmaceuticals as well as other products in an industrial scale [Cal 
and Sollohub 2010]. Thus, it is generally not of concern to scale-up the particle-based 
solid dispersions with spray drying. 
The situation is different with electrospraying which is still mainly used on an 
experimental level with custom built setups being most common. The most well-known 
application of the electrospraying principle is as a sub-process for mass spectroscopy, 
where it is used to ionize fragments of molecules [Takáts et al. 2004]. There are only 
few examples of commercial applications using electrospraying for particle production, 
which are presented on the websites of companies offering such devices (e.g. 
yflow.com), however not on a commercial scale. There have been plenty of efforts in 
scaling-up the electrospraying process, which has become somewhat notorious for its 
low output, by spraying concurrently from multiple closely aligned nozzles or 
holes/slits [Bocanegra et al. 2005, Deng et al. 2006]. Multiple configurations have been 
developed for such scale-up attempts (see Figure 2.12), and it has been shown that 
neighbouring jets have an electrical shielding effect, where the electrical potential 
required to stabilize the jet increases as the distance between the jets is reduced [Regele 
et al. 2002]. It is not clear yet to which extent the output can be improved with such 
multijet models and whether such setups provide stable, continuous jetting and particle 
production.  
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Figure 2.12 Multiple jet electrospraying setup built using a nozzle array system (A) 
(adapted from [Deng et al. 2006]) and a multi-hole injector (B) (adapted from 
[Bocanegra et al. 2005]). 
2.7  Drug release models  
Drug release is a process which involves drug molecules leaving a carrier system and 
can be described in many ways including the time and mode in which the release takes 
place. Drug release studies are recognized as an important element in drug development 
and assessment of formulation performance [Washington 1990]. Several models have 
been developed to describe the drug dissolution from immediate and extended release 
formulations as well as other types of release such as modified, delayed and pulsatile 
release [Edlund and Albertsson 2002]. Most of these are based on dissolution of drug as 
a function of time and the curves obtained from such drug release is quantitatively 
assessed via mathematical interpretation. Here the dissolution curves are mathematically 
translated as a function of different pharmaceutical parameters or equations that are 
obtained from theoretical interpretation of the process. The drug release models are 
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often simple and are typically used to obtain approximate curves used for curve fitting 
of experimental data [Costa and Sousa Lobo 2001]. 
The simplest release model is for the zero order release which is based under the 
assumptions that drug release takes place slowly from a non-disintegrating structure 
with no change in area and without drug release achieving en equilibrium. There would 
then be a linear relationship between the amount of drug released and the time taken. 
Such zero order release can be used to describe several pharmaceutical systems such as 
matrix based delivery systems and transdermal release devices and this is often a 
desirable behaviour since there is a release at a constant rate [Ranade 1991]. 
Drug release from matrix-based systems 
Drug release from a delivery system comprised of a matrix may take place via different 
mechanisms including diffusion and erosion depending on the solubility of the drug and 
the matrix material in the release medium. Drug release from systems were the external 
geometry or matrix structure remains unchanged during drug release would take place 
via diffusion [Washington 1990]. This is the case for non-disintegrating tablets as well 
as solid dispersions prepared with a non water-soluble matrix materials. The models are 
mainly been based on the principles of dissolution and specifically the dissolution at the 
solid-liquid interface of the drug-carrier system and the release medium [Edlund and 
Albertsson 2002]. For non-water soluble matrix systems the most applied drug release 
model is the Higuchi model and was developed by Higuchi et al as the first model to 
mathematically describe the release of drug from an insoluble matrix based on Fick‟s 
law of diffusion [Higuchi 1963]. Higuchi et al showed in several reports that diffusion 
mediated release from spherical pellets could simply be modelled as a function of the 
square root of time (see Equation 2.7), 
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          (Equation 2.7) 
where Qt is the cumulative drug released as a function of time t, D is the diffusion 
coefficient, CD is the solubility of the drug in the release medium τ is the porosity and 
Cm is the content of drug per unit of volume of matrix.  
       
    (Equation 2.8) 
A simplified model of the Higuchi model is presented in Equation 2.8. Again here Qt is 
the cumulative drug released as a function of time t and kH is the Higuchi release 
constant. A plot of a release curve using the Higuchi model has the percentage of drug 
released in the y-axis and the square room of time in the x-axis. When the drug release 
profile of a drug-carrier sample follows the Higuchi model the release profile should 
indicate a linear curve on the plot. In this case the Higuchi release constant represents 
the slope of a plotted curve and is tied to the parameters presented in Equation 2.7 
[Simonelli et al. 1969]. It is most common to use a linear regression to fit the release 
curve to the drug release model. Yet, the use of non-linear regression such as a 
polynomial function is also seen used to perform curve fitting between the empirical 
data and the model. The coefficient of determination, R
2
, is typically used to assess the 
fit of the model or modified model [Lemaire et al. 2003]. 
The release of drug from drug-carrier systems often involve several mechanisms and 
multiple steps influenced by different physicochemical characteristics and it is therefore 
difficult to obtain a mathematical model that accurately describes the release 
mechanism [Costa and Sousa Lobo 2001]. The Higuchi model is often suitable for 
describing matrix-based polymer-drug systems while the zero order model can be useful 
for describing coated formulations. Further there are other models to describe other 
types of release or more specific release mechanisms [Costa and Sousa Lobo 2001].      
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Chapter 3  
Experimental Details 
 
This chapter introduces and describes the materials and experimental procedures used to 
obtain the results in this thesis. For each of the materials and procedures details of the 
supplier and product are given and the methods are explained. The first section 
comprises an overview of the materials used and explains some of the properties and 
common applications of the materials. Further, the selection criteria are explained for 
the drug compounds and polymers used. The following sections introduce and explain 
the methodology used for all preparative and analytical work. A brief theoretical 
background is also provided for most of the analytical methods used. In some cases 
similar methodology has been used with different equipment or with slight differences 
in the methods and this will be further specified in the results chapters.   
3.1 Materials 
The main materials used in this project are the polymers, drug compounds and solvents 
used to prepare the drug-loaded particles. Secondary materials such as buffer solutions 
and certain chemicals are also mentioned in this section.   
3.1.1 Polymers  
Poly(Lactic-Co-Glycolic acid) (PLGA) 
Biodegradable polymers are a class of polymers designed to degrade into non-toxic by-
products at a predetermined rate, thereby releasing their therapeutic payload for 
prolonged and even site-specific delivery. Poly(lactide-co-glycolide) (PLGA) is the 
most commonly used biodegradable polymer for drug delivery application. It is 
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aliphatic polyester (see Figure 3.1A) and is approved by the food and drug 
administration for implants and for oral and pulmonary applications. The by-products of 
PLGA, glycolic acid and lactic acid are a favourable attribute of PLGA as both of these 
acids are naturally occurring substrates in the Krebs cycle. PLGA is easy to work with, 
although only soluble in harsh solvents such as acetone and dimethyl formamide, and is 
amorphous when consisting of 25-70% glycolide:lactide ratio [Edlund and Albertsson 
2002a]. Its degradation takes place via hydrolysis and the degradation rate depends on 
the composition and properties of the PLGA, most notably the glycolide:lactide ratio 
and the molecular weight of the PLGA. The PLGA used in this study was acquired from 
Boehringer Ingelheim (Now Evonik) (Boehringer Ingelheim, Germany) (Evonik, 
Germany) and Purac (Purac Biochem, Netherlands). More specifically the following 
PLGA products were used:  
1: Resomer RG 503H from Boehringer Ingelheim was used, with a molecular weight of 
24,000-38,000 g/mol depending on the given batch (three different batches were used 
during the project due to availability) and a lactide and glycolide ratio of 50:50 (molar 
ratio) and a Tg of 44-48 ºC.  
2: Purac PLGA was used in some studies with a molecular weight of around 18,000 
g/mol. 
 
Figure 3.1 Chemical structures of PLGA and its building blocks. 
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Hypromellose Acetyl Succinate (HPMC AS) 
HPMCAS is in the family of cellulose derived polymers, a commonly used group of 
polymers for preparing solid dispersions. HPMCAS is also used for enteric coating of 
tablets, due to its pH dependent solubility in aqueous solvents. It is insoluble at low pH 
below 5.5-6.5 (depending on the polymer grade) and is thus used to prevent dissolution 
in the gastric fluid while dissolving in values of pH above 5.5-6.5, hence also in 
intestinal fluids. Moreover, HPMCAS has a special property that they act as effective 
precipitation inhibitors prolonging the supersaturation of drugs for many hours after 
dissolution (see section 2.6.1). Much indicates that this ability of the polymer to keep 
the drug in a supersaturated state under non-sink conditions by preventing precipitation 
may provide considerable improvements in the in vivo performance of formulations.  
The HPMCAS used in this study was acquired from Shin Etsu (Shin Etsu, Japan) and 
more specifically AQOAT HPMCAS-LF was used, which is a micronized low 
molecular weight grade in the HPMCAS series. HPMCAS-LF is partly soluble at a pH 
above 5.5 and has a molecular weight of approximately 18,000 g/mol [Fukasawa et al. 
2004].  
           
Figure 3.2 Chemical structure of HPMCAS (A) and chemical structure of CEL (B). 
A            B 
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3.1.2 Drug 
Celecoxib (CEL) was the active pharmaceutical ingredient (API) used in the following 
studies and was used as a model poorly water-soluble drug. CEL is a non-steroidal, anti-
inflammatory drug (NSAID) (see Figure 3.2B) or, more specifically, an inhibitor of the 
enzyme, selective cyclooxygenase-2 (COX-II), responsible for inflammations and pain. 
CEL is widely used for the treatment of osteoarthritis, rheumatoid arthritis and acute 
pain [Thakkar et al. 2004]. It has a very low aqueous solubility (2-7 µg/mL), is weakly 
acidic with a pKa of 11 and is generally acquired as a crystalline powder [Chawla and 
Bansal 2007].  
 
                        
Figure 3.3 XRD diffractogram of CEL crystal form I (A), II (B) and III (C). From 
[Chawla et al. 2003, Lu et al. 2006] 
A          B 
 
 
 
 
 
                          C 
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There are more than four known CEL crystalline polymorphs of which type III with its 
characteristic needle-shaped crystals is the thermodynamically stable form at ambient 
conditions. CEL is further associated with undesirable properties such as low 
compressibility and cohesiveness, and it is found that increasing the dissolution rate of 
CEL improves its oral bioavailability [Chawla et al. 2003; Dolenc et al. 2009; Paulson 
et al. 2001]. CEL crystalline powder was acquired from Dr. Reddy (Hyderabad, India) 
with a purity of 99.9% and with a molecular weight of 381.38 g/mol. 
3.1.3 Solvents 
Acetone 
HPLC grade acetone ([CH3]2CO, Sigma Aldrich, Poole, UK) was used in this work. 
Acetone was used as a solvent component in some electrospraying and spray drying 
feed solutions as well as for cleaning of nozzles and glassware. 
Acetonitrile  
HPLC grade acetonitrile (CH3CN, Sigma Aldrich, Poole, UK) was used in this work. 
Acetonitrile was used as a solvent component in some electrospraying and spray drying 
feed solutions as well as a component of the mobile phase for HPLC measurements. 
Methanol 
HPLC grade methanol (CH3OH, Sigma Aldrich, Poole, UK) was used in this work. 
Methanol was used as a solvent component in some electrospraying and spray drying 
feed solutions. 
Ethanol 
General purpose research grade ethanol (C2H5OH 99.9%, Sigma Aldrich, Poole, UK) 
was used in this work. Ethanol was used as a solvent component in some 
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electrospraying and spray drying feed solutions, used for calibration of measuring 
apparatuses and for the cleaning purposes. 
Dimethyl Sulphoxide (DMSO) 
Research grade DMSO (([CH3]2SO, Sigma Aldrich, Poole, UK) was used in this work. 
DMSO was used in Caco2 drug transport studies to increase the drug solubility in the 
HBSS-based release medium. 
Ultrapure water 
Ultrapure water was produced using a Millipore Filtration device (Millipore, USA) and 
was used to prepare buffers and release medias, used as a solvent component in some 
electrospraying and spray drying feed solutions and for cleaning purposes.  
Properties of solvents used for atomization 
Some of the main properties of the solvents used are presented in Table 3.1.  
Table 3.1 Properties of solvents used for atomization of solutions. Values obtained 
from [Smallwood 1996]. 
 Density 
(kg·m
-3
) 
Boiling 
point (°C) 
Dielectric 
constant 
(20 °C) 
Electrical 
conductivit
y (S/m) 
Viscosity   
(mPa·s)           
(at 25 °C) 
Surface 
tension    
(mN· m
-1
) 
Acetone 790 56 20.6 5E-9 0.33 23.3 
Acetonitrile 782 82 37.5 6E-9 0.38 29.1 
Ethanol 789 78 22.4 1.4E-9 1.08 22.3 
Methanol 792 64 32.6 1.5E-9 0.6 22.6 
Water 998 100 79.7 5.5E-6 0.89 72.8 
Chapter 3. Experimental Details 
84 
 
3.1.4 Miscellaneous materials 
Phosphate buffer solution (pH 6.8) 
Phosphate buffer was prepared from NaHPO4 (Sigma Aldrich, Pool, UK) and NaOH 
pellets (Sigma Aldrich, Pool, UK) and used as a release medium for drug release studies 
Sodium Lauryl Sulphate (SLS) 
SLS powder was acquired from Fagron (Fagron, Waregem, Belgium). SLS was used as 
surfactant in the release medium mixed in phosphate buffer to provide sink conditions 
during drug release.  
3.2. Preparation and characterization of solutions 
Some properties of the solvents and solution used were measured using the following 
methods while other properties were found in literature (see section 3.1.3).  
3.2.1 Electrical conductivity:  
Values for electrical conductivity of solvents and spraying solutions were measured 
using a multimeter (InLab, Mettler Toledo). The electrical conductivity of the 
suspension/solution was measured using the conductivity probe. The measuring range 
of the conductivity meter used was 0.001 to 500 μS/cm (according to Mettler Toledo). 
The conductivity measurements were performed at ambient temperature    25  C  and 
the electrode probe was always cleaned with 99.9% ethanol, which has a very low 
conductivity around 0.0014 μS/cm. The electrical conductivity measurements were 
done by using ~20 mL of solvent/solution in a cylindrical glass container. The electrode 
was immersed in the liquid up to the specified mark for a few seconds, air bubbles 
residing in the suspension were removed by shaking the suspension gently, and the 
reading was recorded. Five consecutive readings were taken and averaged for all 
measurements. 
Chapter 3. Experimental Details 
85 
 
 
3.2.2 Surface tension measurements 
The pendent drop method was used to find values for surface tension in the liquid to air 
interface and a Krüss DSA 100 Drop Shape Analysis System (Krüss, Germany) was 
used. A syringe was filled with the given solvent/solution and connected to a flat-ended 
needle. The liquid was dispensed slowly from the needle tip until a drop was hanging 
from the needle tip. A camera was used to monitor the drop and determine the surface 
tension based on the geometry of the drop. The measurements were performed at 25 °C 
and readings were performed every 2 seconds until the values had stabilized, and a 
mean value was determined.  
3.2.3 Viscosity 
The viscosity of solvents and spraying solutions were determined using an Ubbelohde 
viscometer (Cannon instruments, USA) in a size 50 with a calibration constant of 
0.0036 mPa and measurements were done at 25 ºC in a heated water bath. Viscosity 
was measured for pure solvents and solutions with different concentrations of PLGA. 
The kinematic viscosity (ν) was calculated using the viscometer constant (χ) and the 
measured time (t) for the liquid head to pass the two indicators, 
          (Equation 3.1) 
The dynamic viscosity (η) was calculated from the kinematic viscosity and the solution 
density  ρ ,  
         (Equation 3.2) 
The viscosity results are based on a mean value of two or three readings. 
3.2.4 Properties associated with viscosity 
The specific viscosity (ηsp) divided by the concentration (cx) was found for each of the 
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different polymer concentrations (x=1-7%) using equation 3.3, 
   
  
  
  
        
   (Equation 3.3)    
The intrinsic viscosity  [η]  of PLGA in the different solvents was determined by 
extrapolation of values for the specific viscosity ηsp as the polymer concentration went 
to zero using equation 3.4. The intrinsic viscosity refers to the capability of a specific 
polymer to enhance the viscosity of the solvent in which it is dissolved. This depends 
partly on the molecular weight of the polymer and the polymer-solvent compatibility 
[Jen Tsi 1962]. 
          ( 
   
 
)  (Equation 3.4) 
 Further, the Martin constant (Km) was calculated for solutions with 5% polymer 
concentration by using equation 3.5, the Martin equation [Son et al. 2004]. The Martin 
constant (Km) is similarly used to indicate the interactions between solutes and between 
solute and solvent, with a higher value indicating more polymer-polymer interaction. 
   
    
              (Equation 3.5) 
3.2.5 Evaporation rate 
The evaporation of solvents and solutions used were measured using thermo gravimetric 
analysis (TGA) and the evaporation rate was also found. Briefly, approximately 20 μL 
solvent or solution was transferred into a platinum crucible and placed on the sample 
holder and enclosed inside the temperature-controlled furnace (25 °C, to mimic typical 
ambient conditions in which electrospraying experiments also are performed) 
continuously purged with nitrogen gas at 20 mL/min flow rate. The change of weight as 
a function of time was recorded until stabilizing around 0 for solvents and at the initial 
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solute weight for solutions containing both polymer and drug. Each measurement 
condition was repeated three times to limit the uncertainty of the measurements.  
3.2.6 Solubility studies 
Solubility of polymers and drugs in solvents and solvent mixtures were measured by 
adding the given solute(s) little by little into a container with 5 mL or 10 mL of solvent 
while continuously stirring until the solution reached the cloud point was reached or the 
solute(s) began precipitating out. The solutions were occasionally heated slightly using 
a hot plate or placed in an ultrasound bath to aid the dissolution process.   
3.3 Particle preparation using electrospraying 
Particles were fabricated using a single-nozzle electrospraying setup (see Figure 3.4). 
The same spraying nozzle was used in all experiments and was custom built by Stanley 
Engineering (Birmingham, UK). The nozzle was made of stainless steel with an inner 
and outer diameter of 1.77 mm and 2.34 mm respectively and a length of 40 mm. All of 
the electrospraying experiments were carried out using a nozzle connected to a 
programmable syringe pump (PHD 4400, Harvard Apparatus, Edenbridge, UK). A 
syringe (made from glass or plastic) with the capacity of 5 mL was mounted onto the 
pump and liquid was infused into the nozzle via plastic tubing (Tygon tubing, Sigma, 
UK). The nozzle and a ground electrode were connected to a high voltage DC power 
supply unit (FC30 P4 12w, Glassman Europe Limited, Bramley, UK) using a high 
voltage power cable. The output voltage range of the unit was 0-30 kV and the output 
current range was 0-4 mA. A high speed video camera with an in-built magnifying lens 
(Leica S6D JVC-colour) was used to monitor the jet at the nozzle tip during particle 
generation. Such a high speed camera is necessary to ensure a stable jet as small 
fluctuations or instability in the jet may result in a different particle output. A fibre optic 
light source was also used when the lighting was not sufficient to visualize the jet. 
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All solutions were electrosprayed with an applied electric potential difference of 
between 7-13 kV, depending on the feed solution used, and a direct current of 1.0mA, 
with the positive electrode attached to the tip of the nozzle and the ground electrode 
attached to the collector (see Figure 3.4 A). A continuous flow rate between 10-50 
µL/min was used to obtain a stable cone-jet while adjusting the electrical potential. The 
particles produced were collected at a distance of 70 mm from the nozzle either onto a 
microscopy glass slide, onto a sheet of aluminium foil or into a beaker with deionized 
water. The particle samples were left to dry completely in a desiccator under vacuum. 
All particle samples were prepared in the stable-cone-jet mode to get a narrow particle 
size distribution. 
   
Figure 3.4 Schematic diagram of electrospraying setup (A), photographs of samples 
collected on aluminium foil (B) and in a glass vial (C). 
3.4 Particle preparation using spray drying  
Particle preparation with spray drying was performed using a Büchi Mini Spray Dryer 
B-290 (Büchi Labortechnik AG, Flawil, Switzerland)(see Figure 3.5 A). A sketch of the 
mechanisms in the setup is shown in Figure 3.5 B. A 0.7 mm two fluid nozzle was used 
A 
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for all of the spray drying experiments and spraying solutions were sprayed in a co-
current flow with gas for drying. Due to the use of an organic solvent base and the risk 
of explosion at high temperatures an additional device, an Inert Loop B-295 (see Figure 
3.6), which provides a closed loop of inert gas, was used with nitrogen gas instead of 
atmospheric air. The spray dryer was operated at 90   22500 L h  aspiration rate and 
the remaining adjustable operating parameters were set as follows for all spray drying 
experiments  Liquid feed rate    3 mL/min, inlet temperature 45 ℃, outlet temperature 
30 ℃ and a o  z ng a r f ow rate 742 L/h. The spray drier was flushed using pure 
solvent in the feed before and after spraying the particles.  
 
Figure 3.5 Picture of Buchi spray dryer (A) and schematic image of spray drying 
mechanism (B) (adapted from Buchi B-290 catalogue). 
 
Figure 3.6 Schematic view of inert loop closed circuit 
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Spray-dried powders were separated from the cyclone and collected in a vial. The 
produced powder was scraped off the inside of the glass vial, inserted into capped glass 
vials and stored in a desiccator at ambient temperature. The drying chamber, cyclone 
and collection vial were cleaned between spraying of each sample. 
3.5 Micronization and preparation of physical blend 
3.5.1 Ball milling 
Micronized drug samples were prepared using a two chamber oscillatory ball mill 
(Mixer Mill MM301, Retch GmbH & Co., Haan, Germany. Approximately 500 mg of 
crystalline drug was placed into each of the two milling chambers with three 9 mm 
stainless steel balls and milled at 30 Hz oscillation for 30 min. The ball mill was placed 
in a cold room (+4 °C). The micronized samples were scraped of the walls of the ball 
mill chamber after milling, collected in a capped glass vial and stored at ambient 
temperature in a desiccator. 
3.5.2 Physical blend  
Physical blends of polymer and drug were prepared to set up comparisons with the 
drug-loaded particles. Drug and polymer were weighed at the specified ratio and were 
then mixed using a mortar and pestle for 1 min.  
3.6 Characterization of particle size and morphology 
3.6.1 Size and morphology 
Particle morphology and size were characterized and measured using SEM. Optical 
microscopy was also used to visualise particles immediately after preparation, but was 
mainly used for screening of samples before performing SEM.   
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Optical microscopy 
An optical microscope uses light in the visible wavelengths to magnify images of small 
samples using a system of lenses with different predetermined magnifications. Samples 
are most commonly observed via images from transmitted light but it is also common to 
use reflected light, typically employed for analysis of surface morphology of samples. 
The resolution limit for optical microscopes with conventional lenses is around 200 nm.  
Particles were collected on glass slides either directly onto the glass or covered with a 
film of water, and their general structural appearance was examined using an optical 
microscope (Nikon Eclipse ME 600, Nikon, Japan). Scale-bars and particle size 
measurements were done using „Acquis‟ digital imaging software  Synoptics Ltd., 
Cambridge, UK). 
Scanning Electron Microscopy 
An SEM microscope scans the sample surface with a high-energy beam of electrons to 
obtain an image in the micro- to nano-scale. The signal received in a SEM contains 
information such as surface topography and the composition of the sample. Particle 
morphology and size were characterized in detail using different SEM setups (JEOL 
JSM-6301F, Hitachi VP-SEM S-3400N and Quanta 200 ESEM FEG) depending on 
availability and location. The prepared samples, consisting of a thin layer of particles on 
glass slides, were sputter-coated with gold, mounted on metallic studs with double-sided 
carbon tape and viewed at an accelerating voltage of 3 kV (for JEOL JSM-6301F and 
Quanta 200 ESEM FEG) or 10 kV (for Hitachi VP-SEM S-3400N). Images 
representative of the whole sample were taken at different orders of magnification for 
each of the samples, where possible. If unusual structures were observed there were also 
captured and saved. The images obtained were used to calculate the mean diameter and 
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size distribution for the different particle samples. For each sample 200-300 particles 
were measured from different sites of the sample, using the software ImageJ. The sizes 
were calculated as the Feret‟s diameter based on the circumference of the particles, and 
their diameters were calculated using the image scale bars. 
The particle size distribution of samples was determined by calculating the 
polydispersivity index, a measure indicating how polydisperse a sample is. The 
polydispersivity index is found from the mean diameter and standard deviation of the 
sample and is given as:  
Polydispersivity index = Standard deviation / Mean diameter * 100 
3.7 Inner structure and porosity of particles  
Cross-sectional images of the drug loaded microparticles were prepared using a 
combined dual beam focused ion beam (FIB) – SEM instrument. A FIB/SEM 
instrument contains both an FIB and an SEM source and uses SEM to visualize the 
sample while using FIB both for visualization and ablation of the sample. FIB functions 
by using a focused beam of ions generated from an ion source, which can be focused 
directly onto a small area of the sample with a spot size of only a few nm. This beam 
can then be used for milling (removal of material) a section of the sample to reveal the 
inner morphology of a given particle. The milling process is typically monitored using 
the SEM source. 
A Zeiss XB 1540 Cross Beam SEM equipped with a Gemini SEM column and Orsay 
Physics Canion 31 FIB column was used to prepare FIB/SEM images shown in the 
results sections. Particle samples were sputter-coated with gold and mounted on 
metallic studs with double-sided carbon tape. FIB milling of samples was done with a 
Ga
+
 ion beam at an accelerating voltage of 30 kV. Layer by layer milling of the 
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microparticles was done at a beam current of 30-100 pA, with the final thinning being 
in the lower current range. Secondary electrons formed during the milling process 
enabled simultaneous imaging of the sample. Reducing the beam current generally 
helped to reduce specimen damage during scanning with the ion beam.  
3.8 Crystallinity and physical form of particles 
3.8.1 Differential Scanning Calorimetry 
DSC is a thermal analysis technique used for a broad range of applications for both 
crystalline and amorphous materials. A DSC is typically used to heat or cool small 
samples (a few milligrams) at a predetermined rate inside a closed furnace and then 
measure the difference in heat flow required to increase or decrease the temperature of 
the sample and reference. This heat flux is plotted as a function of time or temperature 
and the curve obtained is used to determine thermal events such as glass transition and 
melting. The glass transition temperature is observed as a change in heat capacity and 
can be used to determine the presence of amorphous material, the miscibility of 
materials and some interactions between materials. The melting peak can be used to 
detect crystallinity and determine polymorphism, and the amount of crystallinity can in 
some cases also be quantified.         
DSC was used in this project to gain information on the physical state of the drug and 
polymer components of the particles and any interaction between the two. The DSC 
analyses were performed using three different DSC instruments, a Netzsch STA 449 C 
Jupiter (Netzsch, USA) instrument together with software, Proteus, a Perkin Elmer 
Diamond with autosampler (Perkin Elmer, Norwalk, CT) and software, Pyris, a Mettler 
Toledo DSC 1 (Mettler Toledo, Columbus, OH) with software, STAR-e depending on 
availability and location performed. For the Netzsch instrument dry particle samples 
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(~10 mg) were prepared in open aluminium pans and were analysed under a helium 
purge (50 mL/min). TGA was performed simultaneously with these DSC measurement 
to verify low residual solvent and hence a relatively constant mass over the 
measurement. For the Perkin Elmer instrument dry particle samples (3-4mg) were 
prepared in closed aluminium pans and were analysed under a nitrogen purge 
(10mL/min). Lastly, for the Mettler Toledo instrument dry particle samples (2-3 mg) 
were prepared in 40 µL aluminium pans with pinned lids and were analysed under a 
nitrogen purge (10 ml/min). The samples were all heated from 10 °C to 200 °C or 20 °C 
to 200 °C at a rate of 10 °C / min.  
3.8.2 X-Ray Powder Diffraction 
XRPD is a versatile technique and one of the main analytical techniques for 
pharmaceutical solid state characterization. XRPD uses an X-ray beam and the 
scattering hereof to determine the distance between the planes in a crystal lattice 
structure. A detector scans the intensity of the reflections over a given angle (2θ  and 
some interference will occur between the reflected beams. The intensity of this scattered 
radiation is then related to the angle of the incident X-ray hitting the crystal using 
Bragg‟s law  equation 3.6 , which is used to calculate the phase information.   
        n   (Equation 3.6) 
XRPD is typically used to detect crystallinity and to identify polymorphism and 
solvates. XRPD is often regarded as the gold standard when it comes to identifying 
whether a sample is amorphous or crystalline. Different crystal structures will result is 
different diffractograms and this also applied for crystalline polymorphs, which would 
also show different peaks in the X-ray diffractograms. An XRPD diffractogram of an 
amorphous product results in a featureless “halo”. The detection limit of crystallinity 
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with XRPD is typically around 0.5% and small nanocrystals may also be overlooked by 
an XRPD measurement. 
X-ray powder diffraction pattern of samples were analysed at ambient conditions using 
a PANalytical X‟Pert P O MPD system  PW3040 60, Philips, The Netherlands  
equipped with a PIXcel detector. The particle powder samples were placed on flat 
aluminium sample holders and measured in reflection mode in the 2θ range of 2-40º 
using a Cu Kα radiation (λ = 1.542 Å). Samples were scanned at an operating voltage 
and current of 45 kV and 40 mA, respectively, and each diffractogram was recorded at a 
scanning speed of 4º min-1 with a step size of 0.02. The diffraction patterns were 
generated using the software, X‟Pert High Score, version 2.2.0 (Philips, The 
Netherlands). Sample spinning was used during the measurements in order to avoid 
effects from preferred orientation.  
3.8.3 Polarized light microscopy  
Polarized light microscopy works similarly to conventional bright-field light 
microscopy but has a pair of polarizers, one between the light source and the specimen, 
and one between the specimen and the observational tubes. The polarizer between the 
light source and the specimen is adjusted to control the transmission of light and usually 
to obtain plane-polarized light. The presence of an anisotropic specimen, a highly 
refractive specimen such as most crystalline materials divides the light rays into 
orthogonal components, which become out of phase but are recombined in the second 
polarizer with constructive and destructive interference. Having the polariser oriented at 
90 degrees means all directly transmitted light can be blocked, so only the contrast from 
the anisotropic specimen is seen. This is used to observe the presence of crystallinity in 
a sample, which would be highly visible and would “light up” while amorphous, 
isotropic material would be dark. 
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A polarized light microscope (Axiolab, Carl Zeiss, Göttingen, Germany) was used for 
detecting crystallinity in the microparticles samples together with XRPD and DSC. A 
thin coating or layer of the particle samples was placed on microscopy glass slides and 
visualized using the microscope at 5x, 10x or 20x magnification. The polarizing filter 
was oriented at 90º to block transmission of direct light and observe the presence of 
crystalline material. A digital camera (Deltapix, Maaloev, Denmark) was used with an 
image resolution of 1024 x 1280 and together with the software, Deltapix, to capture 
images of potential crystallinity in the samples.         
3.9 Drug physical stability 
Physical stability was studied by placing samples prepared using spray drying and 
electrospraying into a desiccator at ambient temperature for several months and then 
examining them using XRPD and DSC to observe changes in their physical form. Some 
samples were placed in an oven for 2-3 weeks at 50 °C and ambient humidity to observe 
if changes would take place at elevated temperature.  
3.10 Surface chemical analysis and drug distribution 
Surface chemical analysis using XPS was mentioned in section 2.5.3 as a technique to 
determine the ratio between drug and polymer on the surface of the particles. The 
measurements would give some information of the distribution of drug in the particles 
and can be used to explain parts of the particle formation process for a specific system.  
The surface chemistry of particle samples was analysed by XPS using a K-Alpha 
spectrometer (Thermo Scientific, Denmark) equipped with a monochromated AlKalpha 
X-ray source. Wide energy survey scans (0-1350 eV binding energy) were made with a 
pass energy of 200 eV and a step size of 1.0 eV. An angle of 90° was used between 
sample surface and analyser (take-off angle). An X-ray spot size of 200 µm was used 
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for the particle samples to take possible inhomogeneity of the sample into account. The 
surface drug content of the microparticles was determined by calculating the ratio of the 
detected amount of fluorine in the samples to the amount of fluorine in pure CEL 
thereby determining the concentration of CEL (in wt %) on the surface of the particles. 
The atomic concentration (in %) of elements C, O, F, N and S (H was not measured) 
used for pure CEL were 65.38%, 7.69%, 11.54%, 11.54% and 3.85%, respectively. 
Similarly, the relative concentration (in %) of elements C and O used for PLGA were 
55.56% and 44.44%, respectively. 
3.11 Drug detection 
3.11.1 Drug detection using UV-Vis spectroscopy and HPLC 
UV-Vis spectrophotometry is commonly used for detection of drugs and other 
molecules that absorb UV and visible light. A UV-Vis spectrophotometer measures the 
intensity of light transmitted through a sample as a function of light with wavelengths in 
the UV and visible range. This absorbance of light is then determined and can be 
correlated to the concentration of the material measured using the Beer-Lambert law. 
Molecules that absorb light in the UV-Vis range can thus be detected and quantitated 
over a certain concentration range where a linear relationship exists between the 
absorbance and the concentration of the molecules of interest.      
When there are several different molecules in the sample that absorb UV-Vis light it can 
be difficult to distinguish these molecules using a conventional UV-VIS 
spectrophotometer. In this case chromatography, and in particular High Performance 
Liquid Chromatography (HPLC), is used to separate the molecules so they can be 
detected and, if necessary quantitated, separately using a UV spectrophotometer or mass 
spectrometer connected to the HPLC chromatograph. Due to the separation of the 
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molecules and the design of modern, automated HPLC instrumentation more sensitive 
and precise measurements can be obtained compared with a conventional stand-alone 
UV-Vis spectrophotometer. 
3.11.2 Drug entrapment efficiency 
Drug entrapment efficiency (EE) was measured by evaluating the total amount of drug 
in the collected samples. Samples with 10-20 mg microparticles were accurately 
weighed, dissolved in acetonitrile (10 mL) and agitated for 1 hour. This solution was 
then diluted 1:10 in acetonitrile:water (20:80 v/v) and centrifuged at 3000 rpm for 10 
min. The drug content in the supernatant was analysed using a HPLC unit with Pump 
P680 and ASI 100 sample injector and UVD340U (Dionex, Germany) equipped with 
Kromasil 126 column (Kromasil, Sweden). A mobile phase of acetonitrile:water (60:40 
v/v) was used at a flow rate of 0.5 mL min
-1
 and the injection volume of 10 μL was 
detected at wavelength 230 nm and a run time of approximately 15 min. A calibration 
curve was obtained from reference CEL solutions between 0.5 μg mL and 50 μg mL 
and a good linear correlation was achieved in the entire range. The drug entrapment 
efficiency was then determined using following equation:  
EE % = 100 · Mass of drug loaded in particles / Mass of drug processed 
3.12 Drug release studies 
Drug release studies from particles were performed using two different methods: A 
method used for initial drug release studies involved release of CEL from particles, in 
30 ml water/ethanol media, while later studies were more in line with official 
compendial methods used to test oral dosage forms, using a paddle dissolution 
apparatus and release media recommended by the United States Pharmacopeia (USP).        
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3.12.1 Initial release study 
A UV-Vis spectrophotometer (Lambda 35, Perkin-Elmer, UK) was used to measure the 
released amount of CEL from the particles at different time points. A suitable UV 
absorption peak of CEL was found at 250 nm where a good linear response was 
observed over the target concentration range. Appropriate calibration and blanking 
procedures were done before the measurements. Release studies were performed by 
dispersing weighed, dry particle samples (~6 mg) in glass vials containing 30 mL 
release medium. The studies were all performed under ambient temperature and under 
continuous magnetic stirring at approximately 250 rpm. A 50:50 volume ratio mixture 
of ethanol and water was used as release medium. At discrete time intervals 3 mL was 
removed from the samples and centrifuged at 4000 rpm for 20 min. The supernatant was 
removed and diluted in methanol to reach the measurable concentration range of CEL 
for UV absorption.   
Four measurements were performed for each particle sample at each sample time and 
the mean absorbance value was found. The measurements were done over a period of 
10 days. 
3.12.2 Paddle drug release study 
Drug-loaded particle powder samples were weighed (10-20 mg) and placed in a release 
media of 500 mL phosphate buffer (0.01M, pH=6.8) + 1.5% w/v sodium lauryl sulphate 
(SLS). Drug release studies were performed on a Sotax AT7 dissolution station (Sotax, 
Switzerland) equipped with a USP II (paddle) apparatus and 1000 mL glass vessels (see 
Figure 3.7). Release samples were drawn from a location on the paddle shaft and up 
through 2.7 μm glass microfiber filters  Whatman Ltd, England  using an autosampler, 
Biolab/Gilson GX-271 (Biolab, UK). During release studies the paddles were run at a 
rotation of 50 rpm and the release medium was kept at 37 ºC with a temperature bath. 
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Samples of 5 ml were taken at 17 time points over 24 hours and later filled into HPLC 
vials. HPLC analysis was conducted as previously described for drug entrapment 
efficiency in 3.9. A minimum of 4 experiments was performed for each sample 
condition and the results were averaged to construct drug release profiles. The drug 
entrapment efficiency was taken into consideration when analysing the drug release data 
and the release data was corrected by linear scaling of data point. The software 
Chromeleon, version 6.8 was used to manage and calculate drug release results. 
 
Figure 3.7 Sotax dissolution tester with 6 vessels. 
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Chapter 4  
Electrospraying of solid dispersions: The influence of 
process parameters and control of particle 
characteristics and drug release 
 
This chapter describes the investigation of electrospraying for preparing solid dispersion 
microparticles using the poorly soluble drug, Celecoxib (CEL). PLGA microparticles 
containing CEL were prepared with the objective of producing near-monodisperse 
microparticles with the drug in an amorphous form. Further, the influence of different 
process parameters on particle characteristics as well as on drug release profile was 
examined to understand how to control these properties. It was found that microparticles 
loaded with CEL could be formed and that these particles could be prepared with a 
near-monodisperse distribution. By adjusting the different parameters it was observed 
that particle characteristics such as size, morphology, shape and porosity could be 
controlled with a good correlation between process parameters and the resulting 
characteristics. Further, the release profiles of the particles could also be controlled via 
these process parameters indicating a link between the release kinetics and the 
characteristics of the particles. Curve fitting of the release curves indicated diffusion 
mediated release from the particles over an extended time. This study forms the 
foundation for studies on electrosprayed solid dispersions described in Chapter 5.  
4.1 Selection and characterization of drug and carrier 
A model drug and a few polymeric carrier materials were investigated for preparing 
solid dispersions using electrospraying and spray drying. These materials and their 
properties were first characterized.  
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4.1.1 Selection and characterization of model drug 
CEL was selected as a model drug due to its very low water solubility and its physical 
characteristics including its relatively high molecular weight (381.38 g/mol) which 
makes it difficult to formulate. CEL is a class II compound under the Biopharmaceutics 
Classification System, thus being poorly soluble but having high intestinal permeability 
[Chawla et al. 2003]. It was also selected due to its commercial interest as a blockbuster 
drug without any salt formulations available, which makes it necessary to deal with its 
inherently low solubility by other means, for use via oral administration. 
Although some of the characteristics of CEL were explained in section 3.1.2 studies 
were performed to examine the characteristics of the specific batch of CEL used in the 
experiments throughout this PhD project. 
Appearance of CEL crystalline powder: 
The unprocessed CEL powders consisted of crystals of variable size and mostly of rod-
shaped appearance (see Figure 4.1). The CEL powder had a fluffy texture and was very 
electrostatic. 
 
Figure 4.1 Optical micrograph of crystalline CEL 
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Physical state and thermal properties of CEL: 
DSC measurement of CEL showed a sharp endotherm peak at 162 °C indicating the 
melting point of CEL crystals (see Figure 4.2). 
 
Figure 4.2 DSC thermogram of CEL indicating melting endotherm. 
The XRPD diffractogram on Figure 4.3 again demonstrates that the CEL powder used is 
crystalline and that the crystalline peaks correspond to the peaks from Figure 3.3 B, the 
crystalline polymorph form II. 
 
Figure 4.3 XRPD spectrogram showing profile of crystalline CEL. 
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4.1.2 Selection and characterization of polymer 
There are many different polymers used in drug delivery applications each with their 
individual properties and functions and each with their advantages and disadvantages. 
In this study, PLGA was selected as the main polymer, partly because it is FDA 
approved and widely recognized, but also because of its prior use and successful 
application with electrospraying [Almeria et al. 2010, Enayati et al. 2010].  
Two other polymers, chitosan and poly-ethylene glycol (PEG, MW= 6000 g/mol) were 
also initially studied but proved difficult to electrospray in the cone-jet mode. These 
polymers were initially sprayed in aqueous solutions, which have a high surface tension 
due to the high surface tension of water. This makes it difficult to form a stable jet 
without the addition of surfactants. Further, water has a relatively high boiling point 
which makes it more difficult to boil off the solvent to obtain dry particles at collection. 
Chitosan also makes the solution very viscous, even at low concentrations, making it 
difficult to atomize a solution at concentrations above 1-2% w/v. PEG was later 
electrosprayed in acetone where a cone-jet could easily be obtained. However, due to 
the preferred crystalline state of PEG, it did not seem to mix well with CEL, resulting in 
rapid crystal growth from the prepared particles. Chitosan and PEG were thus not ideal 
carrier materials for preparing electrosprayed solid dispersions.  
Characteristics of PLGA 
Appearance of PLGA granules: 
Microscopy images PLGA granules showed an indistinguishable appearance (not shown 
here) and the powder was fluffy with low density. 
Physical state and thermal properties of PLGA 
DSC measurement of PLGA powder showed an endothermal event at 54 °C indicating 
the glass transition of PLGA (see Figure 4.4). 
Chapter 4. Results and Discussion 
105 
 
                
 
Figure 4.4 DSC thermograms of pure PLGA powder indicating glass transition event 
(A) and PLGA microspheres measured by [Passerini and Craig 2001] using modulated 
DSC (B). 
It is seen in Figure 4.4A that the glass transition event of PLGA does not have the 
appearance of the typical Tg and instead shows a strong signal with a distinct peak 
unlike the typical Tg events. This may be explained by the graphs presented by Passerini 
and Craig (see Figure 4.4B) where a modulated DSC was used to separate the heat flow 
signal into the reversing and non-reversing heat flow signals thereby facilitating the 
detection of a Tg. The Tg event observed for the non-reversing heat flow signals 
resembles that of the DSC curves for PLGA and CEL-loaded microparticles shown in 
this thesis and could be due to the separation of heat signals [Passerini and Craig 2001]. 
XRPD of PLGA on Figure 4.5 shows a halo indicating amorphous PLGA. 
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Figure 4.5 XRPD spectrogram of PLGA. 
4.1.3 Physical mixture of CEL and PLGA 
Physical mixtures were prepared from CEL and PLGA at 1:4 weight ratio and 1:1 
weight ratio. DSC measurements of the physical mixtures showed an endothermal event 
at around 55 °C and a small endothermal event at 162 °C, which could indicate that 
CEL was partly amorphous and partly crystalline (see Figure 4.6). However, it is also 
possible that most of the crystalline CEL dissolved in PLGA above the glass transition 
of PLGA and thus did not melt. 
XRPD diffractograms of physical mixtures of PLGA and CEL indicate the presence of 
both an amorphous and a crystalline phase (see Figure 4.7). When the CEL:PLGA ratio 
is increased the crystalline peaks become more dominant.  
4.2.1 Selection of solvent and preparation of solutions 
Solvents for particle preparation were initially selected based on the criteria that both 
CEL and PLGA need to be readily soluble in the solvent. Further, it was decided that 
the solutions formed need to have an electrical conductivity (see section 2.5-2.6) and a 
surface tension in a window that allows the cone-jet to be formed without addition of 
salts or surfactants. On the basis of these criteria, four solvents (acetone, acetonitrile, 
dimethylformamide (DMF) and dimethylacetamide (DMAc)) were selected for testing.  
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Figure 4.6 DSC thermogram of PLGA and CEL physical mixtures at 1:4 ratio (A) and        
1:1 ratio (B) indicating melting endotherm. 
         
Figure 4.7 XRPD diffractogram of PLGA and CEL physical mixture.  
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4.2 Preparation and characterization of spraying solutions 
Following preparation of PLGA particles using DMF or DMAc, it was observed that a 
cone-jet was obtained and some droplets were formed and collected on glass slides. Yet, 
the solvent had only partly evaporated at collection and the many wet particles collected 
would re-dissolve on the glass slide, where they later dried to form a film. DMF and 
DMAc have a boiling point of 153 ºC and 165 ºC, respectively, and are thus not volatile 
enough to form dry particles at collection without an active drying mechanism 
[Smallwood 1996]. These solvents were therefore not used any further with this 
experimental setup which makes use of a passive drying process.  
The studies were instead continued with the solvents acetonitrile (ACN) and acetone 
(ACE), both of which are more volatile than DMF and DMAc with a boiling point of  
82 ºC and 56 ºC respectively. ACN and ACE have similar density and surface tension 
while ACN has a slightly higher viscosity and electrical conductivity compared with 
ACE (see Table 4.1). 
Table 4.1 Physical properties of solvents used to fabricate microparticles [Smallwood 
1996]. * Relative to the evaporation rate of Butyl Acetate. 
Property     Acetone Acetonitrile 
Viscosity (mPa·s) at 25 °C       0.33       0.38 
Boiling point (°C)       56       82 
Evaporation rate (BuAc=1)*       5.6       2.0 
Dielectric constant       20.6       37.5 
Electrical conductivity (µS/cm)       0.06       0.23 
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4.2.2 Solubility of CEL and PLGA 
Solubility was measured visually by observation of the onset of a cloud point or 
precipitation of the solute (see Table 4.2). All values are approximations and were 
mainly used to evaluate the solvent power of the different solvents used. For values of 
solubility higher the 50% w/v the solubility could not be clearly determined and instead 
minimum solubility values were given. Table 4.2 indicates that acetone and acetonitrile 
are both good solvents for CEL and PLGA, while methanol and ethanol dissolve CEL to 
some extent but not PLGA. Both CEL and PLGA are practically insoluble in water.      
Table 4.2 Solubility of CEL and PLGA in solvents used in the study. 
Solvent Solubility of CEL (mg/mL) Solubility of PLGA (mg/mL) 
Water (deionized) ~ 2·10
-3 
 Insoluble 
Ethanol ~ 50 Insoluble 
Methanol ~ 100 Insoluble 
Acetone 600-700 500-600 
Acetonitrile 500-600 400-500 
4.2.3 Characterization of spraying solutions 
Electrical conductivity and Viscosity 
Measurements of electrical conductivity showed that ACE was less conductive than 
ACN (see Table 4.2). The addition of 5% PLGA to the solvents did not contribute 
notably to the electrical conductivity whereas the addition of 5% CEL resulted in a 
significant increase in the electrical conductivity, which indicates that CEL carries more 
electric charge than PLGA. With electrospraying the electrical conductivity is known to 
influence the properties of the particles obtained most notably with an increase in 
conductivity resulting in a decrease of particle size, according to the scaling laws 
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[Gañan-Calvo et al. 1997]. 
Measurements of viscosity showed that ACE is less viscous than ACN and that the 
addition of PLGA has a great influence on the viscosity of the solution while the 
addition of CEL does not seem to have noticeable influence on the viscosity of the 
solution. The greater influence of PLGA on the viscosity is explained by much higher 
molecular weight and hydrodynamic volume of PLGA compared with CEL. It was also 
observed that the solution with PLGA in ACE is more viscous than the solution with 
PLGA in ACN, although ACE is less viscous than ACN by itself, indicating that ACE is 
a better solvent for PLGA. In a good solvent the polymer chains are extended and 
interaction between the chains and entanglement of the chains begin taking place at a 
lower concentration than for a not so good solvent, hence resulting in higher viscosity 
[Ayal et al. 1993]. With both electrospraying and spray drying the viscosity of a 
solution is known to influence the properties of the particles obtained most notably with 
an increase in viscosity resulting in an increase in particle size [Jayasinghe and 
Edirisinghe 2002].   
Table 4.3 Properties of solvents and solutions containing CEL or PLGA. 
Solvent/solution 
Electrical conductivity 
(µS/cm) 
Dynamic Viscosity 
(mPa·s), at 25 °C 
Surface tension 
(mN/m), at 25 °C 
ACE 0.11  0.30 25 
ACN 0.28  0.35 30 
CEL in ACE (5% w/v) 1.01  0.37 25 
CEL in ACN (5% w/v) 1.06  0.41 30 
PLGA in ACE (5% w/v) 0.23  1.13 25 
PLGA in ACN (5% w/v) 0.40  1.08 29 
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Measurements of surface tension showed that ACN has a higher surface tension than 
ACE and that the addition of CEL or PLGA to the solvents does not have a noticeable 
influence on the surface tension of the liquid. The surface tension of organic solvents is 
generally low and does not seem to be influenced by the addition of solutes used in this 
study. A relatively low surface tension is necessary in order to obtain a stable cone-jet 
with electrospraying. The values obtained here are much lower than the surface tension 
of water (72 mN/m, at 25 °C) and are thus assumed to be in an acceptable range.     
Viscosity and polymer configuration 
The polymer conformational structure, solubility and behaviour of PLGA molecules in 
ACE and ACN were studied by determining the intrinsic viscosity, overlap 
concentration and Martin constant in these two solvents. Since CEL does not contribute 
much to viscosity compared with PLGA, and since only PLGA is relevant in the context 
of polymer entanglement, only PLGA solutions without CEL were studied. The intrinsic 
viscosity relates to the capability of a polymer to enhance the viscosity of the solution it 
is in, and gives an indication of the molecular weight of the polymer as well as the 
solubility of the polymer in the given solvent. The intrinsic viscosity was determined as 
the y-intercept of the specific viscosity / PLGA concentration curve as described in 
section 3.4.  
The intrinsic viscosity of PLGA in ACE and ACN were 0.276 dL/g and 0.216 dL/g 
respectively (see Figure 4.8).  ACE resulted in a higher intrinsic viscosity than ACN, 
which suggests more extended chains, more polymerization and better solubility of 
PLGA in ACE. The overlap concentration, c*, refers to the cross over from the dilute 
regime to the semi-dilute regime of a polymer in solution. This value represents the 
concentration at which polymer chains begin to entangle with each other and was found 
from the intrinsic viscosity values. The c* for PLGA in ACE and ACN were 3.6% and 
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4.6% respectively. This indicates that polymer chain entanglement begins at a later 
point for PLGA in ACN. The Martin (Km) constant is used to gain information on the 
interactions between solutes, with a higher value indicating more interaction between 
the PLGA molecules. In this case ACN showed a higher value than ACE indicating 
weaker interactions between PLGA molecules in ACE than ACN.  
 
 
Figure 4.8 Specific viscosity of ACE and ACN solutions as a function of PLGA 
concentration, including intrinsic viscosity (intercept with y-axis). 
Table 4.4 Intrinsic viscosity and Martin constant of PLGA solutions. 
 
Solvent ACE ACN 
Intrinsic viscosity (dL/g) 0.28 0.22 
Martin constant (Km) 0.48 0.63 
Evaporation profile 
The evaporation profile of an ACE solution and ACN solution both containing 5%wt 
solutes (90% PLGA and 10% CEL) were studied using TGA at 25 °C (see section 3.2.5) 
and the evaporation curves are shown in Figure 4.9 A. It is observed that both curves 
flatten out around 7% where there is no longer any measurable change in the mass of 
y = 0.0481x + 0.2761 
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the sample. The ACE solution reaches this point four times quicker than the ACN 
solution indicating that ACE evaporates much quicker than ACN at this temperature. 
Figure 4.9 B shows the first derivative of the evaporation curve which is essentially the 
evaporation rate as a function of time. The curves show that the evaporation rate is not 
constant but decreases with time as the solutes become more and more concentrated 
until a critical point where it essentially decreases down to zero. 
        
       
       
Figure 4.9 Evaporation of solutions at 25 ºC (A) and first derivative of evaporation 
curve (B). 
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4.3 Electrospraying of poorly water-soluble drugs 
4.3.1 Sprayability and particle collection 
The prepared solutions were all sprayed using the single nozzle setup shown in Figure 
3.4 and it was demonstrated that a cone-jet can be obtained (see Figure 4.10 A) and that 
particles are formed from the resulting jet (see Figure 4.10 B). Samples of CEL 
microparticles and CEL-loaded PLGA microparticles could be successfully prepared in 
an ACE solution at different operating conditions and their characteristics were studied 
using various techniques.  
By varying the collection distance different levels of dryness of the samples were 
observed via optical microscopy, going from still being wet (~ 1 cm) to being more or 
less dry (~ 5-10 cm). Although a short collection distance results in wet particles, a long 
collection distance spreads out the particles too much and decreases the collection yield 
(see Figure 4.10C), and hence a distance of 7cm was chosen. In this study, it was thus 
assumed that a majority of the solvent had evaporated by the time the particles reached 
the collection surface. 
     
Figure 4.10 Video camera image of stable cone-jet (A), microscopy image of PLGA 
particles on a glass slide (B) and particle drying and yield as a function of collection 
distance (C).  
A                   B                                 C 
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4.3.2 Particle appearance and crystallization 
Particles of pure CEL were prepared by electrospraying a solution of ACE containing 
5%wt CEL and collecting them on different substrates at a distance of 7 cm from the jet. 
SEM images of collected CEL particles are shown in Figure 4.11 and demonstrate that 
it is possible to obtain spherical microparticles without the addition of support materials 
such a polymer. Figures 4.11 A and B show that when collected directly on glass, 
spherical particles are formed and in some areas together with rod like relics connecting 
the spheres, presumably drug crystals. Such crystals would grow as a function of time 
and results in larger crystalline structures which makes them more stable. When 
collected on a glass slide with a film of water needle-shaped crystals begin forming  
(see Figure 4.11 A) immediately after collection and no spherical particles were 
observed. Water induces rapid crystallization of CEL microparticles by allowing more 
interaction between the hygroscopic CEL molecules. The rapid crystallization of CEL 
even in absence of water necessitates mixing it with a carrier material such as a polymer 
in order to stabilize the spherical particle structure and get prepare drug in a stable 
amorphous form. 
 
Figure 4.11 SEM images of CEL particles collected on glass slides without water (A 
and B) and with a thin layer of water (C). 
A                 B                   C 
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CEL-loaded PLGA particles were then prepared in the same way as for the CEL 
particles at different ratios of PLGA and CEL. SEM images of the prepared particles are 
shown in Figure 4.12 and it is seen that the particles all seem to be spherical with no 
characteristic needle-shaped CEL crystals protruding from the particles at the studied 
CEL loading (10%, 20% and 50%). This indicates that PLGA and CEL are mixed well 
within the particles and prevents CEL molecules from going together to form large 
crystal structures. It has also been demonstrated that PLGA can form interactions with 
drug molecules, and in this case hydrophobic interactions are likely between CEL 
molecules and hydrophobic segments of PLGA [Jeon et al. 2000].  
 
 
Figure 4.12 SEM images of CEL-loaded PLGA particles prepared in ACE with varying 
drug loading. 0% CEL (A), 10% CEL (B), 20% CEL (C), 50% CEL (D) and SEM 
images of electrosprayed PLGA particles taken with low magnification (E). 
The size of the particles were generally around 2-5 µm with the particle size decreasing 
as the drug loading was increased. The size distribution was generally narrow as it is 
observed in Figure 4.12 E and 4.13 and all particle samples were found to have a 
A                                          B               
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polydispersivity index below 10%, except for the particles prepared with 50% drug 
loading which were less homogenous. The particles seem to follow a Gaussian 
distribution indicating that particles size is influenced by several factors. The influence 
of different process parameters on particle size, morphology and porosity will be 
discussed in section 4.4. 
 
 
 
 
Figure 4.13 Size distribution of electrosprayed PLGA microparticles prepared with 
50% (A), 20% (B), 10% (C) and 0% drug loading (D).    
4.3.3 Physical form of CEL-loaded particles 
The physical form of the CEL microparticles and CEL-loaded PLGA microparticles 
was analysed using DSC and measured between 10 and 200 ºC at a heating rate of       
10 ºC/min. Figure 4.14 shows DSC thermograms for unprocessed CEL powder (A) and 
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electrosprayed CEL microparticles (B), measured within an hour after particle 
preparation. The unprocessed CEL powder shows a characteristic melting endotherm at 
162 ºC indicating that CEL is in a crystalline form. The electrosprayed CEL 
microparticles show both a similar endotherm peak at 162 ºC and an exotherm peak at 
90 ºC, and further no clear Tg event was observed around 58 ºC, the characteristic Tg of 
CEL [Gupta et al. 2005]. However, the exotherm peak observed could indicate the 
recrystallization of partly amorphous CEL in the microparticles. In this case, it seems 
that the glass transition signal may have been too weak to detect. A similar curve was 
also observed for unprocessed CEL powder which was quench-cooled using DSC to 
obtain amorphous CEL, suggesting that the electrosprayed CEL was also partly 
amorphous.   
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Figure 4.14 DSC thermograms of unprocessed CEL powder (A), electrosprayed CEL 
microparticles (B), CEL-loaded PLGA microparticles prepared in ACE with 50% (C), 
20% (D), 10% (E) and 0% (F) CEL-loading.  
DSC curves of CEL-loaded PLGA microparticles are also presented in Figure 4.14. 
Microparticles with 50% CEL (C) showed an exotherm peak at 97 ºC and an endotherm 
peak at 149 ºC indicating recrystallization and melting of CEL, respectively. The 
melting point may have been shifted downwards here by the presence of PLGA. No 
distinct glass transition event was observed although it seems likely that there would 
have been a glass transition for CEL, PLGA or both. Particles with 20% CEL (D) 
showed an endotherm event around 47 ºC, which is likely to be a glass transition and 
they further showed another event at 126 ºC, which could again indicate a shifted 
melting peak of CEL. Particles with 10% CEL (E) also showed an endotherm event 
around 47 ºC, which is likely to be a glass transition, but no melting endotherm was 
observed. Particles composed exclusively from PLGA (F) showed a glass transition 
around 51 ºC.  
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Generally, small downward shifts in the Tg were observed for particles with 20% CEL 
and 10% CEL compared with the Tg of pure PLGA particles. Only a single glass 
transition event was observed for particles with 20% CEL and 10% CEL although 
containing both CEL and PLGA. The single glass transition events observed could thus 
represent the glass transition of both PLGA and CEL, a common observation for solid 
dispersions where the drug is well dispersed in the polymeric matrix. It was also 
reported by [Dubernet 1995] that a reduction in the polymer Tg and an absence of drug 
melting peak may take place when a drug is in a solid solution inside a polymer matrix. 
The melting endotherms for CEL in CEL-loaded microparticles were shifted 
downwards or disappeared. All in all the observations indicate that CEL is in an 
amorphous form in the CEL-loaded PLGA particles and that interactions are present 
between PLGA and CEL. 
4.3.4 Comparison with micronized drug 
CEL microparticles were also prepared using ball milling for comparing with 
electrosprayed CEL particles. SEM images of ball milled CEL powder are shown in 
Figure 4.15 A and indicate elongated structures a few microns in their long axis. The 
XRPD diffractogram of ball milled CEL shown in Figure 4.15 B demonstrates that 
these micronized particles are partly amorphous and partly crystalline, based on the halo 
shape and crystalline peaks observed.    
Compared with the electrosprayed particles, these ball milled particles were fractioned 
from larger structures and are thus different in their shape, retaining the rod-like shape 
from the CEL crystals. The ball milled particles also seem more likely to stay in a 
crystalline state observed from their X-ray pattern.  
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Figure 4.15 SEM image of ball milled CEL (A) and XRPD of ball milled CEL (B). 
4.3.5 Drug release from drug-loaded PLGA particles 
Initially, drug release studies were performed using glass vials with 30 mL release 
medium where samples were taken at different time intervals, as explained in section 
3.12.1. The release medium consisted of a 50:50 v/v mixture of EtOH and H2O and was 
selected after studying several different solvent mixtures. CEL is poorly soluble in 
aqueous solvents and it was thus necessary to ensure that CEL could be fully dissolved 
in the release medium in order to study the drug release from the particles. The 
EtOH:H2O mixture was selected partly because it provides sink conditions for CEL. 
Also, PLGA is insoluble in EtOH:H2O and allows a diffusion driven release from the 
particles. Sink condition refers to the condition at which the drug is placed in a volume 
of medium which is greater than 3 times its saturation point. In the case where sink 
conditions is not maintained the drug release cannot be consistently measured because 
the medium approaches the saturation point. 
The UV absorbance measurements of the microparticles showed similar absorbance as 
for pure CEL and PLGA and indicates that CEL molecules remain chemically intact 
after being dissolved and exposed to a high voltage in the electrospraying process. UV 
absorbance was measured at 250 nm and showed a linear correlation between the 
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concentration of CEL and the absorbance measured. Drug entrapment measurements of 
the CEL-loaded microparticles showed that the amount of drug in the samples could 
deviate ± 10% from the originally added amount, which is possibly a result of 
measuring uncertainties.  
The drug release curves in Figure 4.16 show that the majority of CEL in the particle was 
released during the measurement for all three samples. A high burst release between  
39-54% was observed for all three samples indicating that a large amount of CEL was 
located near the surface of the particles. Particles with 50% drug loading had the highest 
drug release rate and were quickest to reach a plateau level in the release curve after 4 
days. The release rate decreased as the drug loading was reduced and particles with 10% 
drug loading showed the lowest release rate of the three curves. The drug release from 
particles could thus be modified by changing the drug loading of the particles. A similar 
observation was made by Piñon-Segundo et al., who demonstrated for polymer matrix 
microparticles that an increase in drug release rate results from an increase in porosity 
created in the polymer matrix as well as a reduction in the distance within the matrix a 
drug must diffuse through [Pinon-Segundo et al. 2005]. This may also well be the case 
here where the drug release rate increased when the drug loading was increased.  
Further control of the microparticle characteristics may also result in better control of 
the release profile, for instance a more constant release over a shorter time. The 
measured drug release profiles are not indicative of the release of CEL in vivo due to the 
much different conditions. It is believed that the biodegradable property of PLGA may 
provide increased drug release rates in vivo due to the presence of different enzymes and 
pH environments. The continuous renewal of release medium, in vivo, may also provide 
enhanced dissolution of CEL from the microparticles. Better resemblance to in vivo 
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conditions could be obtained by studying drug release in biorelevant media which 
contain relevant enzymes and solubilisers. 
 
Figure 4.16 Release of CEL from particles with 50% (solid line), 20% (dashed line) 
and 10% (dotted line) drug loading. Error bars indicate standard deviation from UV 
measurements. 
4.4 Parametric Study – Design and setup  
4.4.1 Design of study 
As a continuation of section 4.3, the fabrication of microparticles composed of CEL and 
PLGA were further studied by examining the influence of different formulation and 
operating conditions on the particle characteristics and drug release behaviour. The 
influence of four different parameters, flow rate, solute concentration, drug loading and 
type of solvent were investigated by selecting two or more data points for each 
parameter. For these studies ACE was again used as one of the solvents for dissolving 
and atomizing the solutes and acetonitrile (ACN) was used as the second solvent. ACN 
showed good sprayability, resulting in formation of a stable cone-jet, and is less volatile 
than ACE as clearly observed in Figure 4.10 with the lower evaporation rate of ACN.  
0
20
40
60
80
100
0 2 4 6 8 10
C
u
m
u
la
ti
v
e 
C
E
L
 r
el
ea
se
 (
%
) 
Time (days) 
Chapter 4. Results and Discussion 
124 
 
In section 4.2.3 the intrinsic viscosity of PLGA in both ACE and ACN were found and 
shown in Figure 4.8 and Table 4.4. The intrinsic viscosity gives an indication of the 
solvent power of the solvent to dissolve the specific polymer and the degree of 
interaction between the polymer and the solvent. Moreover, the intrinsic viscosity can 
be used to find the overlap concentration of a polymer:solvent system. The overlap 
concentration, c*, is given as: 
    
 
   
     (Equation 4.1) 
and indicates the transition concentration of polymer in a solvent at which the 
intermolecular interactions become important and transient networks are formed. In 
other words, this is the concentration at which the intra and inter-polymer chain 
entanglements begin to form [Baldursdóttir et al. 2003]. From the intrinsic viscosities of 
PLGA in ACE, 0.276 dL/g, and PLGA in ACN, 0.216 dL/g, the c* of the two systems 
were found to be 3.62% w/v and 4.63% w/v respectively. These values were considered 
for designing the experimental setup in order to also investigate the role of polymer 
chain entanglements in the spraying solutions on the electrospraying process. Three 
values for solute concentration were thus selected for each solvent system, one near the 
c* value for the polymer-solvent system, one below the c* value and one above the c* 
value. Thereby, the influence of c* and polymer conformational state on the particle 
attributes could be investigated. 
The values for drug loading were selected based on earlier observation from section 4.3. 
For this study a more incremental difference in the drug loading was examined. As for 
the flow rate, initial observations were made from applying high and low values for the 
flow rate, to see whether a stable jet could be maintained and if dry particles could be 
prepared. Based on these observations a suitable range was determined, 10-50 µL/min. 
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Other important parameters for the electrospraying process such as the applied voltage, 
current and sample collection distance were not studied in detail but optimized to 
achieve a stable cone-jet and uniform particles, and otherwise kept constant during the 
study (see Table 4.5).  
Table 4.5 List of microparticle samples prepared. 
Sample Solvent 
Solute conc. 
(%) 
Polymer conc. 
(%) 
Drug loading 
(%) 
Flow rate 
(µL/min) 
N1 ACN 7 6.3 10 10 
N2 ACN 7 6.3 10 30 
N3 ACN 7 6.3 10 50 
N4 ACN 7 4.9 30 30 
N5 ACN 5 4.5 10 30 
N6 ACN 3 2.7 10 30 
N7 ACN 3 2.1 30 30 
N8 ACN 3 2.7 10 10 
N9 ACN 3 2.7 10 50 
A1 ACE 7 6.3 10 10 
A2 ACE 7 6.3 10 30 
A3 ACE 7 6.3 10 50 
A4 ACE 7 4.9 30 30 
A5 ACE 5 4.5 10 30 
A6 ACE 3 2.7 10 30 
A7 ACE 3 2.1 30 30 
A8 ACE 3 2.7 10 10 
A9 ACE 3 2.7 10 50 
A10 ACE 7 7.0   0 30 
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4.5 Parametric Study – Particle characteristics 
Particle characteristics were studied by examining the particle morphology, size, 
porosity and inner structure using methodology described in the experimental section. 
The results for particles prepared with ACN are presented first and the results for 
particle prepared with ACE are presented subsequently for each section in order to 
divide the results for clarity.   
4.5.1 Particle morphology 
Particle size and morphology were studied using SEM, and representative SEM images 
of each sample produced are shown in Figure 4.17. Generally, the particles fabricated 
were spherical and some had visible pores on their surface while others appeared to 
have a smooth surface. The very small particles observed in some of the images are 
most likely offspring particles arising from Coulomb fission of the evaporating droplet 
[López-Jerrera and Gañan-Calvo 2004].  
Particles from samples N3, N6 and N7 all appeared to have small pores on their 
surfaces and particularly those from sample 3 were covered with homogenously 
distributed pores around 100 nm in size (see Figure 4.17J). In all cases the small surface 
pores were formed for droplets with a low surface area to volume ratio relative to their 
polymer concentration, for N3 due to their large volume and for N6 and N7 due to their 
low polymer concentration. The presence of such small pores on the surface could be 
explained by a pressure developing inside the particles during particles formation. 
Assuming that the particle shell was initially formed and was rigid enough to prevent it 
from collapsing, small pores may have formed to release some of the pressure 
accumulated inside [Park and Lee 2009].  
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Figure 4.17 Representative SEM images of different microparticle samples prepared in 
ACN: Samples N1(A), N2(B), N3(C), N4(D), N5(E), N6(F), N7(G), N8(H), N9(I), 
close-up of sample N3(J) and overview of sample N5(K).  
Particles from sample N7 were collapsed with a visible opening on one side, resulting in 
a cuplike morphology and revealing the inner particle structure. The collapse of these 
particles is explained by the low polymer concentration in the processed solution (≈ 
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2%). When the polymer concentration is low (relative to the c* of the system) it can 
result in the particle shell not being strong enough and collapsing due to lack of 
structural support, during solvent evaporation [Bittner and Kissel 1999]. 
 
 
    
Figure 4.18 Representative SEM images of different microparticle samples prepared in 
ACE: Samples A1(A), A2(B), A3(C), A4(D), A5(E), A6(F), A7(G), A8(H), A9(I), 
overview of sample A5(J).  
Representative SEM images of microparticle samples prepared with ACE are shown in 
Figure 4.18. The SEM images show that most of the generated microparticles had a 
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spherical-like geometry with either smooth or corrugated surfaces. Particles from 
samples A6-A9, prepared with 3% solute concentration (Figure 4.18 F-I), showed 
visible pores on their surface as observed with some of the samples prepared with ACN. 
This observation may be explained by the higher amount of solvent that needs to escape 
the electrosprayed droplets during solvent evaporation for 3% solute concentration, 
which could result in channels forming through the particle shell as the solvent escapes. 
A study by Megelski et al. also reported that the presence of humidity during particle 
formation can result in pores on the particle surface due to condensation of air 
surrounding the droplet, from the evaporative cooling of the droplet, resulting in water 
droplets which leave an imprint on the particle surface [Megelski et al. 2002, 
Srinivasarao et al. 2001]. A similar event may have taken place in the present study. 
Further, while particles from samples 4.18 A-E had smooth surfaces particle from 
samples 4.18 F-I showed corrugated raisin-like morphology. This type of morphology 
could have resulted from a collapse of the particles in the late stages of particle 
formation. Compared with the samples prepared with ACN more samples prepared with 
ACE have a rough morphology, indicating that at similar solute concentrations particles 
prepared with ACE are more prone to collapsing. The morphological differences 
between particles from Figure 4.17 G and 4.18 F-I could indicate that the former 
collapsed by exploding while the latter collapsed by letting out the remaining solvent 
from small pores on their surface. A similar event has been described by Farid et al. 
[Farid 2003]. The collapse of particles from sample N7 indicates that the solvent did not 
fully managing to evaporate before the particles were being collected.  The impact of the 
particle at collection may then have resulted in its collapse due to a thin shell. 
In similar studies, using ultrasonic atomization combined with spray drying for 
preparing drug-loaded microparticles, it was also reported that particle morphology may 
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depend both on solute concentration and on drug loading. With low solute 
concentrations it was observed that spherical particles could not form and that particles 
tended to collapse or shrink to give a “raisin-like” morphology [Bittner and Kissel 
1999]. In a study using electrospraying it was observed that particles became more 
spherical and less concave as the polymer concentration was increased towards the 
maximum value, at which a stable jet could be achieved [Xue et al. 2010]. These 
findings support the observations made from Figures 4.17 and 4.18, where particles 
with both raisin-like appearance and collapsed particles were observed at low solute 
concentrations, whereas higher concentrations gave rise to spherical particles, although 
not elongated particles.  
The particle morphologies observed could be explained by the c* of PLGA in the two 
solvents. Of the particle samples prepared with ACN, samples N5-N9 had a PLGA 
concentration below the calculated c* of the system (4.63% w/v) while for samples 
prepared with ACE, samples A6-A9, had a PLGA concentration below the c* of the 
system (3.62% w/v). This indicates that polymer entanglement had not yet initiated at 
the time of atomization. Polymer chain entanglement took longer time for particles from 
these samples and some of the samples thus may not have managed to become spherical 
and smooth. The differences in morphology seen between particles from sample N7 and 
A7 prepared using ACN and ACE, respectively, could be explained by the higher 
solubility of PLGA in ACE and hence a greater ability to retain the particle shell 
through polymer diffusion during drying. They may thereby manage to avoid collapsing 
and instead shrink. Xie et al observed in a similar study using electrospraying, that a 
faster evaporation rate of the droplets resulted in a smoother particle surface [Xie et al. 
2006b]. 
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Images of particles acquired using AFM (tapping mode) (see Figure 4.19) indicates that 
the particle surface was not smooth but had small pores (A) for particles prepared with 
ACN and a dotted pattern (B) for particles prepared using ACE. The morphology 
observed using AFM could be more representative of the actual surface morphology of 
the particles since the samples were not sputter coated and because the image depth 
contrast seems to be better with AFM compared with SEM. The particles were flattened 
before scanning with AFM, in order to provide a smaller curvature range for the 
cantilever and for better visualization of the surface morphology.  
        
Figure 4.19 Atomic Force Microscopy images of samples N2 (A) and A2 (B). 
4.5.2 Particle size 
The particles prepared ranged between 2-8 µm in diameter depending on the sample 
conditions and all samples had a relatively narrow size distribution with a 
polydispersivity index between 6.0% and 16.1% (see Table 4.6). Figure 4.20 
demonstrates that the particle size was dependent on a combination of processing 
parameters. Flow rate had the greatest influence on particle size with as much as a 
three-fold increase in size resulting from an increase in flow rate from 10 µl/min to 50 
µl/min (see Figure 4.20 A+B). This was the case for 3% and 7% solute concentration 
A                   B 
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and samples prepared with both ACN and ACE. The results are further consistent with 
previous studies [Chang et al. 2010; Jaworek and Sobczyk 2008] where a similar 
relationship was observed.  
The solute concentration also showed a clear trend with the particle size increasing as 
the solute concentration was increased (Figure 4.20 C). The solute concentration is 
proportional to the viscosity of the solution and the results obtained were consistent 
with similar reports on the influence of viscosity on particle size [Jaworek and Sobczyk 
2008; Rohner et al. 2004].  
Table 4.6 Characteristics of particle samples. 
Sample Yield (%) Entrapment eff. (%) Particle size (µm) Polydispersivity index 
N1 85  94 +/- 3 2.5 +/- 0.2  9.3 
N2 87  88 +/- 1 4.9 +/- 0.4 8.3 
N3 86  92 +/- 2 7.2 +/- 0.9 12.3 
N4 93  98 +/- 1 4.1 +/- 0.4 9.9 
N5 81  89 +/- 1 4.2 +/- 0.3 6.0 
N6 91  99 +/- 1 3.4 +/- 0.3 8.7 
N7 85  90 +/- 1 3.0 +/- 0.3 8.3 
N8 89  97 +/- 2  2.0 +/- 0.2 7.3 
N9 86  95 +/- 1 4.5 +/- 0.4 8.1 
A1 90 94 +/- 3 2.6 +/- 0.3 10.8 
A2 89 97 +/- 2 5.6 +/- 0.9 16.1 
A3 95 101 +/- 2 7.6 +/- 1.0 13.1 
A4 92 98 +/- 3 4.4 +/- 0.5 11.4 
A5 90 99 +/- 1 4.3 +/- 0.4 9.3 
A6 88 93 +/- 3 3.6 +/- 0.4 10.6 
A7 92 97 +/- 2 3.3 +/- 0.4 11.8 
A8 90 99 +/- 2 1.6 +/- 0.2 9.4 
A9 N/A N/A N/A N/A 
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Finally, the drug loading also had an influence on the particle size with the particle size 
decreasing as the drug loading was increased (Figure 4.20 D+E). Moreover, the effect 
observed was correlated with the solute concentration and a greater effect was seen 
between samples N2 and N4 (7% solute conc.) than between N6 and N7 (3% solute 
conc.). The influence of drug loading on particle size can be partly explained by the less 
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Figure 4.20 Mean diameter of 
particles prepared at different flow 
rates (A, B), solute concentrations 
(C) and drug loading (D, E). Error 
bars indicate standard deviation 
from the mean.  
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significant contribution of the drug compared with the polymer on the viscosity of the 
solution. The drug loading is further related to the electrical conductivity of the solution 
as shown in Table 4.3.  
The particle sizes measured were similar for particles prepared using ACE and ACN 
following the same trends as a function of flow rate, solute conc. and drug loading. Yet, 
the particles prepared with ACE were slightly larger than those prepared with ACN, for 
all sample pairs except those prepared with 3% solute conc. and 10 µL/min. 
Several studies have demonstrated that an increase in solute concentration and hence 
viscosity results in larger particles due to the larger diameter of the atomizing jet and the 
higher polymer density of the droplets formed [Jayasinghe and Edirisinghe 2002]. In the 
present study good proportionality was demonstrated between the solute concentration 
and particle size with good control of the particle size in a narrow range. An increase in 
flow rate had a similar increasing effect on particle size due to the larger droplets 
formed at high flow rates. In this case, larger droplets were formed with increasing flow 
rate, but since the droplets are unchanged in concentration, a larger volume of solvent 
must evaporate per unit surface area for the larger droplets to dry. Again proportionality 
was shown between the flow rate and particle size with good control of particle size. 
The drug loading mainly influences polymer concentration and hence solution viscosity 
but also has a significant effect on the electrical conductivity of the solution as seen in 
Table 4.3. An increase in the electrical conductivity reduces the particle size by 
increasing the tendency for the droplets to undergo Coulomb fission [Hartman et al. 
1999b]. A decrease in particle size was observed in all cases where the drug loading was 
increased thus supporting the explanation.  
The influence of the type of solvent on the particle size appeared to mainly be driven by 
the differences in electrical conductivity. The electrical conductivity of ACE is the 
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lower of the two solvents used and would therefore result in the larger particles as was 
the case in the study. Similar effect of the type of solvent on particle size was observed 
by Xie et al. [Xie et al. 2006b]. Further, the viscosities of ACE and ACN were similar 
and if anything they showed contradictory effects. Also, the lower evaporation rate of 
ACN (see Figure 4.9) could have resulted in more pronounced droplet shrinking and 
was further enhanced by the later polymer chain entanglement with ACN (explained 
from Figure 4.8). This effect of solvent evaporation rate on particle size can only be 
speculated upon in the work, as information on particle density is necessary to assess 
whether more porous particles were produced with ACN due to the balance between 
polymer diffusion and solvent evaporation. 
4.5.3 System yield and entrapment efficiency 
The collection yield of particles was measured to be between 81 and 95 wt% of the 
actual solute mass that was electrosprayed (see Table 4.6). Microparticle samples were 
collected onto electrically grounded sheets of aluminium foil and most of the particles 
were attracted onto the sheets. Yet due to the wide angle of the atomized jet some of the 
particles, possibly including small satellite droplets in the peripheries of the jet 
[Hartman et al. 1999a], were lost during flight, dispersed out in the surroundings or 
attracted onto other nearby surfaces. A part of the spraying solution may have also 
precipitated out on the outer surface of the nozzle wall during spraying.  
The collection yield could possibly be optimized by coating the surface of the nozzle 
with a non-conductive, hydrophobic material, by shielding all conductive surfaces in the 
vicinity of the jet and by increasing the area of the collection surface. In an actual 
manufacturing process the particles would most likely be atomized into a closed-loop 
chamber, similar to setups used for both laboratory-scale and commercial-scale spray 
dryers, and loss of material would be limited when producing large batches. Further, by 
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implementing a continuous manufacturing approach the material loss could be further 
reduced as the concept of batches would no longer be of same relevance. In this study 
there was no obvious correlation between the measured yield and the sample 
preparation conditions. However, the yield values in wt% obtained here are comparable 
or slightly higher than values reported with other liquid atomization techniques such as 
spray drying and ultrasonic atomization [Bittner and Kissel 1999, Maa et al. 1998, 
Sollohub and Cal 2010]. 
The drug entrapment efficiency ranged between 88-101% without any specific 
correlation between the parametric condition of the samples and the entrapment values 
observed. Using an Energy-dispersive X-ray spectroscopy (EDX) function built within 
the SEM apparatus used, the elements present in the particles were measured. This was 
done to examine whether the CEL molecules were actually entrapped within the particle 
observed in the SEM images to support the data from the drug entrapment efficiency 
(see Figure 4.21).  
EDX was performed on a single particle by marking the visible surface of the particle 
(Figure 4.21 A). The measurements indicated the presence of the elements sulphur (S) 
and fluorine (F), which are elements specific for CEL in this system. The gold (Au) and 
carbon (C) peaks derive from the gold sputter coating and carbon tape, respectively, 
both of which are present on the whole sample surface. An EDX measurement was also 
done in an empty area right beside the particle (Figure 4.21 B) as a negative control and 
showed that there was no measurable sulphur or fluorine. This suggests that CEL is at 
least partially present inside or on the surface of the microparticles. 
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Figure 4.21 EDX spectra of a single CEL-loaded PLGA microparticle (A) and a blank 
area of same size beside the particle (B). Carbon peaks were cropped due to their height.  
4.5.4 Porosity and inner architecture 
The porosity and internal structure of the microparticles was studied by making cross 
sections of the particles using FIB/SEM, and images from selected particle samples are 
shown in Figure 4.22. The images indicate that it was possible to section the particles 
using a weak FIB beam while preventing the particle from melting or collapsing. The 
images in Figure 4.22 A-J were captured using an SEM beam while the images in 
Figure 4.22 K+L were captured using a FIB beam. The latter are only shown to give an 
idea of the image resolution with FIB and the sectioning process.  
It was not possible to see different phases of CEL or PLGA which would indicate the 
presence of aggregates, and the images support that CEL molecules are dispersed within 
the PLGA matrix. Figure 4.22 indicates that all particle samples prepared using ACN 
(Figure 4.22 A-F) as well as A5 (Figure 4.22 G) had a porous interior while samples A2 
and A10 had a solid interior. Sample N6 was the most porous of the four samples 
prepared using ACN with large holes dominating its interior. Figures 4.22 C-E indicate 
that the porosity decreased as a function of solute concentration with sample N2 being 
the least porous. Further, the samples prepared with ACE were generally less porous 
than those prepared with ACN.  
Chapter 4. Results and Discussion 
138 
 
     
    
    
Figure 4.22 FIB/SEM images of microparticles showing the cross-sectional structure of 
sample N6 before (A) and after (B, C) milling, sample N5 (D), sample N2 (E), sample 
N1 (F), sample A5 (G) and sample A2 (H, I), sample A10 (J), and FIB beam images of 
samples N6 (K) and A10 (L). 
The formation of pores in the particles could be explained by several mechanisms that 
influence the formation of particles. During particle formation solvent evaporation takes 
place at the surface and a shell is typically formed entrapping solvent in the particle core 
[Yao et al. 2008]. As the remaining solvent evaporates across the shell it may leave 
behind pores and result in visible pores on the surface of particles as was observed. In a 
A              B         C       D  
E             F         G     H  
 I              J           K      L  
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study by Park and Lee it was reported that the solvent used influenced the porosity of 
the particles prepared with electrospraying, and with volatility solvents resulting in 
more porous particles than low volatility solvents [Park and Lee 2009].  
In this study, ACN had a lower evaporation rate than ACE but the particles prepared 
using ACN were more porous than those prepared using ACE. Thus the opposite 
relationship between solvent volatility and particle porosity was observed. The 
contradicting results could be explained by differences in properties of the solvents 
used, in addition to evaporation rate, such as the solubility of polymer in the solvent or a 
combination of different properties. 
The lower solvent power and lower evaporation rate of ACN could have led to earlier 
PLGA precipitation and shell formation, and resulted in larger amount of solvent 
trapped within the solidifying particles compared with particle formation using ACE. 
The larger amount of solvent entrapped inside the shell is likely to result in higher pore 
volume as was observed. A higher degree of porosity was observed for particles 
prepared at 3% solute conc. compared with particles prepared at 5% and 7% solute 
conc. This is again explained by the larger volume of solvent that had to escape the 
particle core and the lower polymer concentration available to maintain the inner 
particle structure. The drug loading is likely to have had similar but smaller effect on 
particle porosity by altering the polymer concentration of the solution but was not 
examined. Flow rate was demonstrated to have the greatest influence on droplet size 
and hence particle size, with more solvent likely to be entrapped within their large 
particle shell. Particles prepared at high flow rates are thus believed to be more porous 
than particles prepared at low flow rates. This is also indicated by the porous surfaces of 
particles prepared at 50 µl/min (see Figure 4.17 J). However, flow rate is believed to 
have less influence on porosity at high solute concentration since the polymer 
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concentration is unchanged and could maintain the internal structure during solvent 
evaporation.  
4.5.5 Solid state form of CEL 
The solid state form of CEL within the particles was studied using XRPD and selected 
diffractograms are shown in Figure 4.23. It was observed from Figures 4.3 and 4.7 that 
CEL was crystalline both in its pure form and when physically mixed with PLGA, by 
the characteristic peaks observed.  
      
Figure 4.23 XRPD diffractograms of particle samples prepared using electrospraying at 
different parametric conditions. Samples N1 (A), N2 (B), N4 (C), N5 (D), N6 (E), N7 (F). 
 
4.5.6 Physical stability 
Selected CEL-loaded microparticles were stored in a climate chamber at a temperature 
of 20 ºC and a humidity of 60% at all times after particle preparation to determine the 
physical stability on the solid dispersions prepared. A well-known disadvantage of solid 
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dispersions and amorphous drugs is their possible instability under storage [Kaushal et 
al. 2004]. The solid-state stability of the microparticles was therefore studied for a 
period of 8 months using XRPD analysis to detect possible changes in crystallinity. 
Figure 4.24 shows XRPD diffractograms of microparticles from sample N2 taken with 
two months gaps. No visible changes were observed during the 8 months in storage, 
which indicates good physical stability. To further support these findings, SEM images 
of samples were taken after 8 months of storage and it was observed that the particles 
still maintained their shape and size, indicating no crystalline growth or agglomeration. 
      
Figure 4.24 XRPD diffractograms of microparticles taken during 8 months of storage. 
4.6 Parametric Study – Drug release 
4.6.1 Solubility measurements 
In this study the drug release was studied using a paddle dissolution apparatus described 
in section 3.12.2. Initially, the solubility of CEL in phosphate buffer added Sodium 
Lauryl Sulphate (SLS) was determined in order to ensure sink conditions. 
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1.2 mg CEL was added to 100 mL of Phosphate buffer with and without SLS and stirred 
for 3 hours at slightly elevated temperatures, and subsequently the amount of CEL 
dissolved was measured using HPLC. The maximum concentration of CEL used in the 
release studies was   6 mg in 500 mL of release medium and thus 1.2 mg CEL was 
added to 100 mL medium. The percentage of CEL dissolved in phosphate buffer with 
different SLS concentrations is shown in Table 4.7 and indicates that 0.3% SLS is 
required to fully dissolve the given concentration of CEL. In the subsequent drug 
release studies phosphate buffer with 1.5% SLS was used to ensure sink conditions for 
all samples.  
Table 4.7 Solubility of CEL in phosphate buffer containing different conc. of SLS. 
Drug release medium % CEL dissolved  
H2O 4.8 
Phosphate buffer + 0% SLS 3.2 
Phosphate buffer + 0.05 %wt. SLS 13.9 
Phosphate buffer + 0.1 %wt. SLS 66.6 
Phosphate buffer + 0.2 %wt. SLS 72.2 
Phosphate buffer + 0.3 %wt. SLS 103.7 
Phosphate buffer + 0.4 %wt. SLS 104.3 
Phosphate buffer + 0.8 %wt. SLS 104.8 
Phosphate buffer + 1.5 %wt. SLS 102.2 
Further, drug release studies performed for electrosprayed microparticles in release 
media consisting of phosphate buffer with and without SLS showed that the addition of 
SLS had a significant influence on the amount of CEL released from the particles (see 
Figure 4.25). 
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Figure 4.25 Drug release profile of microparticles prepared with 5% solute 
concentrations, with 20% drug loading using ACE, measured over 24 hours in release 
medium with and without SLS. 
4.6.2 Drug release profiles 
CEL release profiles from the microparticles are shown in Figures 4.26-4.30. Drug 
release from the microparticles took place at a time-varying rate, with an initial burst 
release followed by a diffusion driven release. The burst release in the first 15 min was 
between 5 and 50% of the cumulative release, depending on the particle sample. All 
microparticle samples released between 84 and 98% of their drug content within 20 
hours of exposure to the dissolution medium under sink conditions. Figure 4.26 shows 
that pure CEL dissolved almost instantaneously and stayed dissolved in the dissolution 
medium. Many of the samples did not reach above 90% release during the 24 hours of 
measurement, indicating that there was still drug entrapped within the polymer matrix. 
Degradation of PLGA typically does not take place within this time span and this could 
explain the residual drug trapped within the polymer network [Klose et al. 2008]. 
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Figure 4.26 Drug release profile of microparticles prepared with different solute 
concentrations, with 10% drug loading and at a flow rate of 30 µl/min, measured over 
24 hours. Error bars indicate standard deviation. 
 
Figure 4.27 Drug release profile of microparticles prepared with different drug loading 
at a flow rate of 30 µL/min, measured over 24 hours.  
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It was observed that the drug release rates increased as the solute concentration was 
reduced, both for ACE and ACN (see Figure 4.26 and 4.30), and samples A2 and N2 
with the highest solute concentration had the release curve closest to a linear curve. The 
drug release curves of samples prepared with different drug loading (see Figure 4.27) 
showed that an increase in drug loading resulted in a significant increase in drug release 
rates, both for 3% and 7% solute concentration. Comparison of drug release from 
particles prepared at different flow rates (see Figure 4.28) did not show a clear trend. 
Samples A1 and A3 both release their drug quicker than sample A2.   
 
Figure 4.28 Drug release profile of microparticles prepared with ACN and with 7% 
solute concentration and 10% CEL at different flow rates measured over 24 hours. 
Figures 4.26-4.28 indicate that solute concentration, drug loading and flow rate all had 
an influence on the measured drug release profiles. Translating to the observed particle 
properties particle size, morphology, porosity and drug density all influenced the drug 
release from the particle. A reduction in particle size resulted in an increase in the drug 
release rate. This can be explained by the increase in the surface area to volume ratio of 
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the particles as the size was reduced, resulting in an increase in the dissolution rate 
according to the Noyes-Whitney equation, and therefore not surprising. Although the 
flow rate had the greatest influence on particle size the correlation between surface area 
and release rate was not clear in Figure 4.28. This could be due to a high degree of 
surface porosity in the particles from sample N3.  
The degree of porosity observed from the cross section images (Figure 4.22) was 
inversely proportional to the size of the particles (Figure 4.20) and also seemed to 
influence the release rate. Drug release rate increased with increasing porosity which is 
partly explained by the differences in particle size but can also be due to an increase in 
the surface area to volume ratio as a result of porosity. Access of release medium 
through pores into the core of the particles would most likely result in an increase in 
drug release rate. However, it is difficult to distinguish between the effect of particle 
size and porosity on the release rate based on the data from this study.  
The influence of drug loading on drug release is consistent with observations from other 
studies [Berkland et al. 2002; Pinon-Segundo et al. 2005] and could have two 
explanations:  
1) that the increase in drug density reduces the relative amount of polymer matrix acting 
as a diffusional barrier. 
2) that a partial phase separation occurs between the drug and polymer molecules 
resulting in increased release rate due to pores created by the drug phase.  
Both of these explanations may account for the increased release rate observed.  
Comparisons of drug release from samples prepared using ACE and ACN (Figure 4.31 
and 4.32) show that particles prepared with ACN release slightly quicker than those 
prepared in ACE in most cases, except for samples A2 and N2 where A2 released 
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quicker. Moreover, a large difference is observed between the release rates of A4 and 
N4. The higher release rates from particles prepare with ACN could be explained by the 
smaller particles produced with ACN which thereby release their drug load quicker. 
Further, particles prepared using ACN were slightly more porous on their surface 
(Figure 4.18). Also, inside the particles cross section images for instance showed 
porosity for sample N2 whereas the particle from sample A2 was solid (Figure 4.23) 
explained by less polymer entanglement and slower drying with ACN. Even a modest 
presence of pores is believed to have a visible effect on the drug release rate from the 
particles given the larger surface area they result in. Particles that were collapsed 
(Figure 4.18 and 4.19) exposed more surface area and are therefore also expected to 
have quicker release. Finally, the more extended and interactive polymer conformation 
of PLGA in ACE could mean that can incorporate more drug molecules within its 
matrix compared with PLGA in ACN.  
 
Figure 4.29 Drug release profile of microparticles prepared with ACE at different 
solute conc. at a flow rate of 30 µL/min and 10% CEL. 
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Figure 4.30 Drug release profile of microparticles prepared with ACN or ACE at 3% 
solute conc. and 10% or 30% CEL measured over 20 hours. 
 
Figure 4.31 Drug release profile of microparticles prepared with ACN or ACE at 3% 
solute concentration and 10% or 30% CEL measured over 20 hours. 
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4.6.3 Drug release models 
Curve fitting 
Drug release from the electrosprayed microparticles mainly took place via diffusion 
mediated release and this was demonstrated by fitting the selected release curves with 
the Higuchi model. In the Higuchi model, release of drug is based under the 
assumptions that the drug molecules are dispersed within a solid matrix and are released 
through diffusion from the surface, mediated by the surrounding solvent. According to 
the Higuchi model, drug is released linearly as a function of the square root of time 
[Higuchi 1963]. Figure 4.32 shows drug release curves of microparticles prepared with 
ACN at 7% solute concentration and 10% CEL loading as a function of the square root 
of time. All three curves were fitted with linear regression in the first 6 hours of release 
and gave the R
2
 values 0.976, 0.995 and 0.998 and dissolution constants 27, 22 and 24 
% release / s
1/2
 for samples N1, N2 and N3, respectively.  
It is observed that the curves all follow their trend line very well with only minor 
deviation in the first 6 hours of drug release as seen in the figure. After the first 6 hours, 
drug release decelerates and begins deviating from the model in the remaining 18 hours. 
The good accuracy of the curve fitting indicates that the Higuchi model fits well for a 
major part of the drug release data points and thus indicates that the drug release from 
the electrosprayed particle samples is controlled by diffusion driven release. However, 
the Higuchi model did not apply well on the drug release from microparticles prepared 
with less than 5% solute concentration as well as samples with a drug loading of 30%. 
The fitted release curves for these samples are therefore not shown here. It is believed 
that the model did not fit on these samples due to their higher degree of porosity inside 
the particles and because of the lower diffusion barrier provided by PLGA with 
increasing drug loading (the latter is mentioned in section 4.3.5).   
Chapter 4. Results and Discussion 
150 
 
 
Figure 4.32 Selected drug release curves fitted to the Higuchi model.  
 
Figure 4.33 Selected drug release curves fitted to the Higuchi model.  
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and 0.995 for samples N5, A4 and A2, respectively. It is again observed that the curves 
follow their trend line very well with only minor deviation in the first 6 hours of drug 
release indicating good fitting with the Higuchi model. Thus, the drug release from 
these particles samples can be said to take place by diffusion mediated release, at least 
in the first 6 hours of release.  
 
Figure 4.34 Selected drug release curves fitted to the modified Higuchi model.  
Figure 4.34 shows selected drug release curves fitted with a modified version of the 
Higuchi model as a function of the square root of time. Here the curves were fitted with 
a level 2 polynomial regression instead of a linear regression and gave the R
2
- values 
0.997, 0.998, 0.999, 0.995 for the samples N5, A4, A2 and N2, respectively. All of the 
curves fitted very well with their trend line for a period of 20 hours. Although the linear 
regression on Figure 4.32 gave lower R
2
 values than the polynomial regression these 
curves only followed the trend lines in the first six hours of drug release. In comparison, 
with the polynomial regression the curves followed the trend lines for the whole 20 
hours, indicating a better fit of the polynomial regression. Again, the modified Higuchi 
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diffusion model was not compatible with the release profile of some particle samples as 
they released their drug load at a quicker rate.   
Curve fitting of selected drug release curves for samples with low release rates (see 
Figures 4.32-4.34) supports the hypothesis of a diffusion driven release mechanism 
according to the Higuchi release model [Higuchi 1963]. However, the Higuchi model 
was modified by using a level 2 polynomial regression due to improved correlation over 
a straight line. The drug release rate from the CEL-loaded PLGA particles was observed 
to fall off with time (after 6 hours of release) compared with a conventional linear 
Higuchi model. This could be explained by an inhomogeneous radial distribution of 
CEL in the particles, a reduced diffusion rate due to the distance travelled or a lack of 
sink condition. Also, samples with quicker release rates did not fit well with the Higuchi 
model, indicating either high porosity in the particles, an uneven drug distribution 
towards the surface of the particles or clustering of drug molecules due to lack of 
interaction with the polymer chains.  
Other researchers have reported similar trends in the release profile with an initial burst 
followed by a diffusion-mediated release [Mu and Feng 2001, Wang and Wang 2002, 
Xu and Hanna 2006] from drug-loaded, biodegradable microparticles prepared with 
electrospraying and other particle preparation techniques. In many of these studies drug 
release took place over longer time, from several days to weeks, including partial 
release through erosion of the polymer, although the particles were of similar size. The 
quicker release observed in this study could be explained partly from the porosity of the 
particles, the sink conditions provided in the present study and the relatively small size 
of the drug (Mw=381.38 g/mol), which has been shown to increase drug mobility and 
enable quicker release [Freiberg and Zhu 2004, Huang and Brazel 2001, Klose et al. 
2006]. 
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4.7 Particle elongation 
It has been shown in several studies that the shape of particles has an influence on the 
mechanisms of drug delivery as well as on the interactions with cells. It affects the drug 
release kinetics from the particles and can be tailored to obtain controlled release 
profiles [Abebe 2002, Klose et al. 2008]. A large surface to volume ratio of the particles 
results in both quicker release as well as better attachment to cells for targeting purposes 
[Fugh-Berman 2000]. Also, it has been demonstrated that the vascular clearance rate of 
particles by phagocytes is dependent on the geometry of the particles, with elongated 
particles being phagocytised much slower than spherical particles [Champion and 
Mitragotri 2006].   
With electrospraying it is known that spraying of high viscosity solutions may result in 
fibre-like appearance of the resulting particles, typically with thin fibres connecting 
individual particles, like beads on a string [Shenoy et al. 2005b]. Also, in section 2.4.5 it 
was mentioned that droplets produced with electrospraying undergo Coulomb fission 
due to accumulation of charge on the droplet surface as the droplet shrinks from solvent 
evaporation. Further, it was predicted by Rayleigh that at a threshold, known as the 
Rayleigh limit, Coulomb instabilities would result in a temporary elongation of the 
droplet and emission of thin jets from the droplets [Rayleigh 1882]. This was 
experimentally confirmed by Duft et al. who captured microscopy images of the 
elongation and jet emission of a droplet using single droplet levitation (see Figure 4.35) 
[Duft et al. 2003]. It was observed that droplet became more and more elongated until it 
emitted lateral jets, and then gradually returned to its spherical shape. Also, Li et al. 
have demonstrated that elongated particles can be produced by solidifying droplets 
during Coulomb instability using a sol-gel reaction (see Figure 4.36). This indicates that 
if solidified at the right moment, particles of different geometry can be formed with the 
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electrospraying process. However, the mechanism is believed to be very difficult to 
control given the short intervals noted in Figure 4.35. 
             
 
               
 
In the present study CEL/PLGA solution were electrosprayed at high solute 
concentration (> 10% w/v) to study the effect on particle shape. Particles were prepared 
using 10% and 11% solute concentration, with 20% drug loading and sprayed at a flow 
rate of 25 µL/min. A different PLGA product (from Purac) was used for this study, with 
a lower molecular weight, than the PLGA (from Evonik) used in the previous studies 
(see section 3.1.1). A stable cone-jet was obtained and particle samples were collected 
Figure 4.35 A droplet (radius, 24 µm) during Coulomb instability elongates and 
fires lateral jets and returns to its original spherical shape. Images taken at time (in 
µs) 140 (A), 150 (B), 155 (C), 160 (D), 180 (E) and 210 (F) [Duft et al. 2003]. 
Figure 4.36  Elongated particles produced from Titanium oxides using sol-gel 
reaction to capture shape during Coulomb instability [Adams and Brantner 2010]. 
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on glass slides for the two samples. SEM images of the particle samples collected 
indicated mainly two types of particle shapes, tadpole-shaped particles (Figure 4.37 A, 
B) in samples prepared at 10% solute concentration and elongated, rod-shaped particles 
(Figure 4.37 C, D, E) in samples prepared at 11% solute concentration. Although some 
elongated particles were observed at 10% solute concentration and some tadpole-shaped 
particles were observed at 11% solute concentration the particle samples were 
surprisingly homogeneous. The results observed could be explained by the Coulombic 
elongation phenomenon described earlier in this section. The particles may have 
solidified during the droplet elongation phase, by chance, due to the high solute 
concentrations used. Yet the results have been reproduced several times demonstrating 
that such structures can be produced and perhaps controlled.  
          
  
Figure 4.37 SEM images of particles prepared at 9% solute concentration (A, B) and 
particles prepared at 10% solute concentration (C, D, E). 
 A          B           C 
 
 
 
 
D       E 
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4.8 Summary 
PLGA microparticles containing CEL, a low solubility drug, were prepared using 
electrospraying with the objective of producing near-monodisperse microparticles with 
the drug in an amorphous form. It was found that near-monodisperse CEL-loaded 
PLGA microparticles could be produced at different polymer:drug ratios. Thermal 
analysis and XRPD measurements further indicated that CEL was present in an 
amorphous form inside the microparticles. Drug release studies showed diffusion driven 
release with an initial burst release and indicated drug release kinetics dependent on 
particle characteristics.  
Parametric studies on particle characteristics demonstrated that electrospraying is a 
precise and controllable technique for producing drug-loaded microparticles with 
pharmaceutically useful physicochemical properties. The size and morphology of CEL-
loaded, electrosprayed PLGA microparticles particles could be controlled by adjusting 
the flow rate, solute concentration and drug loading, with flow rate having the greatest 
influence. The porous inner structure of the particles was explained by an early shell 
formation and subsequent evaporation of ACN during particle formation. Particle 
porosity was dependent on solvent concentration but remains to be investigated in 
detail. Although, CEL was presumably in an amorphous state, XRPD analysis 
demonstrated that the CEL dispersion in the PLGA particles were physically stable for 
more than 8 months.  
The release of CEL from the particles could be controlled to provide a rapid release 
over a few hours or a sustained release over 24 hours. Particle size, porosity and drug 
loading had the greatest influence on the release rate and some of the release profiles 
could be fitted to the Higuchi diffusion release model. Particles prepared at 5 or 7% 
solute concentration with a drug loading of 10% and at a flow rate of 10 or 30 µl/min 
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thus seem the most suitable of the samples from this study and depending on the desired 
release rate these parameters can be chosen accordingly. Careful control of the drug 
distribution within particles would greatly impact the drug release mechanism, possibly 
resulting in more useful extended release behaviour with improved bioavailability and 
therapeutic efficacy.  
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Chapter 5 
Electrospraying of solid dispersions: The influence of 
mixed solvent systems on particle formation, particle 
characteristics and controlled drug release 
 
This chapter describes the further investigation of electrospraying for preparing solid 
dispersion microparticles using the poorly soluble drug Celecoxib (CEL) as a model 
drug. Microparticles from poly(lactic-co-glycolic acid) (PLGA) as well as hypromellose 
acetyl succinate (HPMCAS) containing CEL were prepared with the objective of 
producing microparticles with controlled particle characteristics and drug release 
profile. Particles were prepared with solvent mixtures at different ratios to investigate 
the influence of solvent composition on the resulting particle morphology, porosity, 
drug distribution and drug release profile as well as the particle formation process. For 
CEL-loaded PLGA particles it was found that microparticles were highly influenced by 
the presence of an anti-solvent, methanol, to PLGA, and the particle size, morphology, 
drug distribution and drug release changed gradually with increasing amounts of anti-
solvent. CEL-loaded HPMCAS particles were also influenced by variations in the 
solvent composition, especially with respect to their particle morphology. However the 
drug distribution in the HPMCAS microparticles and their drug release profiles did not 
seem to be greatly influenced, compared with the PLGA particles. 
5.1 Mixed solvent study – Characterization of solvents and solutions 
As a continuation of the parametric study described in sections 4.4-4.6 the same model 
polymer, PLGA, and drug molecule, Celecoxib, were used to study particle formation 
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and performance with the focus shifted towards the solvent compositions used in 
preparation of the particles. The study was performed with a specific interest in 
studying the resulting particle morphology, the distribution of drug within the particles 
and the drug release profile.    
5.1.1 Selection of solvents 
The solvents and solutions for particle preparation were again selected based on some 
conditions that allow consistent preparation of near-monodisperse particles and 
differentiation in particle attributes and performance. For this study a binary solvent 
system was used with the two solvents having markedly different evaporation and 
solubilisation properties, in order to influence the resulting particle properties. It was 
established in the previous chapter that solvent properties such as their evaporation rate 
and solvent power have an important influence on particle formation. Other studies have 
also reported, both with electrospraying and with other liquid atomization techniques, 
that the interplay between evaporation rate of solvents and solubility and migration of 
solutes within droplets has an important role in the formation of polymeric particles 
[Tsapis et al. 2002, Vehring et al. 2007, Yao et al. 2008].  
Table 5.1 Physical properties of the solvents used to fabricate microparticles. Values in 
italic are adapted from [Smallwood 1996]. 
Property Acetone Methanol 
Viscosity (mPa ·s) at 25 °C       0.30          0.57 
Boiling point (°C)       56.0         64.0    
Evaporation rate (BuAc=1)*       5.6         4.1 
Dielectric constant       20.6         32.6 
Electrical conductivity (µS/m)       6         50 
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Acetone was again selected as one of the solvents due to its good ability to dissolve 
PLGA and its high evaporation rate, allowing dry particles to be formed at collection. 
Methanol was selected as the other solvent due to its poor ability to dissolve PLGA but 
intermediate capacity to dissolve CEL. The difference in the solubility of the solutes, 
i.e. CEL and PLGA in MeOH is thought to have an influence on the solidification 
process during particle formation. Further, MeOH has a lower evaporation rate than 
ACE and thus the concentration of MeOH would increase as the solvents evaporate and 
result in a greater effect on the solidification process. 
5.1.2 Design of study – solutions and samples 
The solubility of CEL and PLGA in ACE and MeOH were measured and shown in 
Table 5.2. Four different ratios of the solvent compositions of ACE and MeOH, i.e. 
100:0, 90:10, 75:25, 69:31, all indicated in molar ratio, were selected to dissolve CEL 
and PLGA. These values were selected to have a few ratios between pure ACE and a 
ACE:MeOH ratio close to the saturation point for PLGA (ACE:MeOH - 65:35) for a 
solute concentration of 5%, at which PLGA is precipitated out to form a suspension. A 
solute concentration of 5% was chosen due to the successful previous preparation of 
microparticles at 5% solute concentration and in order to set up comparisons with spray 
drying at similar concentrations. Samples were prepared at a constant flow rate using 
10% or 20% drug loading to examine differences in particle characteristics and release 
upon different values of drug loading.  
5.1.3 Characterization of spraying solutions 
Electrical conductivity  
Measurements of electrical conductivity of the CEL and PLGA solutions showed that 
solutions containing CEL were much more electrically conductive compared with 
solution containing PLGA (see Table 5.3), which indicates that CEL carries more 
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electric charge relative to PLGA. Further, the electrical conductivity increased as the 
MeOH concentration was increased both in solutions containing CEL and PLGA, 
indicating that MeOH is more conductive than ACE. As observed in the previous 
chapter, the electrical conductivity of solutions influences the properties of particles 
prepared with electrospraying, most notably with an increase in conductivity resulting 
in a decrease in particle size [Gañan-Calvo et al. 1997].  
Table 5.2 List of microparticle samples prepared. 
Sample ACE:MeOH 
molar ratio 
Solute conc. 
(%) 
Polymer conc. 
(%) 
Drug loading 
(%) 
Flow rate 
(µL/min) 
10D100:0 100:0 5 4.5 10 30 
10D90:10 90:10 5 4.5 10 30 
10D75:25 75:25 5 4.5 10 30 
10D69:31 69:31 5 4.5 10 30 
20D100:0 100:0 5 4.0 20 30 
20D90:10 90:10 5 4.0 20 30 
20D75:25 75:25 5 4.0 20 30 
20D69:31 69:31 5 4.0 20 30 
 
Table 5.3 Electrical conductivity of solutions containing CEL or PLGA. 
Solution Electrical conductivity (µS/m) 
5% CEL in ACE:MeOH (100:0) 101 
5% CEL in ACE:MeOH (90:10) 105 
5% CEL in ACE:MeOH (75:25) 109 
5% CEL in ACE:MeOH (69:31) 111 
5% PLGA in ACE:MeOH (100:0) 23 
5% PLGA in ACE:MeOH (90:10) 26 
5% PLGA in ACE:MeOH (75:25) 32 
5% PLGA in ACE:MeOH (69:31) 37 
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Viscosity and polymer configuration 
Rheological measurements of the spraying solutions showed that the viscosity decreases 
as a function of the MeOH concentration of the solution (Table 5.4). Yet, it was 
observed from Table 5.1 that ACE is less viscous than MeOH, which seems 
contradictory with the dynamic viscosity values observed in Table 5.4. This can be 
explained by the better solvent power of ACE compared with MeOH which allows the 
polymer chains to extend out and possibly interact with each other, resulting in a steeper 
increase in viscosity as a function of polymer concentration. The addition of CEL did 
not have a noticeable influence on the viscosity of the solutions compared with PLGA 
and was thus left out in the measurements to simplify the study on polymer 
conformation. The greater influence of PLGA on the viscosity is explained by the much 
higher molecular weight and hydrodynamic volume of PLGA compared with CEL.  
 
Figure 5.1 Specific viscosity / PLGA concentration of spraying solutions plotted as a 
function of PLGA concentration.  
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The conformational structure and solubility of PLGA in ACE:MeOH feed solutions 
were studied by determining the intrinsic viscosity, Martin constant and overlap 
concentration. The intrinsic viscosity was determined as the y-intercept of the specific 
viscosity / PLGA concentration curve (see Figure 5.1) as described in the methods 
section (see section 3.2.4). The Martin constant and overlap concentration were then 
found using equations 3.5 and 4.1. The intrinsic viscosity of PLGA in the feed solutions 
ranged between 0.15 and 0.24 dL/g and decreased as the MeOH content was increased. 
The observed trend indicates that solubility of PLGA is highest in pure ACE with more 
extended chains and gradually decreases as MeOH is added, until PLGA begins to 
precipitate at 65:35 ACE:MeOH molar ratio. The Martin constant calculated at 5% 
PLGA concentration increased as a function of MeOH concentration and indicated more 
interaction between PLGA molecules and between PLGA and solvent, as the MeOH 
concentration was increased. The overlap concentration, c*, ranged between 4.23 and 
6.49 and increased as a function of MeOH concentration. This indicates that the cross 
over concentration at which polymer chains begin to entangle with each other becomes 
higher as the MeOH content is increased.  
Table 5.4 Viscosity related properties of PLGA solutions with different solvent ratios.  
Solution 
Dynamic viscosity 
(mPa·s) at 25 °C 
Intrinsic 
viscosity 
(dL/g) 
Martin 
constant  
(5% PLGA) 
Overlap 
conc. (c*) 
PLGA in 
ACE:MeOH (100:0) 
1.13 0.24 0.71 4.23 
PLGA in 
ACE:MeOH (90:10) 
1.04 0.22 0.82 4.90 
PLGA in 
ACE:MeOH (75:25) 
1.03 0.18 0.88 5.45 
PLGA in 
ACE:MeOH (69:31) 
0.95 0.15 1.19 6.49 
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Evaporation profile 
The evaporation profiles of the solvent mixtures and the feed solutions are shown in 
Figure 5.2 A-D. Figures 5.2 A and 5.2 C show that evaporation of solvent from the 
solvents and feed solutions took place at a steady rate until the solvent had fully 
evaporated (A) or until a lower limit was reached corresponding to the solid 
components (C). The time scale of the evaporation process was similar for all the 
samples but with evaporation taking place at a slightly lower rate with increasing 
MeOH concentration. Figures 5.2 B and 5.2 D show the evaporation rate of the solvent 
mixtures (B) and the feed solutions (D) as a function of time and indicate that the 
evaporation rate decreased continuously for all samples. Initially, a high evaporation 
rate was observed, which decreased gradually and then more sharply, followed by 
another slow decrease. The evaporation time was generally shorter for the solvent 
mixtures than for the feed solutions. Figures 5.2B and 5.2D also indicate that the 
evaporation rate became slightly lower with increasing MeOH concentration.   
Although the evaporation rate was here measured by mimicking the drying process with 
electrospraying it may be quite different from the actual drying process. Under the 
current setting it was not possible to directly measure droplet drying rates during the 
actual electrospraying or spray drying process due to the small size and short 
evaporation times of the atomized droplets. Therefore, model systems are typically used 
to study the drying kinetics such as the single droplet models described in section 2.3.2. 
Here, we studied the drying kinetics of different solvent systems by measuring the 
evaporation rates of the solvents and the feed solutions as a function of time, by 
monitoring the weight loss of a drop using TGA under fixed temperature, surface area 
and nitrogen flow. Although the drop that was studied here is many times larger than 
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the small droplets produced from the atomizing nozzle the same heat and mass transfer 
processes were assumed to apply during drying of the larger drop.    
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Figure 5.2 Evaporation of solvent mixtures (A) and solutions (B) at 25 ºC and the first 
derivative of the evaporation curve for solvents (C) and solutions (D).  
5.2 Mixed solvent study – Particle formation 
Particle engineering relies largely on understanding the underlying particle formation 
mechanisms. Electrospraying (production of particles) and electrospinning (production 
of fibres) are essentially two sub-techniques based on similar physical principles with 
solutions of higher viscosity being used for electrospinning. It has been reported that the 
formation of chain entanglement of the polymer in the solution has an important effect 
on the progression in fibre formation with electrospinning [Shenoy et al. 2005b, Zhang 
et al. 2012]. It is equally important that the absence or limited progression of such chain 
entanglement leads to the formation of particles instead of fibres at a given critical limit 
with some overlap between the two resulting types of products [Almeria et al. 2010]. 
The overlap concentration is an indicator for degree of inter-chain entanglement in a 
given polymer/solvent combination. Further, polymer entanglement levels cannot be 
very high before Coulomb fissions have occurred as the particles would otherwise 
become elongated or fibre-like at fission due to early precipitation of the polymer. 
Entanglement and precipitation occur at different concentrations depending on the 
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solvent system but whereas polymer chain entanglement would take place at a lower 
concentration in a good solvent compared with a poor solvent, precipitation would take 
place at a lower concentration in a poor solvent compared with a good solvent.   
As solvent evaporates from the surface of the droplets, which it does relatively quickly 
given the high surface to volume ratio of the droplets, and the solutes will naturally 
begin to deposit at the droplet surface. This process is, however, counteracted by the 
inwards diffusion of solutes towards the centre of the droplet where the solutes are less 
concentrated. The ratio between the solvent evaporation and the solute diffusion rates is 
crucial for the particle formation process and the resulting characteristics of the particles 
depend thereon. This ratio is referred to as the Peclet number (see section 2.3.2), a 
dimensionless quantity that has been studied by several groups in order to understand 
particle formation from droplets [Tsapis et al. 2002, Vehring 2008]. 
The evaporation kinetics of solvents in a passive drying process is determined by the 
vapour pressure of the solvent and the temperature and humidity of the environment. In 
this study the evaporation measurements were performed at 25 °C and it may be seen 
from Figure 5.2 A that the evaporative weight loss took place almost linearly in the first 
four minutes, and an increase of the MeOH concentration reduced the evaporation rate. 
Figures 5.2 B and 5.2 C, however, show that the evaporation rate of the solvents 
decreased in the presence of PLGA indicating that there were interactions between 
PLGA and the solvent molecules, which influenced the evaporation rate. 
The solubility of the solutes in the solvent is another important factor for consideration 
for any liquid atomization process. In the present study two different solutes, i.e. CEL 
and PLGA, were used with binary mixtures of two solvents. In this case both the 
solubility of the polymer and the drug in the two solvents is of importance as it can 
result in separation of the solutes into two solute phases. Both PLGA and CEL are 
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soluble in ACE while only CEL is soluble in MeOH. The boiling point of ACE is lower 
than that of MeOH resulting in a decrease in the ACE:MeOH ratio as solvent 
evaporation progresses leading to less favourable conditions for PLGA dissolution. In a 
“good” solvent the individual polymer chain is extended thus taking up the maximum 
amount of space. When the solubility of a polymer in the solvent decreases, the polymer 
chains begin to coil up or crumple and take up less space in the solution until a point 
where the polymer begins to precipitate out. In a good solvent the polymer chains 
interact well with the solvent and mainly form polymer-solvent interactions while in a 
poor solvent the interaction mainly takes place between polymer chains [Grosberg et al. 
1997].  
The particle formation process is dependent on the solution properties such as 
evaporation rate, electrical conductivity and viscosity as well as the polymer 
conformation in the solutions, both before and after droplet formation. In Table 5.4 it is 
seen that the intrinsic viscosity is highest for PLGA in 100% ACE and decreases with 
the proportion of MeOH added. This indicates that the polymer chains interact well with 
solvent molecules in 100% ACE whereas the interaction between polymer chains 
becomes predominant in the ACE-MeOH solvent mixtures.  
Polymer solutions are typically electrosprayed in the concentration region close to the 
c* of the system [Park and Lee, 2009]. When the polymer concentrations are below the 
c* of the system polymer chain entanglements begin after the droplets have been 
formed thereby easing breakup of the liquid. In Table 5.4 it was observed that the 
overlap concentrations of the solutions increased as the MeOH content was increased. It 
can be seen that all feed solutions used had a PLGA concentration below the overlap 
concentration apart from 10D100:0, which had a PLGA concentration slightly above the 
c*. Thus for most of the solutions used chain entanglement would have taken place 
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between droplet formation and droplet drying while for 10D100:0 some chain 
entanglement would have existed before droplet formation.   
In a solvent with high capacity to dissolve both solutes particle formation would mainly 
be controlled by solvent evaporation and solute diffusion, while in the presence of a 
poor solvent particle formation could also be influenced by the polymer precipitation 
process. ACE evaporates at a higher rate than MeOH, and thus the MeOH fraction of 
the solution increases over time and is likely to reach the limit at which PLGA 
precipitates. Once saturation is reached with the mixed solvent system the PLGA 
molecules would be expected to curl up and form compact precipitates while the solvent 
continues to evaporate.  
5.3 Mixed solvent study – Particle characteristics 
Particle characteristics were studied by examining the particle size, morphology, inner 
structure and physical form using methodology described in the experimental section.  
5.3.1 Particle size 
The size and size distribution of the particles prepared using different solvent ratios and 
drug loads are presented in Table 5.5. Particles ranged between 2-4 µm in diameter and 
had a relatively narrow size distribution with the exception of sample 20D69:31.  
A correlation is observed between the ACE:MeOH ratio and particle size, with the 
particle size decreasing as the MeOH content is increased. This size dependency is 
partly explained by the increasing electrical conductivity as a function of the MeOH 
content, which is known to result in smaller droplets and hence smaller particles 
[Gañan-Calvo et al. 1997]. It can also be explained by the decrease in viscosity with 
increasing MeOH concentration (see Table 5.4), which would result in smaller droplets 
and particles such as observed here.  
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It was further observed that particles prepared with 20% drug loading were slightly 
smaller than those prepared with 10% drug loading for all sample pairs. This is 
explained by the lower polymer concentration and thereby lower viscosity of feed 
solutions with 20% drug loading resulting in smaller particles (see section 2.4.6). The 
higher electrical conductivity of solutions with 20% drug loading is also likely to have 
had a small influence on the resulting particle size (see section 4.5.2).  
The difference in particles size between the different samples was quite subtle with the 
average size ranging from 2-4 μm. The polydispersivity indices of the samples indicated 
that the particle size distribution became wider as the MeOH ratio was increased.  
Table 5.5 Particle samples prepared and their size, size distribution and drug 
entrapment efficiency. 
Sample  Size (μm) 
Polydispersivity 
index (%) 
Drug entrapment       
efficiency (%) 
10D100:0 3.83±0.37 9.53 97.4 
10D90:10 2.73±0.30 10.93 102.9 
10D75:25 2.61±0.35 13.40 100.4 
10D69:31 2.62±0.42 15.88 99.6 
20D100:0 3.06±0.31 10.19 100.2 
20D90:10 2.47±0.34 13.92 96.3 
20D75:25 2.28±0.34 14.84 97.4 
20D69:31 2.10±0.51 24.38 99.8 
 
5.3.2 Particle morphology and porosity 
The morphology of the particles may be seen in Figures 5.4 and 5.5 which show SEM 
images from each of the microparticle samples at different magnifications. While the 
particles prepared with only ACE appeared to have a relatively smooth surface the 
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particles prepared with varying proportions of MeOH all had a rough, grain-like 
appearance with the roughness increasing as the MeOH ratio was increased. This is 
explained by the differences in the properties of the two solvents used and the 
differences in solubility of CEL and PLGA in the two solvents.    
 
Figure 5.4 SEM images of microparticle samples, 10D100:0 (A), 10D90:10 (B), 
10D75:25 (C), 10D69:31 (D), 20D100:0 (E), 20D90:10 (F), 20D75:25 (G), 20D69:31 
(H) and overview of 10D100:0 (I).  
Both ACE and MeOH would have evaporated rapidly from the surface of the droplets 
and hence the solutes, especially PLGA, would have become concentrated and in turn 
created localized regions of very high viscosity, from which the PLGA would have 
precipitated out to form a shell structure. The PLGA precipitation would have been 
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influenced by the solvent composition and thus would have influenced the particle 
formation process and surface morphology of the resulting particles. The particles 
produced with ACE were relatively smooth while those produced with ACE/MeOH all 
had a rough appearance with the level of surface roughness increasing with the MeOH 
content (see Figure 5.5). In a solvent mixture with high intrinsic viscosity the polymer 
chains would be stretched out but entangled with each other within the solution. They 
would thus precipitate out in a homogenous network, more likely to have a smooth 
appearance on the surface as seen in Figures 5.4 A and E. Meanwhile, if the solvent 
mixture has a low solubilisation capacity for the polymer, in this case by the addition of 
MeOH to ACE, the polymer chains would already be in a compact conformation in the 
solution, before atomization. As the solvent evaporates, the molecules would have 
adopted a more compact conformation and could have precipitated out as small clusters, 
producing a grainy morphology such as that seen in Figure 5.4 B, C, D, F, G and H.  
    
Figure 5.5 Close-up SEM images of microparticle samples, 10D100:0 (A), 10D90:10 
(B), 10D75:25 (C) and 10D69:31 (D).  
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Similar observations were made by Roula et al. who showed that a poor solvent resulted 
in early polymer precipitation and wrinkled particle appearance [Raula et al. 2004]. 
Zhou et al also studied mixed solvent systems using spray drying and found that when 
applying low drying heat, hence low evaporation rate, nanoclusters were formed, whilst 
high drying heat gave rise to a highly porous honeycomb structure [Zhou et al. 2001].  
5.3.3 Particles porosity 
Cross sectional images of the particles taken using FIB/SEM show that the particles had 
varying degrees of porosity. It may be seen that particles from sample 10D100:0 were 
hollow while particles prepared with various MeOH contents in the solution had 
multiple pores inside (Figure 5.6). Although it appears that 10D90:10 was more porous 
than 10D75:25 and 10D69:31, which appeared to be denser, the degree of porosity was 
not further quantified.   
At a fixed feed concentration the degree of porosity is mainly determined by two 
factors, the solvent evaporation rate and the average size of droplets formed as has been 
demonstrated in several studies [Bae et al. 2009, Kim et al. 2006]. Porosity typically 
stems from a non-uniform distribution of solutes in the solidifying droplet where some 
areas, most often at the droplet surface, become more concentrated than others [Wu and 
Clark 2007]. Pores can thus derive from the areas of lower concentration or localized 
phase separation within the droplets. When the concentration of solutes increases in the 
surface region during evaporation of solvent from the droplet surface, it is likely that a 
hollow structure forms if the diffusion of solutes towards the core cannot keep up with 
the evaporation of solvent. This effect is more pronounced if the droplets are initially 
larger, partly because the particles will dry more slowly due to their smaller surface area 
to volume ratio and the longer diffusion path for the solutes, which makes it difficult for 
the solutes on the surface to diffuse to the core of the particles.   
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Figure 5.6 FIB/SEM images of microparticles at progressing sections, samples 
10D100:0 (A), 10D90:10 (B), 10D75:25 (C) and 10D69:31 (D).  
In the present study we showed that porosity is also influenced by adjusting the ratio 
between the solvents. The FIB/SEM images showed that particles prepared with ACE 
were nearly hollow and were larger than the particles prepared with ACE-MeOH 
mixtures. This indicates that larger droplets were formed and rapid evaporation resulted 
in pores inside the particles. The particles prepared with ACE-MeOH mixtures were 
also porous and the number of pores inside the particles was higher for the samples 
prepared with lower MeOH concentrations. This could be explained by the slightly 
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smaller droplets and particles produced with samples 10D75:25 and 20D75:25 
compared with 10D90:10 and 20D90:10, respectively (see Table 5.5). Also, the more 
rapid precipitation of PLGA with increasing MeOH concentrations likely did not 
provide sufficient time for an extensive porous network to form.  
5.3.4 Physical state of drug  
The XRPD diffractograms in Figure 5.7A demonstrate that CEL is crystalline in its 
powder form and also when it is physically mixed with PLGA, indicated by the 
consistency of the characteristic peaks. PLGA is amorphous in its powder form. The 
diffractograms for the electrosprayed microparticles prepared using different solvent 
ratios shown in Figure 5.7B do not have any characteristic crystalline peaks and the 
particles are therefore all presumably in an amorphous state.  
 
Figure 5.7 XRPD patterns of pure CEL, PLGA and the physical mixture of these (A) 
and CEL-loaded PLGA microparticles prepared with different solvent ratios at 10% 
drug loading (B). 
A        B 
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Observations made with polarized light microscopy (data not shown) also indicated that 
no crystallinity was present at this microscopic scale in any of the particles samples, 
supporting the results from DSC and XRPD. Polarized light microscopy generally has 
high sensitivity to the presence of anisotropic crystals, even a few small microcrystals.    
5.4 Mixed solvent study – Drug distribution and Drug release  
5.4.1 Drug distribution in microparticles 
As mentioned in section 2.5.3 it is important to have some knowledge of the 
homogeneity of the drug in the solid dispersion and whether there are some areas with a 
higher drug concentration or phase separation. Also, it is important to know more about 
the spatial distribution of drug in cases where the drug is not present as a homogeneous, 
molecular distribution as this would most likely influence the release kinetics and the 
physical stability [Urbanetz and Lippold 2005]. Several methods were mentioned for 
measuring the drug distribution in particles including X-ray photoelectron spectroscopy 
(XPS). XPS has previously been used to examine the chemical composition of the outer 
surface layer of solid dispersions and can give an estimate of the concentration of drug 
in the measured area. XPS has been used to study the surface drug concentration in 
order to examine the possible tendency for drug to migrate towards the surface of spray 
dried particles [Dahlberg et al. 2008]. 
The surface chemical compositions of the dry microparticle samples were examined 
here using XPS to give an estimate of the distribution and general homogeneity of CEL 
in the PLGA matrix. The relative theoretical atomic concentration (in %) of C, O, F, N 
and S (H was not measured) of pure CEL were 65.38%, 7.69%, 11.54%, 11.54% and 
3.85%, respectively. Similarly, the relative theoretical atomic concentration (in %) of C 
and O for PLGA were 55.56% and 44.44%, respectively. The concentration of CEL 
could be estimated directly from the atomic concentration of F, N and S atoms. In order 
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to eliminate the errors, ratios of N/F, S/F and F/C were used to calculate the CEL 
concentration at the surface of the microparticles. The chemical structure of CEL and 
PLGA are shown on Figures 3.1 and 3.2B. 
The surface concentration values of CEL as well as ratios of the three elements 
exclusive to CEL in these particles are shown in Table 5.6. The CEL concentration on 
the surface of the microparticles ranged between 20-57% depending on the sample. It 
was observed that the particles containing 20% CEL generally showed higher surface 
CEL concentration than those containing 10% CEL. Additionally, there was a clear 
trend for the surface drug concentration to increase when the MeOH concentration 
increased, both for samples containing 10% CEL and 20% CEL. 
Table 5.6. Surface chemical composition of CEL-loaded PLGA microparticles prepared 
at different drug loadings and with different solvent ratios. 
Sample N/F S/F F/C CEL concentration 
10D100:0 0.92 0.33 0.053 20 ± 1% 
10D90:10 0.94 0.33 0.071 31 ± 2% 
10D75:25 0.84 0.28 0.077 38 ± 1% 
10D69:31 0.96 0.26 0.096 41 ± 1% 
20D100:0 0.95 0.32 0.074 32 ± 1% 
20D90:10 0.82 0.31 0.099 43 ± 4% 
20D75:25 0.80 0.28 0.114 46 ± 3% 
20D69:31 0.79 0.29 0.125 57 ± 2% 
 
All surfaces analysed contained more than the 10% and 20% CEL initially loaded, 
respectively, indicating a migration of drug towards the surface of the particles during 
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particle formation. This is explained by the early precipitation of PLGA and the 
significantly lower molecular weight of CEL. PLGA is insoluble in MeOH while CEL 
can be dissolved up to 100 mg/mL in MeOH. At 5% solute concentration, PLGA 
precipitates at around an ACE:MeOH molar ratio of 65:35. During evaporation of ACE 
from the surface of the droplet both PLGA and CEL move towards the core of the 
droplet following the diffusion gradient. Then, as the solute concentration reaches a 
critical level PLGA begins to precipitate while presumably CEL is still dissolved in the 
droplet and can move in and around the PLGA molecules. After a shell has formed, 
some ACE is still trapped within it. ACE then slowly escapes through the shell provided 
that the particle does not collapse.  
In this process it is believed that the CEL molecules, small as they are, can diffuse out 
to the surface together with the ACE resulting in a slightly uneven drug distribution.  
When MeOH is added to the system the MeOH ratio increases during evaporation due 
to its lower boiling point compared with ACE and so PLGA begins to precipitate earlier 
while CEL is still in solution. CEL could thus have more time to diffuse towards the 
particle surface once the PLGA has precipitated and the compact conformation of 
PLGA, in presence of MeOH, may allow easier movement out to the surface.  
The surface drug content reached up to 41% for particles prepared with 10% drug 
loading and the XRPD measurements showed that the drug was still in an amorphous 
state. This indicates that there was not an actual separation of the solutes into a crystal-
rich CEL phase and an amorphous PLGA phase, but instead that CEL remained highly 
dispersed in the PLGA matrix. The polymer molecular conformation in the solvent 
mixture immediately before atomization into droplets is likely to have had a strong 
influence on the resulting matrix structure and on the polymer-polymer and polymer-
drug interactions. However, detailed understanding of such interactions between solutes 
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and of the molecular distributions in solid dispersions is still lacking and is needed to 
achieve better control of the process. There have nevertheless been cases where an 
improvement in in vitro performance was observed for drug dispersions prepared with 
solvent mixtures [Paudel and Van den Mooter 2012].  
5.4.2 Drug release from microparticles 
The drug entrapment efficiencies of the microparticle samples were seen to be 96% or 
above, with no correlation to the solvents used (see Table 5.5). The particles were 
collected directly onto a dry surface and therefore no significant loss in total drug 
content was expected. Drug release studies were all performed using the paddle 
dissolution apparatus described in section 3.12.2 and using phosphate buffer (pH 6.8) + 
1.5% SLS as the release medium. Drug release rate was measured for each of the 
particle samples and the drug release profiles are shown in Figures 5.8 and 5.9.  
 
Figure 5.8 Drug release profile of microparticle samples 10D100:0, 10D90:10, 
10D75:25, 10D69:31. 
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For all microparticle samples more than 90% of their drug content was released during 
the 20 hours of exposure to the dissolution medium. Generally, a large burst release was 
observed especially for particles prepared in solutions with high MeOH content. 
Further, the drug release rate also increased as a function of the MeOH content for the 
samples prepared with both 10% and 20% drug loading. The difference in release rate 
was most significant between particles prepared in ACE alone and those prepared from 
a mixture of MeOH and ACE. This indicates a clear relation between the addition of 
MeOH and the resulting near-instantaneous drug release. 
 
Figure 5.9 Drug release profile of microparticle samples 20D100:0, 20D90:10, 
20D75:25, 20D69:31. 
The drug release curves for particles prepared with 10% drug loading and 20% drug 
loading both demonstrate a high drug release rate for most of the particle samples 
considering that PLGA is insoluble in the dissolution medium and that the release of the 
drug thus took place via diffusion. There is a clear difference in the release profile of 
10D100:0 compared with 10D90:10, 10D75:25 and 10D69:31 and a trend that the 
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release rate increases with increasing MeOH content. Drug release from samples 
10D75:25 and 10D69:31 take place rapidly with most of their drug load released within 
30 min. A similar trend was observed for samples with 20% drug loading, which had an 
even higher drug release rate. The results correlate well with the XPS results as well as 
the observations from the SEM images (see Figure 5.4). The samples which were shown 
to have a high surface drug content also exhibited rapid burst release as would be 
expected given the lower diffusion boundary to be overcome. The particles produced 
with high MeOH content were also smaller with a grainy surface and hence a higher 
surface area to volume ratio and shorter diffusion distances.  
In the presence of MeOH, limited polymer chain entanglement takes place during 
solvent evaporation from the droplet and the polymer precipitates into compact clusters 
within the droplet. Drug molecules diffuse out towards the surface as the remaining 
solvent escapes. In ACE some polymer chain entanglement takes place at droplet 
formation and the chains form a network as the solvent evaporates. The dense polymer 
network at the surface results in the formation of a smooth shell which the remaining 
solvent escapes across, while some drug molecules also diffuse towards the surface.   
Figure 5.10 shows SEM images of particles captured after being used for drug release 
studies. The images indicate that particles from sample 10D100:0 were still structurally 
intact, retaining their shape after losing 10% of their dry weight. In comparison, 
particles from samples 10D90:10, 10D75:25 and 10D69:31 showed no preservation of 
their shape and morphology. They seemed to have disintegrated during the drug release 
studies and agglomerated into an unrecognizable, bulky mass. This supports the 
morphological findings in Figure 5.5 where particles seemed to be formed from small 
grains and the rheological measurements, which indicated that the polymer chains were 
compact with less entanglement compared with particles prepared using ACE. The 
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disintegration into smaller fragments would result in an even higher surface to volume 
ratio for release and again shorter drug diffusion distances. This disintegration of the 
PLGA structures could be explained by the compact conformation of the polymer 
chains and the lack of interaction between polymer chains to maintain structural 
stability (see Figure 5.11). 
 
Figure 5.10 Representative SEM images of Electrosprayed microparticles loaded with 
20% (w/w) CEL taken after drug release studies. Images represent samples 20D100:0 
(A), 20D90:10 (B), 20D75:25 (C) and 20DD69:31 (D). 
5.4.3 Summary of study with mixed solvent system 
CEL-loaded PLGA microparticles were produced from a mixed solvent system at 
different solvent ratios using electrospraying to investigate the interactions of solvents 
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with the solutes and the influence of solvent compositions on the particle formation 
process. This study demonstrated that particle formation in the electrospraying process 
depended markedly on the solubility of the solutes, i.e. CEL and PLGA and also on the 
evaporation rate of the solvents. By using an anti-solvent (MeOH) for PLGA in the 
solvent mixtures the molecular conformation of PLGA became more compact and 
further resulted in early precipitation of PLGA during the formation of the particles.  
 
Figure 5.11 Particle formation process for solutions containing MeOH (A) and solution 
consisting of only ACE (B). 
Depending on the amount of the anti-solvent (MeOH), different degrees of roughness 
were observed in the surface morphology as well as different accumulation of CEL at 
the particle surface. A clear correlation was observed between the concentration of the 
anti-solvent in the solvent mixture and the surface content of CEL, which was also 
evident from the release rates observed in the drug release studies. This shifting in the 
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drug distribution is likely to have taken place as a result of the better solubility of CEL 
in both solvents and its higher molecular mobility than PLGA. The mechanisms by 
which the different particle morphologies and drug distributions have formed with 
different solvent mixtures were related to the balance between precipitation of solutes 
and evaporation of solvents.  
5.5 Water-soluble microparticles – Introduction and setup 
5.5.1 Introduction to study 
In extension of the mixed solvent study with electrosprayed CEL-loaded PLGA 
particles, another polymer and different solvent mixtures were studied to investigate the 
influence of solvents in more detail. Since all of the previous studies were performed 
using the water-insoluble polymer PLGA, in the present study a water-soluble polymer 
was chosen to look at that aspect of particle-based solid dispersions and also to observe 
the difference in release profiles compared with PLGA. Here the polymer HPMCAS 
was chosen due to its good solubility in water at a pH values above 5.5-6 (depending on 
the molecular weight of the polymer).  
As mentioned in section 3.1.1, HPMCAS is used for enteric coatings due to its pH 
dependent solubility and further it has commonly been used to prepare solid dispersions. 
HPMCAS is also special due to its ability to interact with dissolved drug molecules and 
act as an effective precipitation inhibitor, whereby poorly soluble drug compounds can 
be kept in a supersaturated state for many hours after their release (see section 2.6). 
HPMCAS is soluble in several organic solvents including ACE and is further soluble in 
mixtures of solvents such as ACE and H2O, H2O and EtOH at certain ratios.  
To follow up from the previous study using PLGA, different solvent mixtures were here 
investigated not only focusing on the solubility of the polymer but also on the solubility 
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of the drug. Four different combinations of solvents were selected based on solubility 
studies using HPMCAS and CEL. Based on the previous experience where high surface 
CEL concentrations were observed with an increase in anti-solvent for PLGA, in this 
study solvent mixtures with higher solubility for the polymer were examined.  
5.5.2 Experimental design 
In order to direct the focus of the study towards the solvent compositions, the solute 
concentration and drug loading were kept constant for the different sample conditions. 
Similar to the previous studies using PLGA a solute concentration of 5% was selected 
based on the higher viscosity of HPMCAS compared with PLGA since with PLGA the 
solute concentration was slightly in the low range resulting in hollow and porous 
particles. Further, a drug loading of 20% was selected in order to demonstrate a clearer 
correlation between the solvent compositions and the surface drug distribution 
measured using XPS.  
Different solvent compositions were studied by testing the solubility of HPMCAS and 
CEL in the mixtures.  Pure ACE was used as a reference solvent since it has previously 
been used for PLGA and was shown to be a good solvent for both HPMCAS and CEL. 
HPMCAS was soluble in ACE:H2O mixtures with up to 70% H2O v/v if it was first 
dissolved in ACE, and HPMCAS + CEL was soluble in ACE:H2O up to 50% H2O due 
to the poor solubility of CEL in H2O. ACE:H2O mixtures were studied because of the 
lower solubility of CEL compared with HPMCAS at increasing H2O concentrations, 
and ACE:H2O volume ratios 95:5, 85:15 and 65:35 v/v were selected based on the 
inability to electrospray solutions with higher H2O concentrations. HPMCAS was found 
to be more soluble in EtOH:H2O mixtures than in pure EtOH where it is insoluble. It 
was soluble in mixtures with >50% H2O, whereas CEL could only be dissolved in 
mixtures with up to 25% H2O. Thus the EtOH:H2O mixtures were studied at the ratios, 
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95:5 and 85:15 v/v. Both CEL and HPMCAS are soluble in ACE:EtOH mixtures at 
various ratios and HPMCAS is, however, insoluble in pure EtOH. Since EtOH 
evaporates slower than ACE, EtOH concentration is expected to increase during droplet 
evaporation resulting in an early precipitation of HPMCAS. ACE:EtOH mixtures were 
used at the solvent ratios 95:5, 85:15 and 65:35 v/v. The samples prepared are shown in 
Table 5.7. 
Table 5.7 List of CEL-loaded HPMCAS microparticle samples prepared. 
Sample Solvent volume ratio 
(ACE:EtOH:H2O)  
Solute 
conc. (%) 
Polymer 
conc. (%) 
Drug 
loading (%) 
Flow rate 
(µL/min) 
AE100:0 100:0:0 5 4.5 10 25 
AE95:05 95:5:0 5 4.5 10 25 
AE85:15 85:15:0 5 4.5 10 25 
AE65:35 65:35:0 5 4.5 10 25 
AH95:5 95:0:05 5 4.5 10 25 
AH85:15 85:0:15 5 4.5 10 25 
AH65:35 65:0:35 5 4.5 10 25 
EH85:15 0:85:15 5 4.5 10 25 
EH65:35 0:65:35 5 4.5 10 25 
AEH70:15:15 70:15:15 5 4.5 10 25 
AEH50:25:25 50:25:25 5 4.5 10 25 
5.6 Water-soluble microparticles – Particle characteristics 
5.6.1 Particle morphology 
The morphology of CEL-loaded HPMCAS particles prepared using electrospraying was 
studies using SEM and selected images are shown in Figure 5.12. It is observed that 
particles with relatively different morphologies could be obtained by altering the solvent 
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systems used and all of the particles were relatively similar in size, being around 2-3 μm 
in diameter. It was seen that particle samples prepared with mixtures of ACE and EtOH 
(Figures 5.12 A-D) were similar in their appearance, all being disc shaped with no 
exceptions observed (see overview in Figure 5.12 L). This disc shape is believed to 
result from the collapse of hollow particles and could be due to the slow diffusion of 
HPMCAS during droplet drying or from impact of landing. In all samples the particles 
had a smooth surface indicating high solubility of HPMCAS in these mixtures.  
  
   
   
      
(Figure 5.12 Continued)  
A                                      B                
C           D       E 
F       G       H 
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Figure 5.12 Representative SEM images of different microparticle samples: Samples 
AE100:0 (A), AE95:5 (B), AE85:15 (C), AE65:35 (D), AH95:5 (E), AH85:15 (F), 
AH65:35 (G), EH85:15 (H), EH65:35 (I), AEH70:15:15 (J), AEH50:25:25 (K), 
overview of sample AE85:15 (L) and overview of sample AH95:5 (M). 
Figures 5.12 E-G show particles prepared using ACE:H2O mixtures and particles here 
had a rougher appearance. These samples were again more disc shaped than spherical 
and were similar in morphology, but sample AH65:35 was slightly different seeming 
more wrinkled than the other two samples. The flattened appearance could be due to the 
collapse of porous or hollow particles during formation. The rough appearance indicated 
that solvent mixtures of ACE and H2O did not have a high solubility for the solutes. 
Samples prepared with EtOH:H2O mixtures (Figure 5.12 H+I) again have a rough 
appearance and whereas sample EH95:5 seemed to be wrinkled, EH85:15 seemed to be 
rough in a different way. Their morphology once again indicates that the solubility of 
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HPMCAS in the solvent mixtures was not very high.  Particles prepared with a mixture 
of ACE, EtOH and H2O (Figure 5.12 J+K) were very similar to the particles from 
sample EH85:15. 
5.6.2 Physical form of drug 
XRPD measurements of the particle powder samples showed a halo curve for all of the 
samples indicating that CEL was in an amorphous form in all of the samples (see Figure 
5.13). However, for some of the samples (e.g. Figure 5.13 J and K) minor peaks were 
observed in the spectra, which could indicate a small presence of crystallinity in the 
samples.  
   
Figure 5.13 XRPD patterns of electrosprayed CEL-loaded HPMCAS particle samples, 
AE100:0 (A), AE95:05 (B), AE85:15 (C), AE65:35 (D), AH95:5 (E), AH85:15 (F), 
AH65:35 (G), EH85:15 (H), EH65:35 (I), AEH70:15:15 (J) and AEH50:25:25 (K).   
The physical form of the CEL-loaded HPMCAS particle samples was also analysed 
using DSC and measured between 10 and 200 ºC at a heating rate of 10 ºC/min and 
measurements of selected samples are shown in Figure 5.14. The DSC curves of 
microparticle samples show no visible event while a small peak it is seen around 160 ºC 
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for the HPMCAS:CEL physical mixture. This could indicate that CEL was in an 
amorphous state in all microparticles samples but the signal from the glass transition 
event was not strong enough to detect. Also, no glass transition even was observed for 
HPMCAS neither in the particles, the physical mixture nor the pure HPMCAS sample 
although a halo was seen in the XRPD measurements. This could indicate that the Tg is 
above the measurement range. In the case that CEL was in a crystalline state in the 
particle sample it would be expected to see a melting endotherm around 160 ºC which 
was not seen in these measurements.  
 
Figure 5.14 DSC curves of selected CEL-loaded HPMCAS particles.  
5.6.3 Drug distribution 
The surface concentration of CEL was analysed using XPS as in the previous studies. 
The concentration of CEL was again estimated directly from the atomic concentration 
of F, N and S atoms which are not present in the HPMCAS molecules. In order to 
eliminate the errors, ratios of N/F, S/F and F/C were used to calculate the CEL 
concentration at the surface of the microparticles. The surface concentration values of 
CEL as well as ratios of the three elements exclusive to CEL in these particles are 
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shown in Table 5.8. The CEL concentration on the surface of the microparticles ranged 
between 19-29% depending on the sample. It was observed that microparticles prepared 
using EtOH:H2O mixtures had the lowest surface CEL concentration while  samples 
AE65:35 and AH95:5 had the highest surface concentration of CEL. Further, for the 
samples prepared with ACE:EtOH mixtures the surface drug concentration increased 
consistently as a function of the EtOH concentration and for the samples prepared with 
ACE:H2O mixtures it decreased as a function of the H2O concentration. 
Table 5.8 Surface chemical composition of CEL-loaded HPMCAS microparticles 
prepared at different drug loadings and with different solvent ratios. 
Sample N/F S/F F/C CEL concentration 
AE100:0 0.885 0.308 0.044 22.7 ± 0.3% 
AE95:5 0.885 0.346 0.046 22.5 ± 0.6% 
AE85:15 0.862 0.310 0.050 25.4 ± 1.9% 
AE65:35 0.848 0.333 0.054 28.8 ± 1.0% 
AH95:5 0.833 0.300 0.054 26.1 ± 0.6% 
AH85:15 0.828 0.310 0.060 25.3 ± 2.1% 
AH65:35 0.760 0.320 0.054 21.5 ± 2.0% 
EH85:15 1.000 0.364 0.051 19.3 ± 1.5% 
EH65:35 1.174 0.348 0.049 19.6 ± 1.2% 
AEH70:15:15 0.815 0.346 0.050 22.5 ± 0.9%  
AEH50:25:25 0.812 0.333 0.044 23.2 ± 0.8% 
 
The surface drug content reached up to 28% for the particle samples, which were 
initially prepared with 20% drug loading, and two of the samples had a surface drug 
content slightly below the 20% initially loaded. This is different from the results 
obtained with CEL-loaded PLGA particles (see Table 5.6) where much higher drug 
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concentrations were measured. Further, the differences in surface drug concentration 
between the samples were not so great indicating only a small effect derived when using 
different solvent mixtures. This observation is explained by the differences in solubility 
of the solutes in the solvents (see Table 5.9), differences in evaporation of the solvents 
and the properties of the polymer.  
Table 5.9 Solubility of CEL and HPMCAS in solvent mixtures. Values are based on 
solutions with approximately 5% solute concentration and 20% CEL loading.   
Solvent mixture Solubility of CEL Solubility of HPMCAS 
Pure ACE Fully soluble Fully soluble 
ACE:EtOH Fully soluble  EtOH < 90% 
ACE:H2O H2O < 50% H2O < 70%  
EtOH:H2O H2O < 25% H2O > 5% 
 
For the samples prepared with ACE:EtOH mixtures both CEL and HPMCAS were 
soluble. During droplet evaporation, ACE will evaporate quicker than EtOH resulting in 
high EtOH concentrations, which would result in early precipitation of HPMCAS. This 
is similar to the case with CEL-loaded PLGA particles where an increase in MeOH 
concentrations leads to early polymer precipitation and migration of CEL to the surface. 
With HPMCAS microparticles an increase in the EtOH content in ACE:EtOH mixtures 
lead to an increase in the surface drug concentration, which correlates with the increased 
and quicker accumulation of EtOH during the process of particle formation and hence 
quicker precipitation of HPMCAS.  
For the samples prepared with ACE:H2O mixtures the HPMCAS has a good solubility 
until a certain point while the solubility of CEL is reduced when the H2O content is 
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increased, and here a different trend was observed. During the process of particle 
formation, ACE would evaporate much quicker than H2O resulting in higher H2O 
concentrations, which results in precipitation of CEL early in the drying process. In this 
case it is likely that CEL molecules solidify before HPMCAS resulting in lower surface 
CEL concentration with increasing H2O content. Such a trend was indeed observed 
although the general levels of surface drug concentration were not that low. 
For the samples prepared with EtOH:H2O mixtures the solubility of HPMCAS was 
intermediate to good depending on the EtOH content, while the solubility of CEL was 
low from the beginning and decreased as the H2O content was increased. In this case, 
EtOH would evaporate quicker than H2O, although both evaporating relatively slowly, 
and result in higher H2O concentrations and early precipitation of CEL during droplet 
evaporation. Also, the solubility of HPMCAS increases as the H2O content is increased 
and thus HPMCAS is expected to precipitate late in the droplet evaporation process. It 
is thus likely that CEL molecules solidify before HPMCAS resulting in lower surface 
CEL concentration with increasing H2O content. In fact, the surface drug concentration 
measured here were slightly lower than the loaded concentration supporting the 
explanation. 
5.8 Water-soluble microparticles – Drug release 
Drug release from CEL-loaded HPMCAS microparticles were studied using a paddle 
dissolution device and were studied in different dissolution media. Since HPMCAS is 
soluble in water at a pH above 6 drug release takes place via a different process 
compared with the CEL-loaded PLGA particles. In this case, HPMCAS is likely to 
dissolve with time resulting in quicker release of drug. For this study, water was 
selected as one of the dissolution media and the release of CEL from the HPMCAS 
microparticles was also studied in phosphate buffer (pH 6.8). In addition, drug release 
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was tested under sink conditions, and here phosphate buffer (pH 6.8) + 0.5% SLS was 
used as the dissolution medium. 
 
Figure 5.15 Drug release curves of CEL-loaded HPMCAS particles in H2O. The 
smaller insert Figure shows drug release over a longer time interval. 
Drug release profiles for microparticle samples in H2O are shown in Figure 5.15. It is 
observed that all samples released between 44 and 52% of their drug load in 4 hours of 
exposure to the release medium. Further, it is seen with the pure CEL powder and the 
physical mixture of CEL and HPMCAS that only up to 5% was dissolved after 4 hours. 
This indicates that the solid dispersion microparticles result in a significant 
enhancement in drug dissolution rate compared with the pure drug and the physical 
mixtures, regardless of the microparticles produced from different solvent mixtures. 
This improved dissolution can be attributed to the smaller size of the particles as well as 
the amorphous form of the drug in the microparticles.  
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There was no clear relationship between the drug release profiles of the different 
samples and they were all relatively similar in their shape. Further, it is observed in the 
insert Figure that the drug was released continuously beyond the first 4 hours but the 
release rate slowed down after the first few hours plateauing at a maximum of 60% 
cumulative release. The released CEL molecules are presumably supersaturated in the 
medium but stay dissolved, most likely due to the precipitation inhibiting effect of 
HPCMAS. However, the cumulative drug release did pass beyond 60% due to the 
limited dissolution enhancement in water. 
 
Figure 5.16 Drug release curves of CEL-loaded HPMCAS particles and in phosphate 
buffer pH 6.8. 
The release study performed in phosphate buffer (pH 6.8) (see Figure 5.16) resulted in 
quicker release of CEL compared with release in H2O but otherwise showed a similar 
trend as with H2O. Pure CEL powder and physical mixture of CEL and HPMCAS again 
showed very limited dissolution indicating a much enhanced release from the 
electrosprayed particles. The maximum cumulative release was slightly higher than in 
0
10
20
30
40
50
60
70
0 1 2 3 4
C
u
m
u
la
ti
v
e 
d
ru
g
 r
el
ea
se
 (
%
) 
Time (hours) 
CEL powder
CEL + HPMCAS PM
AE100:0
AH95:5
AH85:15
AH65:35
Chapter 5. Results and Discussion  
196 
 
H2O and was reached after 1-2 hours whereas it took much longer time when released in 
H2O. With this Figure, there was a clearer trend in the drug release indicating that drug 
release rates decreased with increasing H2O content in the ACE:H2O for particle 
preparation. This finding correlated with the surface CEL concentration observed which 
also decreased as the H2O concentration was increased. Also again the insert Figure 
indicated that CEL were kept dissolved for at least 20 hours probably due to the 
precipitation inhibition of HPMCAS. 
 
Figure 5.17 Drug release curves of CEL-loaded HPMCAS particles in phosphate buffer 
(pH 6.8) + 0.5% SLS. 
Drug release from microparticle samples in phosphate buffer + 0.5% SLS is shown in 
Figure 5.17 and indicated much higher release rates as a consequence of the sink 
conditions provided. Here, all particle samples were fully dissolved, some almost 
immediately and some after an hour of release. The pure CEL powder was also fully 
dissolved but was clearly the slowest to be dissolved, once again indicating the 
dissolution enhancement from the electrosprayed microparticle formulations. Also, it 
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was observed that the drug release rate from the samples decreased with increasing H2O 
content of the solvent mixtures used for particle preparation. This supports the 
observation in Figure 5.16 where the same trend was demonstrated indicating that the 
drug release was influenced by the solvent composition used and the resulting attributes 
of the particles, including their drug distribution. The influence of the size and 
morphology of particles from different samples on their drug release kinetics could not 
be seen from the drug release profiles in Figures 5.15-5.17 indicating that they were too 
similar to show distinctive release patterns. Thus, the small differences observed in the 
surface drug concentration indicate that the drug distribution was the main characteristic 
distinguishing the drug release profiles of the microparticles.  
5.9 Summary 
Microparticles of CEL molecularly embedded in a polymer matrix were prepared by 
electrospraying using different solvent mixtures and two different polymers to 
investigate the influence upon the resulting particle characteristics and release 
behaviour. The first set of mixtures studied consisted of a good solvent, ACE, and an 
anti-solvent, MeOH, for PLGA at different ratios. Particle formation, particle 
characteristics, drug distribution and drug release were examined and all of these were 
found to be influenced by the solvent composition. 
Particle formation was strongly influenced by the polymer molecular conformation 
during droplet formation and by the anti-solvent concentration during droplet drying. A 
strong correlation was found between particle size and morphology, the solubility of the 
polymer in the solvent mixtures and the electrical conductivity of the solutions. The 
lack of chain entanglements in droplets containing anti-solvent resulted in compact 
polymer conformation and a grain-like appearance of the particles. Smaller particles 
were produced from the addition of anti-solvent as this produced smaller droplets and 
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compact polymer chains. Further, the early precipitation of polymer and low chain 
interaction with increasing content of anti-solvent resulted in surface enrichment of drug 
(from 10 and 20% up to 41 and 57% respectively), which was also demonstrated by the 
increasingly faster drug release rates observed.  
A different polymer, HPMCAS, was introduced for the second set of studies, partly to 
examine whether a polymer with higher solubility than CEL in the solvents used would 
result in higher drug distribution towards the centre of the particles. Solvent mixtures of 
ACE, EtOH and H2O were used, which can be a poor solvent for either of the solutes, 
CEL and HPMCAS, depending on the ratios used. It was expected that in different 
mixtures and ratios the solute with the poorer solubility in the mixture would precipitate 
first, leading to a lower concentration of that solute near the surface of the particles. 
CEL-loaded HPMCAS microparticles were prepared with different shapes ranging from 
collapsed disc shape to compact particles with different surface roughness and 
appearance. The particle morphology was dependent on the solvent combinations and 
solubility of the solutes in the solvent mixtures. XRPD measurements indicated that 
CEL was amorphous in all particle samples and that it was finely dispersed in the 
polymer forming a solid dispersion. The surface drug concentrations of particles were 
similar among samples although samples prepared with EtOH and H2O showed slightly 
lower concentration than initially loaded. The drug release studies showed improvement 
in dissolution rate and effective precipitation inhibition provided by HPMCAS. The 
differences in release rate was difficult to observe although some differences were 
observed under sink conditions. 
The results all in all demonstrate the importance of solvent composition in particle 
preparation and indicate potential for exploiting this dependence to improve 
pharmaceutical particle design and performance. 
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Chapter 6 
Spray drying of solid dispersions: The influence of 
mixed solvent systems on particle characteristics and 
comparisons with electrospraying 
 
This chapter introduces the use of spray drying for preparing solid dispersion 
microparticles composed of Celecoxib and PLGA. The influence of process parameters, 
with specific focus on the solvent system, the particle characteristics as well as the drug 
release kinetics was examined. It was found that spherical particles were formed with a 
relatively broad size distribution from the spray drying process. The spray dried 
particles were prepared using the same solvents used in the electrospraying process, 
including mixed solvent systems with acetone and methanol, and the resulting particles 
were compared with the electrosprayed particles. The spray dried particles were similar 
in morphology regardless of the solvents used and generally showed a broad size 
distribution. They were less porous both on their surface and inside the particles and 
resulted in a more homogeneous drug distribution compared with the electrosprayed 
counterparts. Drug release from the spray dried particles varied depending on the 
solvent composition used but in general took place at a slower rate than the 
corresponding electrosprayed particles. Spray drying showed less control over particle 
characteristics compared with electrospraying for the studied setup and formulations. 
6.1 Spray drying and particle preparation 
The spray drying technology has commonly been used to prepare drug-loaded 
microparticles and solid dispersions and it is therefore prior knowledge that drug can be 
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highly dispersed in polymeric microparticles as a solid dispersion [Kojima et al. , 
Paudel et al.]. Drug-loaded PLGA particles have successfully been prepared by several 
researchers using laboratory scale spray-dryers and generally together with an inert loop 
device in order to use organic solvents [Meeus et al. 2012, Wang and Wang 2002]. In 
order to provide a reasonable basis for setting up comparisons between the 
electrosprayed and spray dried particles the operation parameters for the spray drying 
equipment was adjusted to obtain particles with similar diameter as the particles 
prepared with electrospraying, i.e. around 2-4 µm.  
6.1.1 Introduction to setup and conditions with spray drying 
The main adjustable operation parameters in spray drying are: the liquid feed rate, 
atomizing gas flow rate, drying gas flow rate, inlet temperature and outlet temperature, 
where outlet temperature is mainly controlled by the inlet temperature. A liquid feed 
rate of around 3 ml/min was selected based on previous studies done with the spray 
drier where polymeric particles around 1-5 µm were obtained depending on the 
remaining parameters. In order to prevent agglomeration and aggregation of particles 
during the drying process it is important to keep the outlet temperature well below the 
Tg of the processed materials. PLGA and CEL were both shown to have a Tg around   
50 °C and thus initially an outlet temperature of 40 ºC was used to prepare the particles 
as demonstrated by O‟Hara and Hickey [O'Hara and Hickey 2000].  
Particles were prepared applying the above conditions and examined using SEM and it 
was observed that the particles had agglomerated forming bridges between the particles 
(see Figure 6.1). The surface morphology observed resulted from prolonged exposure to 
the electron beam and the particles had a smooth surface otherwise. The bridges 
between the particles are likely to have resulted from the close proximity of the outlet 
temperature to the Tg of PLGA, hence in the further studies an outlet temperature of    
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30 ºC was used in order to ensure temperatures below the Tg of PLGA during the whole 
spraying process. This required an inlet temperature of around 45 ºC. The disadvantage 
of using a low outlet temperature relative to the boiling point of the solvent is that the 
particle samples are likely to contain more residual solvent. Due to the low outlet 
temperature the maximum atomizing gas flow rate of 12.4 L/min and the maximum 
drying air aspiration rate of 375 L/min were used to best avoid residual moisture.  
          
Figure 6.1 Particles prepared with ACE at 3 ml/min and 40 ºC outlet temperature. 
6.1.2 Spray drying of CEL-loaded PLGA particles – solutions and setup  
In order to study the effect of different solvents on the formation of microparticles in the 
spray drying process, microparticles were examined as a function of the solvent while 
the solute concentration and drug loading were kept constant at 5% w/v and 20% w/w, 
respectively. Particles were prepared in ACE and ACN again (see Table 6.1) similar to 
the electrosprayed particles to compare the particles and the process with 
electrospraying and the electrosprayed products. Since the composition of feed solution 
were identical to those used for some of the electrospraying experiments the 
characteristics of the solutions were the same as those once measured. Thus, the 
evaporation rate, solubility, dynamic viscosity, intrinsic viscosity and electrical 
conductivity can be seen on Tables 4.3-4.4 and Figures 4.8-4.9.  
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Table 6.1 Composition of feed solutions spray dried and the operational values applied. 
Feed 
solutions 
Drug 
loading 
Feed rate 
Atomizing 
gas flow rate 
Aspiration 
rate 
Inlet 
temp. 
Outlet 
temp. 
5% Solute 
conc. in ACN 
20% 3 mL/min 12.4 L/min 375 L/min 43-47 ºC 30 ºC 
5% Solute 
conc. in ACE 
20% 3 mL/min 12.4 L/min 375 L/min 43-47 ºC 30 ºC 
 
6.1.3 Characteristics of particles 
SEM images of the spray dried microparticles prepared with ACN and ACE are 
presented in Figure 6.2 and it is observed that the particles were all spherical with 
smooth surfaces. None of the particles seemed to be fused together as a low outlet 
temperature was used. There were no visible differences in the morphology between the 
particle prepared using the two solvents and in both cases the mean diameter of the 
particles was around 2 µm. Both samples had a relatively broad particle size distribution 
(with a polydispersivity index of 42 and 38 for particles prepared with ACN and ACE 
respectively), compared with the electrosprayed samples prepared at similar conditions 
(see Table 4.6). The range of the particle diameters observed spanned from around     
0.2 µm to around 5µm and the particles were thus in the same size range and the 
particles prepare with electrospraying using ACE and ACN, although particles below 1 
µm were produced with spray drying. However, there were visible differences in 
particle morphology compared with microparticles prepared using electrospraying. The 
spray dried particles observed here were not porous on their surface and were in fact 
very smooth and spherical in appearance compared to their electrosprayed counterparts.  
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Figure 6.2 Representative SEM images of spray dried microparticles prepared in ACN 
(A, B) and ACE (C, D) prepared with an outlet temperature of 30 ºC. 
The internal structure of the spray dried microparticles prepared using ACE and ACN 
was studied using FIB/SEM to also determine the porosity of the particles (see Figures 
6.3 and 6.4). The images in Figure 6.3 show that particles of different size were 
sectioned and none of the particles show any visible porosity at any section of the 
particle. The images in Figure 6.4 also show no visible pores in the particles examined. 
The particles prepared with both solvents are thus assumed to be solid with little 
porosity and would thereby have a higher density compared with porous particles of the 
same diameter. Many of the particles prepared using electrospraying had an extensive 
porous network inside the particles and some were even hollow (see Figures 4.26 and 
5.6). They therefore must have had a lower density than the spray dried particles. This 
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is, however, still to be confirmed quantitatively, for instance by measuring the 
differences between their geometric and aerodynamic diameters of the particles or by 
using a gas pycnometer.  
 
Figure 6.3 FIB/SEM images of spray dried microparticles prepared in ACN. The 
numbers indicate progression through the sample. 
 
Figure 6.4 FIB/SEM images of spray dried microparticles prepared in ACE. The 
numbers indicate progression through the sample. 
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Analysis of the solid state form of CEL in the spray dried particles is shown in     
Figures 6.5 and 6.6. The DSC curves show that there is an endothermal peak around   
57 ºC for both curves which is similar to the Tg of PLGA used in this study. A small 
endotherm event can be seen in Figure 6.5 A around 130 ºC, which could be due to a 
very small portion of crystalline CEL or a CEL solvate. However, due to its much 
smaller area compared with the glass transition event it is also likely to be a 
measurement error. Since no CEL melting peak was observed the DSC curves indicate 
that CEL was highly dispersed in the system in the amorphous state (see Figure 6.5).  
 
Figure 6.5 DSC curves of spray dried particles, prepared in ACE (A) and ACN (B).  
The physical state of CEL in the spray dried particle was confirmed by XRPD analysis, 
in which both the spray dried samples prepared show no distinct peaks crystalline 
peaks, thus indicating that both CEL and PLGA were amorphous in the microparticles.  
The single Tg observed in DSC measurement suggests that CEL and PLGA were likely 
to be in a single amorphous phase with no noticeable difference in the shape or location 
of the peaks for the two curves. Further, no recrystallization was seen indicating that 
CEL was very well dispersed in the PLGA matrix or dissolved in molten PLGA. The Tg 
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found here is consistent with the ones observed for the electrosprayed samples (Figure 
4.14) being in between the glass transition for particles with 10% and 30% drug 
loading.  
 
Figure 6.6 XRPD curves of spray dried particles prepared in ACE (A) and ACN (B). 
6.1.4 Drug release from microparticles 
Drug release from the spray dried particles prepared in ACE and ACN was studied 
using the same methodology as for the electrosprayed particles, a paddle dissolution 
apparatus with 500 mL of phosphate buffer (pH 6.8) + 1.5% SLS and analysed using 
HPLC (see section 3.12.2).  
Also, it is worth mentioning that two types of spray dried samples were collected, a 
compact powder mass from the region between the cyclone and the collection vial, and 
a fine powder from the collection vial. Both types of powder samples were 
characterized to observe any differences and no noticeable differences were seen on 
XRPD and optical microscopy. The results in section 6.1.2-6.1.3 were collected and 
analysed using the fine powder. Drug release profiles of the compact and fine powder 
samples showed lower release rates (~50% release after 24 hours) for the compact 
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sample compared with the corresponding fine powder (~90% release after 24 hours) 
both prepared at 5% solute concentration, 20% drug loading in ACE. The lower release 
rates for the compact powder is not surprising due to their lower effective surface area 
to volume ratio from which the release can take place. 
The drug release curves of the spray dried particles are presented in Figure 6.7 and show 
that drug release took place similarly to the electrosprayed particles prepared with the 
same formulation composition but with two quite different processes with different 
operational parameters.  
 
Figure 6.7 Drug release profile of microparticles prepared with 5% solute concentration 
and 20% drug loading in ACE or ACN, using spray drying and electrospraying, 
measured over 20 hours. Error bars indicate the standard deviation from the mean. 
For both of the spray dried samples a small burst release was observed as with 
electrospraying but the burst release for the spray dried samples was smaller indicating 
less drug situated near the surface of the particles. Although the spray dried particles 
were smaller on average than the electrosprayed particles, with some of the particles 
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being significantly smaller, the release rates observed were similar. It was again 
observed that an extended release took place during the 20 hours the particles were 
exposed to release medium and between 89 and 93% of their drug content was released 
in this time. The particles prepared with ACE had a slightly lower release rate than 
those prepared with ACN, during the first 6 hours of release, and from then on their 
release curves were nearly indistinguishable. This could be explained by the broader 
size distribution observed for ACN where a larger population of small particles released 
their drug load early on. 
6.2. Spray drying mixed solvent study and solution characteristics 
6.2.1 Introduction to spray drying of mixed solvent systems 
In continuation of the study on electrospraying of CEL-loaded PLGA particles using 
different solvent mixtures, the same solvent mixture composed of ACE (good solvent 
for PLGA) and MeOH (poor solvent for PLGA) were employed to vary the solvent 
power and the evaporation rate systematically. To further study the process of particle 
formation and influence of the solvent compositions on particle characteristics, the 
resulting microparticles were characterized using different analysis methods to examine 
the morphology, inner structure, surface chemistry, solid state properties and drug 
release rates. Moreover, the effect of polymer molecular conformation on processes that 
govern drug release from CEL-loaded PLGA microparticles prepared by spray drying 
were investigated similar to the studies performed electrospraying (section 5.1-5.5).  
6.2.2 Setup and sample preparation 
All microparticle samples were prepared at similar drying conditions (inlet temperature 
of 45 ℃, outlet temperature of 30 ℃, drying air flow rate of 375 L/min; atomizing air 
flow rate: 12.4 L/min and feed flow rate: 3 mL/min). The gentle drying conditions, and 
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in particular the low outlet temperature was again chosen due to the low glass transition 
temperatures of PLGA and CEL as explained in section 6.1.1.  
Particle samples were prepared at four different ratios of solvent mixtures. The solute 
concentration was kept constant at 5% w/v and a drug loading of 10% was used. An 
overview of the samples prepared is presented in Table 6.2. 
Table 6.2 Overview of solutions used for spray drying and their characteristics.  
Sample 
Drug loading 
(%w/w) 
Polymer conc. 
(%w/v) 
ACE:MeOH ratio 
(molar ratio) 
Intrinsic 
viscosity 
SD100:0 10 4.5 100:0 0.24 
SD90:10 10 4.5 90:10 0.22 
SD75:25 10 4.5 75:25 0.18 
SD69:31 10 4.5 69:31 0.15 
 
6.2.3 Solubility and polymer configuration 
Polymer molecular conformation in feed solutions was evaluated by characterizing the 
rheological properties of feed solutions, which was done to study the polymer molecular 
conformation in solidified microparticles. It is assumed that droplet evaporation and 
particle formation take place so quick with spray drying that it does not provide enough 
time for polymer molecules to change their conformational structure from droplet 
formation to solidification. The solubility studies were performed as explained in 
section 5.1.4 and because the feed solutions used for the electrospraying (section 5.1) 
and spray drying (section 6.2) studies were exactly the same only the same set of 
solubility measurements are used (section 5.1.4). 
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6.2.4 Evaporation study 
The evaporation profiles of the solvent mixtures and the feed solutions used for the 
spray drying studies are shown in Figure 6.8. The evaporation profiles were measured 
using TGA and the temperature was in this case kept constant at 30 °C to mimic the 
outlet temperature during the spray drying process. The weight loss was recorded as a 
function of time. 
 
 
Figure 6.8 Estimation of the evaporation rates of the pure solvent mixtures (A) and the 
spraying solutions (B) performed at 30 °C. Results denote mean values for evaporation 
rate (n = 3). 
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The evaporation rate profiles of pure solvents (without CEL and PLGA) all showed 
reverse S-shaped curves representing three drying phases (Figure 6.8 A); a slowly 
declining evaporation rate in the beginning, a fast declining evaporation rate next and a 
slowly declining evaporation rate in the end. In the first phase, a loss in % solvent 
weight took place at a high rate, and the evaporation of solvent was mainly governed by 
the affinity between the solvent molecules. In the subsequent phase, the evaporation 
slowed down rapidly, indicating that the majority of the solvent had evaporated. In the 
final drying phase, the evaporation rate remained low as the residual solvents 
evaporated, possibly due to the reduced solvent volume.  
The evaporation profiles of the solvents were changed when PLGA and CEL were 
added to the solvent systems (Figure 6.8 B). Four evaporation phases were observed at 
solvent ratios 69:31 and 75:25, whereas three phases were observed at solvent ratios 
90:10 and 100:0. Further, a general decrease in the evaporation rates and an extended 
drying time were observed when PLGA and CEL were added to the solvent mixtures 
(compare Figures 6.8 A and 6.8 B). The slow final stage could be explained by the 
reduced solvent concentration and the closer interaction between solvents and solutes.  
It was found that for solvent systems without solutes, a prolonged evaporation time was 
observed with an increase in the MeOH content of the systems (Figure 6.8 A), 
indicating the lower evaporation rate of MeOH. During the last part of the drying 
process, the evaporation rate approaches the rate of the solvent with the lowest 
volatility, in this case MeOH. The evaporation curves of the feed solutions containing 
PLGA and CEL showed lower evaporation rates compared with the pure solvent 
mixtures (Figure 6.8 A). The prolonged evaporation times with the feed solutions is 
explained by the interactions between the molecules of the solvent and the polymer, 
which could have led to a reduction in the rate of solvent evaporation. It has previously 
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been reported that the evaporation rate of a solvent in suspension is the same as the 
evaporation of the pure solvent while the evaporation of a solvent in a solution is 
different from the evaporation rate of the pure solvent [Charlesworth and Marshall 
1960, Ranz and Marshall 1952]. The reduction in evaporation rate observed for the feed 
solutions could be explained by changes in the vapour pressure resulting from the 
addition of solutes. 
The drying profiles of ACE:MeOH = 90:10 and ACE:MeOH = 100:0 were similar 
during the first drying phase, while in the second drying phase, ACE:MeOH = 90:10 
showed a delayed drying profile (Figure 6.8 B). This indicates that addition of MeOH 
prolongs the drying time of the solution due to its lower evaporation rate. However, no 
clear differences were observed in the drying time by further increasing the MeOH 
content from 10% (90:10) to 31% (69:31) in the feed solution, even thought this was 
observed for the solvent mixtures (Figure 6.8 A). This could suggest that for all 
solutions containing MeOH, PLGA molecules begin precipitating according to their 
MeOH content and go from solution to form a suspension where the evaporation may 
be closer to that of the pure solvents, and hence faster. This increase in evaporation rate 
during precipitation may compensate for the decrease in evaporation rate experienced 
from the lower evaporation rate of MeOH.    
Due to the lower evaporation of MeOH compared with ACE and the poor solubility of 
PLGA in MeOH, anti-solvent precipitation of PLGA will occur when the ACE:MeOH 
ratio decreases during evaporation and reaches the solvent saturation point for PLGA. 
This takes place at 65:35 ACE:MeOH molar ratio at 5% solute concentration and 10% 
drug loading, but this ratio becomes higher as the solute become more concentrated 
during solvent evaporation. CEL would still be dissolved at the saturation point of 
PLGA due to its better solubility in MeOH and its lower concentration in the solutions. 
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Also, considering the difference in molecular weight between CEL and PLGA, a 
difference in mass transfer is expected between the two molecules when the solutes 
move in the evaporating droplet. This is likely to have an influence on the distribution 
of the two molecules in the resulting microparticles. 
6.3 Characteristics of spray dried particles 
6.3.1 Drug entrapment and moisture content of particles 
CEL-loaded PLGA microparticles were prepared with the 4 different solvent systems at 
10% drug loading and otherwise at identical solute concentration and operation 
conditions. For all four particle formulations prepared, the entrapment efficiency was 
around 100% or slightly above 100% indicating good entrapment of the drug within the 
PLGA matrix (see Table 6.3). There was no obvious correlation between the processing 
conditions of the samples and the measured drug entrapment. The residual moisture in 
the particles was also measured after preparation of the spray dried samples. For all 
samples the residual moisture content was between 0.47% and 0.55% which can be 
regarded as low. There was again no correlation between the solvent composition of the 
solutions and the residual moisture observed although it was expected that SD69:31 
would have a higher moisture content due to the higher MeOH content in these 
particles. Yet, possibly due to the small differences in boiling point and the rapid drying 
with the spray dryer no solvent related influence was observed. Further, the low residual 
moisture content in the microparticles suggests that the process parameters used in the 
present study were appropriate for effective drying of the PLGA microparticles. 
6.3.2 Morphology and size of particles 
SEM images of the particles prepared are presented in Figure 6.9. The microparticles 
were all spherical with smooth surfaces. The variation in solvent compositions did not 
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seem to have a visible influence on the morphology of the microparticles. All four 
microparticle samples exhibited similar morphology without fusion between the 
individual particles and could not be distinguished based on their appearance. The 
images indicate that the differences in properties between the two solvents used to form 
mixtures did not have detectable influence on the morphology of the particles. This 
could be explained by the rapid drying process of spray drying, which may not have 
allowed sufficient time for PLGA to change its structural conformation during drying of 
individual droplets at varying levels of ACE and MeOH. The PLGA chains may thus 
have stayed stretched out and well entangled resulting in smooth a surface morphology.    
Table 6.3 Composition of feed solutions and physicochemical properties of CEL-loaded 
PLGA microparticles (5% solid concentration, 10% drug loading). Results denote mean 
± SD (n = 3).  
Sample 
Mean diameter 
(μm) 
Polydispersivity 
index (%) 
Entrapment 
efficiency (%) 
Surface CEL 
concentration (%) 
SD100:0 2.0 ± 0.8 41.5 106.4 ± 1.0 14 ± 2 
SD90:10 2.1 ± 0.7 31.6 106.9 ± 1.5 10 ± 1 
SD75:25 1.8 ± 0.7 41.2 102.7 ± 0.0 18 ± 7 
SD69:31 1.4 ± 0.5 32.2 101.4 ± 0.1 22 ± 1 
  
The mean diameter of the microparticles was measured to be in the range of 1.4-2.2 μm 
(see Table 6.3), although many smaller and larger particles were prepared as seen in 
Figure 6.9. The particle size distribution was relatively wide with the polydispersivity 
index of the samples being in the range of 32-42% for all samples (see Table 6.3). 
Particles seemed to become smaller as the MeOH content was increased with particle 
from SD69:31 being the smallest and particles from SD 100:0 and SD 90:10 being the 
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largest. Although all of the samples were of similar size with a relatively large standard 
deviation, particles from SD69:31 were found to be significantly smaller compared with 
particles from SD100:0 and SD90:10. 
 
Figure 6.9 Representative SEM images of spray dried PLGA microparticles loaded 
CEL, samples SD100:0 (A), SD90:10 (B), SD75:25 (C) and SD69:31 (D). 
With spray drying, it is known that a more viscous feed solution gives rise to larger 
particles. Figure 6.10 shows with at increasing PLGA concentrations solutions with 
high solvent power increase more in viscosity. Further, it was shown that the 
evaporation rate of the solvents decreased with increasing MeOH content, resulting in 
prolonged drying times of microparticles and possibly also smaller particles with denser 
inner structure (see Figure 6.8). It was thus expected that particles would become 
increasingly smaller as the MeOH content was increased and similar effect has 
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previously been reported [Shenoy et al. 2005a]. Such a trend was observed for the 
particles produced in this study, although the samples had a broad size distribution.    
    
Figure 6.10 Viscosity of PLGA solutions with different solvent ratios as a function of 
concentration  
6.3.3 Inner structure and porosity 
Cross section images of the spray dried microparticles (see Figure 6.11) indicate that 
microparticles produced with high MeOH content (SD75:25 and SD69:31) exhibited a 
more solid inner structure compared to microparticles prepared with low MeOH content 
(SD90:10 and SD100:0). In the latter two samples particles containing visible pores 
were observed as seen on Figure 6.11 C and D. Although a majority of particles were 
solid in all four samples the presence of pores in two of the samples indicates a 
difference in the particle formation process.   
The absence of visible pores in the majority of particles could be attributed to the high 
solute concentrations used in this study as well as the mild drying conditions applied in 
this study. The high solute concentration results in a denser polymer network at shell 
formation in the droplet evaporation process, while the low drying temperature gives 
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more time for the polymer to diffuse towards the core of the solidifying particle, both 
leading to denser particles (see section 2.3.3). This also correlates well with the 
observation in particle size, where the smaller particles were here the non-porous 
particles indicating that the particles are more densely arranged inside.  
 
 
Figure 6.11 Representative FIB/SEM images of PLGA microparticles loaded with 10% 
(w/w) CEL, samples SD100:0 (A, C), SD90:10 (B, D), SD75:25 (E) and SD69:31 (F). 
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The pores observed in particles of samples SD100:0 and SD90:10 could be explained by 
the differences in evaporation rate and solubility measured for the four solvents 
compositions. The faster evaporation rate of pure ACE:MeOH = 100:0 and ACE:MeOH 
= 90:10 result in less time for the droplets to shrink due to earlier polymer precipitation 
and shell formation compared to ACE:MeOH = 75:25 and  ACE:MeOH = 69:31 solvent 
mixtures. This could lead to a less dense inner structure and higher chance of getting 
pores. Moreover, the higher solubility of PLGA in solutions with ACE:MeOH = 100:0 
and ACE:MeOH = 90:10 result in more stretched out PLGA structural conformation 
and more chain entanglement. This could result in slower polymer diffusion rate and 
therefore slower shrinking of the droplets, again leading to less dense and more porous 
particles. The same can be said for the higher viscosity of solutions with less MeOH 
which result in larger droplets and therefore also less dense particles. 
6.3.4 Solid state characterization of particles 
The physical state of CEL in the spray dried microparticles were studied using DSC and 
XRPD and the DSC curves are presented in Figure 6.12. All samples showed a single 
endothermic event at approximately 55 °C, indicating the glass transition of PLGA 
alone or PLGA and CEL combined. The absence of a recrystallization and melting 
event may further provide indication that the CEL was dispersed in the PLGA matrix in 
an amorphous state.  
Results from the DSC curves are supported by the XRPD data presented in Figure 6.13, 
in which no crystalline peaks were observed in the diffractograms of the spray dried 
microparticles. All spray-dried microparticles formulations exhibited a halo shape 
characteristic for materials in their amorphous state. 
The different solvent compositions used in this study did not result in detectable 
differences in the solid state properties of CEL in the PLGA matrix,  
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Figure 6.12 DSC thermogram of spray dried microparticles with 10% (w/w) CEL, 
samples SD100:0 (A), SD90:10 (B), SD75:25 (C) and SD69:31 (D). 
 
 
Figure 6.13 Representative XRPD profiles (B) of CEL-loaded microparticles with 10% 
(w/w) CEL, samples SD100:0, SD90:10, SD75:25 and SD69:31. 
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6.3.5 Drug distribution in particles 
XPS was used to obtain the relative atomic concentrations (in %) of CEL on the surface 
of the spray dried particles. The surface CEL concentration was found to be in the range 
of 10-22% (see Table 6.3) whereas all samples were loaded with 10% drug. The results 
indicated a correlation between the solvent composition used to prepare the particles 
and the surface CEL concentration with the CEL concentration increasing as the MeOH 
content was increased. Again, as with the particles size sample SD90:10 did not quite 
follow the trend indicating that there could be an indirect correlation between the 
particle size and surface CEL concentration.   
The increase in CEL concentration observed at high MeOH contents could be explained 
by differences in the diffusion rate of CEL and PLGA during the particle formation 
process (see section 2.3.3). For example, in the mixed solvent systems of ACE:MeOH = 
75:25 and ACE:MeOH = 69:31, anti-solvent precipitation of PLGA is likely to occur 
prior to the precipitation of CEL due to the poor solubility of PLGA in both MeOH and 
ACE. Further, the PLGA molecules are much larger than the CEL molecules making 
them less mobile in the solution, especially when part of the solvent has evaporated. 
When PLGA has precipitated, part of the CEL molecules may still be dissolved moving 
around in the forming particles. When solvent escapes from inside of the particles the 
CEL molecules may thus migrate towards the particle surface together with the residual 
solvents (i.e. ACE and MeOH) resulting in the surface enrichment of CEL. This effect 
was, however, much less pronounced with the spray dried microparticles compared with 
the electrosprayed microparticles shown in Table 5.8.  
6.4 Drug release from spray dried particles 
The drug release behaviour of the CEL-loaded PLGA microparticles was investigated 
using the paddle dissolution method described in section 3.12.2. The release profiles of 
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CEL from the spray dried particles are shown in Figure 6.14. It was observed that all of 
the spray dried samples had a lower drug release rate relative to the dissolution of pure 
CEL and all of the samples showed a low burst release below 10% except for sample 
SD69:31. Further, the four microparticle samples exhibited different release profiles 
with an increase in release rate observed as the MeOH content was increased. Samples 
SD100:0 and SD90:10 were close with many of their corresponding points being within 
the standard deviation. The results correlated well both with the particle size data and 
with the XPS surface chemistry results all showing a trend between the solvent ratio 
used and their respective data.  
 
Figure 6.14 Drug release profile of spray dried microparticles prepared with different 
solvent ratios at 5% solute conc. and 10% drug loading, in phosphate buffer (pH 6.8) + 
1.5% SLS, measured over 20 hours. Error bars indicate standard deviation (n=3-4). 
Drug release from PLGA microparticle matrices will typically take place either via 
diffusion-driven or diffusion-driven followed by erosion-driven release due to the 
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hydrolysis of ester bond linkages in the PLGA molecules [Giteau et al. 2008]. For the 
uncapped PLGA such as the one used in this study, erosion of the PLGA matrix has 
been reported to take place after 15 days [Giteau et al. 2008] but would depend on the 
size and porosity of the particles as well as the release medium used. In the present 
study, the release from PLGA microparticles were investigated in a phosphate buffer 
solution (pH 6.8) containing SLS for 20 hours. Due to the negligible solubility of PLGA 
in phosphate buffer and the ability of the buffer to maintain the pH in a narrow range 
the drug release was most likely diffusion-driven. Release is further believed to have 
been mainly influenced by the PLGA matrix structure and the radial distribution of the 
drug in the microparticles.  
  
Figure 6.15 SEM images of spray dried microparticles after drug release in phosphate 
buffer + 1.5% SLS, samples SD100:0 (A), SD90:10 (B), SD75:25 (C) and SD69:31 (D).   
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The absence of critical erosion of the PLGA matrix structure could be supported by 
SEM images of the particles taken after the release studies (see Figure 6.15). The 
images show that particles were generally still intact after they had released most of 
their drug, which accounted for 10% of their mass. The connecting areas between some 
particles is most likely residual SLS from the release medium. Some of the particles in 
Figure 6.15 D seem to have lost their spherical structure possibly indicating that 
polymer molecules in SD69:31 were more loosely interconnected and thus lost their 
structure after releasing their drug load. This would make sense from the perspective of 
polymer structural conformation which was more compact and less entangled for 
SD:69:31 compared with the other samples.  
The differences observed in the release profile of the particle samples could be 
attributed to the different physicochemical properties of the particles resulting from the 
spray drying process when using different solvent compositions. As expected, burst 
release was highest for sample SD69:31 (Figure 6.14), which also showed the highest 
surface CEL enrichment and the smallest particle size. The same trend was observed 
throughout the whole release curve and both the particle size and the surface CEL 
concentration correlated well with the release rate, which changed according to the 
MeOH content. The trends observed indicate that the increased surface area to volume 
ratio from the smaller particle size and the shifted radial drug distribution both have an 
influence on the drug release kinetics. Further, the structural conformation of PLGA in 
the microparticles may also have had an influence on the measured release rates. The 
fast precipitation of PLGA in the spray drying process for all of the solvent systems 
used may have resulted in different conformation of PLGA in the microparticles 
depending on the initial state within the solvents, which in turn influenced the CEL 
release profiles.  
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6.5 Comparison of spray dried and electrosprayed particles 
In the previous sections the preparation of CEL-loaded PLGA microparticles using 
electrospraying and spray drying was described and the influence of various processing 
parameters on particle formation and the resulting particle characteristics was discussed. 
In this section some of the results obtained with electrospraying and spray drying are 
compared and the differences observed are discussed. The comparisons are mainly 
drawn on studies where similar formulation were used, that is formulations where CEL-
loaded PLGA particles were prepared with 5% solute concentration, 10% drug loading 
and using the solvents ACE, ACN or solvent mixtures of ACE and MeOH.   
6.5.1 Particle size and size distribution 
In studies using electrospraying, mean particles sizes of 4.3 µm and 4.2 µm were 
observed for ACE and ACN, respectively, and generally particles prepared with ACN 
were slightly smaller than those prepared using ACE (see Table 4.6 and Figure 4.20). In 
studies using spray drying, mean particles sizes around 2 µm were observed for both 
ACE and ACN with no clear difference in the size of particles prepared with ACE and 
ACN. These results indicate that particles produced with electrospraying were generally 
larger than those prepared with spray drying at the same formulation condition. Yet, 
with both techniques the particle size could be altered by increasing or decreasing 
different parameters such as the viscosity of the solution, the flow rate of the feed 
solution, the electrical conductivity of the feed liquid (for electrospraying) and the 
drying settings (for spray drying). 
Since the two techniques operate by different means and at very different mass outputs 
(high output for spray drying and low output for electrospraying) it is difficult to 
compare the resulting particle sizes based on a fixed set of formulation conditions. By 
increasing the liquid feed rate with spray drying, larger particles could have been 
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produced but would have required higher drying temperatures and would therefore be at 
the cost of inferior drying conditions for this specific PLGA/CEL system. Yet, it was 
observed with electrospraying that the solvents ACE and ACN resulted in slightly 
different particle size whereas no difference was observed with spray drying. The 
dynamic viscosities of the feed solutions were measured to be 1.01 mPa·s for the ACE 
solution and 0.97 mPa·s for the ACN solution, thereby being very close and possibly 
insignificant for the particle sizes. The differences in the electrical conductivity of ACE 
and ACN (see Table 4.3) are however, believed to have had an influence on the size of 
the electrosprayed particles but not on the spray dried particles. Thus more factors were 
involved with electrospraying determining the size of particles produced. 
With the microparticles prepared using mixed solvents the same trend was observed 
with respect to particle size. Particles prepared with electrospraying were again larger 
than those prepared with spray drying but for both techniques the particles became 
smaller as the MeOH content was increased. Again, for electrospraying the influence of 
MeOH content on particle size was more pronounced, most likely due to the differences 
in electrical conductivity as well as the much slower drying process, which allowed 
longer time for droplet shrinking. However, as mentioned, electrospraying and spray 
drying are two different techniques and the two setups used have markedly different 
output and drying mechanisms. Therefore, the comparison in particle size was limited to 
observations made on the differences among samples for each of the two techniques and 
differences in the particle size distributions.      
The size distribution measured for electrosprayed and spray dried particle samples were 
significantly different and was consistently observed throughout the studies performed. 
Whereas the electrosprayed particle samples had a polydispersivity index ranging 
between 6-24 (between 6-11 for 16 out of 25 samples measured) the spray dried 
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particles samples had a polydispersivity index between 32-42. This indicates that a more 
homogeneous population of microparticles can be achieved using electrospraying 
compared with the spray drying setup used in the present studies. Whereas 
electrospraying is known for its capability of producing near monodisperse particles this 
is not an easy task with spray drying. Some types of spray dryers are claimed to produce 
particles within a more narrow size distribution, for instance by using an internal mixing 
two-fluid nozzle (see Niro, http://www.niro.com/niro/cmsdoc.nsf/webdoc/ndkw653cl6) 
as opposed to the conventional two-fluid nozzle which was used in this study. Also, the 
Nano Spray Dryer produced by Buchi is claimed to produce smaller particles within a 
relatively narrow size range by utilizing a vibrating mesh in the spray dryer head 
(http://www.buchi.com/Nano-Spray-Dryer-B-90.12378.0.html). However, it is difficult 
and inappropriate to compare these spray drying setups with electrospraying at the 
current stage until a semi-commercial electrospraying setup is developed.  
6.5.2 Morphology and Porosity of particles 
In the studies using electrospraying several types of shapes were observed for the 
particles, ranging from spherical or elongated shapes to several types of collapsed 
shapes such as disc or bowl shaped particles. Further, different types of surface 
morphology were observed with electrospraying, such as smooth, porous, corrugated 
and grainy, all depending on the process parameters applied. In comparison, the spray 
dried particles all seemed to have similar shape and morphology. All of the particles 
produced were spherical with a smooth surface, regardless of changes in process 
parameters that were otherwise critical for particle shape and morphology with 
electrospraying. 
The different shapes observed with electrospraying resulted either from changes in the 
solute concentration or from collapsing of the particles which in some way also was 
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determined by the solute concentration or viscosity of the solution. By modifying the 
viscosity of the feed solution, particles went from being collapsed (~2-3% PLGA) to 
spherical (~4-7% PLGA) and to elongated (~10% PLGA) and further increase in 
viscosity would have led to fibres being produced (electrospinning). That said, 
collapsed particles have also been demonstrated to be produced with spray drying by 
applying certain parametric values similar to electrospraying [Alamilla-Beltrán et al. 
2005, Iskandar et al. 2003]. Elongated particles have also been produced [Corrigan et 
al. 2002, Gilani et al. 2005] but were generally not smooth as with electrospraying and 
formed via another mechanism, such as via crystallization.   
The different morphologies observed with electrospraying were explained partly by the 
polymer conformation in the solvents used and due to heat and mass transfer 
mechanisms during particle formation, which resulted in several interesting 
morphologies. In the study with solvent mixtures using electrospraying, particle 
morphology could be modified depending on the solvent:anti-solvent ratio (see section 
5.3.2). With spray drying no differences were observed in the resulting particle 
morphology when changing the solvent:anti-solvent ratio, although polymer 
precipitation and molecular level changes in the polymer conformation were expected to 
take place.  
With electrospraying, PLGA began to precipitate during droplet evaporation, with a 
MeOH content of only 10% (ACE:MeOH 90:10), while with spray drying the polymer 
did not manage to precipitate even with a MeOH content of 31% (ACE:MeOH 69:31), 
despite being very close to the saturation point of PLGA (ACE:MeOH ~65:35). This is 
explained by the much quicker drying process with spray drying compared with 
electrospraying, which is believed to allow particles to solidify almost instantaneously 
before any changes can happen in the polymer matrix structure. The evaporation studies 
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using TGA showed that drying of drops at 25 ˚C and 30 ˚C were very similar in 
duration and indicate that the quick drying with spray drying results from higher mass 
and heat transfer, due to the warm drying gas and the high air circulation rate.   
In the studies using electrospraying it was observed that most of the particles prepared 
were porous to some degree while some were hollow and others were solid. The spray 
dried samples were mainly absent of pores but in two of the samples prepared some 
pores were observed although not as porous as the electrosprayed particles. The 
differences observed in the porosity of spray dried and electrosprayed particles prepared 
using the same solutions can be attributed to differences in the particle formation 
process in the two techniques. Again, spray drying involves an active drying process 
with warm dry gas to dry droplets while the present electrospraying setup relies on 
passive drying. Thus, with spray drying the heat from the active drying could have 
reached into the core of the particles, at some point in the process, while with 
electrospraying solvent evaporation is likely to have only taken place at the surface, 
creating an imbalance in the radial distribution of solid material.  
From the cross sectional images in Figure 4.22 it was observed that the particle porosity 
increased with increasing solvent concentration. Further, particles prepared with ACE 
were less porous than those prepared using ACN. These findings suggested that the 
porosity is influenced by the amount of solvent that needs to evaporate or escape to 
form the dry particle and the rate at which they dry. Solutions with low solute 
concentration (high solvent concentration), solvents with high boiling points and a 
passive, slow drying process would thus all result in increased porosity. This correlates 
well with the findings from this study. Moreover, in that case that the range of polymer 
concentrations at which electrospraying and spray drying form porous particles is 
different, pore formation could possibly be avoided for electrosprayed particles simply 
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by using higher solute concentrations. Yet, for mixed solvent solutions where early 
precipitation of PLGA took place, the particle formation process was different and 
resulted in less porous structures. It is believed that when PLGA precipitates in the 
droplet, the polymer interacts less with the solvent and shell formation does not take 
place. Instead, polymer nano-clusters move inwards towards the centre of the droplet 
and go together as the solvent evaporates (Figure 5.11). 
Although it is obvious that the drying process in spray drying is much quicker than in 
electrospraying, this is somewhat contradicting with the common principle in spray 
drying that high drying rates result in a more porous particles than low drying rates 
[Vehring 2008; Yao et al. 2008]. Spray drying resulted in less porous particles even 
though it dried the particles at a quicker rate than with electrospraying. This further 
reaffirms that the drying process of the two techniques are not comparable. Also, 
although not investigated in this work, there is likely to be a difference in the density of 
the spray dried and electrosprayed particles given the differences in porosity and size of 
the particles. It is believed that the electrosprayed particles are generally less dense 
compared to the spray dried particles, based on the greater porosity and larger particles 
observed. This could be further investigated in future studies. 
6.5.3 Solid state characteristics of the particle based solid dispersions        
Comparing the solid state characteristics of microparticles produced with 
electrospraying and spray drying, both XRPD and DSC analysis showed similar data for 
the two techniques. DSC curves of electrosprayed particle samples (Figures 4.14) and 
spray drying particle samples (Figures 6.5 and 6.12) were absent of a melting 
endotherm around 162.7 ˚C, the measured melting endotherm for pure CEL. However, 
for some electrosprayed samples with higher drug loading (Figure 4.14B) and 
exothermal event indicating recrystallization and a shifted melting endotherm was 
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observed, which could also have been the case for spray dried samples at higher drug 
loading, had it been examined. Only a single glass transition event was observed, 
suggesting that the drug was highly dispersed in the polymer matrix. The presence of 
two nearby glass transition events would have indicated separate amorphous phases. 
Yet, in this case the individual Tg‟s for CEL and PLGA may have been too close to 
detect, as demonstrated by the single Tg observed for the physical mixture of CEL and 
PLGA (see Figure 4.6). Also, a relatively high solubility of CEL in PLGA, above the Tg 
of PLGA, was indicated by the small or shifted melting endotherm of the physical 
mixture. The absence of a melting peak for most of the electrosprayed and spray dried 
samples is thus partly attributed to the dissolution of CEL in PLGA before it reaches its 
melting point. Thus the solid state form of CEL within a PLGA matrix cannot be 
accurately determined only using DSC.  
XRPD measurements for electrosprayed (Figure 4.23, 5.7) and spray dried samples 
(Figure 6.5, 6.13) all indicated that the samples were amorphous from the “halos” 
observed and the absence of sharp peaks. The diffractogram of electrosprayed samples 
and spray dried samples were very similar and could not be distinguished. However, the 
physical mixture of CEL and PLGA on Figure 4.10 showed clear peaks indicating 
crystallinity in the sample. Although the XRPD data strongly suggested that the samples 
were amorphous for both electrospraying and spray drying, differences in the solid 
dispersions produced could not be evaluated by this data. As with XRPD, observations 
made using polarized light microscopy did not indicate the presence of anisotropy in 
neither the electrosprayed nor the spray dried samples, which reaffirms the absence of 
crystallinity in the samples. 
The results indicate that with both particle preparation processes CEL is well dispersed 
within the PLGA matrix preventing small crystals from forming at a drug concentration 
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up to 30% and perhaps also even higher. This, however, does not tell whether the drug 
is homogeneously distributed within the particles or more concentrated in some regions 
for either for the processes. Comparisons of drug release results suggest that some 
samples have a higher concentration of drug on their surface, with their faster release 
rates but this is not certain. 
6.5.4 Drug distribution in particles 
The surface chemistry of microparticle samples were studied to investigate the drug 
distribution and homogeneity of the solid dispersion prepared. XPS measurements of 
electrosprayed samples indicated that CEL was generally distributed towards the surface 
of the particles. All of the measured samples showed higher surface drug concentration 
than what was initially loaded into the particles. Further, the surface drug concentration 
increased with an increase in MeOH concentration for the binary solvent systems and 
also with an increase in drug loading. With the spray dried samples XPS measurements 
indicated that particles prepared mainly with ACE had similar surface drug 
concentration as initially loaded into the particles. Also for the spray dried samples the 
surface drug concentration increased with increasing MeOH concentration. The 
differences in the general surface drug concentration of particles prepared using the two 
techniques are seen in Tables 5.6 and 6.3 and shown together in Table 6.4.  
For all of the four sample conditions the electrosprayed samples showed a higher 
surface drug concentration than the spray dried samples. This indicates that there are 
differences between the two processes which results in higher accumulation of drug 
towards the surface of the particles. For both techniques the increased migration of CEL 
towards the surface of the particles with increasing MeOH content was attributed to the 
small molecular weight and better solubility of CEL in MeOH. This would have 
allowed CEL molecules still dissolved in the droplet to move out through the polymer 
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network towards the forming particle surface together with the solvent. The higher 
surface drug concentrations observed for electrosprayed samples could thus be 
explained either by the slower solvent evaporation experienced with the passive drying 
process of electrospraying, or the influence of electrical charge on the molecular 
distribution of the particles. The electrical charge on the surface of droplets during 
particle formation could have attracted CEL molecules, slightly more than PLGA 
molecules, to distribute CEL molecules near the surface of the particles. This could be a 
result of polar groups in the CEL molecules although both molecules are generally 
nonpolar. The role of the electrical charge on the charging and distribution of individual 
molecules in droplet with electrospraying has not been reported but would be interesting 
to understand better. 
Table 6.4 Surface drug concentration of electrosprayed and spray dried particle samples 
prepared with 10% drug loading using solvent mixtures of ACE and MeOH. 
Sample Electrosprayed samples Spray dried samples 
ACE:MeOH (100:0) 20 ± 1% 14 ± 2 % 
ACE:MeOH (90:10) 31 ± 2% 10 ± 1 % 
ACE:MeOH (75:25) 38 ± 1% 18 ± 7 % 
ACE:MeOH (69:31) 41 ± 1% 22 ± 1 % 
 
XPS analysis of electrosprayed CEL-loaded HPMCAS particles showed a relatively low  
surface drug concentration compared with the CEL-loaded PLGA particles. In fact, 
some of the samples had a surface drug concentration lower than initially loaded 
concentration (see Table 5.8). This could suggests that the drug distribution not only is 
determined by the solvent evaporation rate and electrical charge but also influenced by 
the solubility of solutes in the solvents and solvent mixtures used as well as the 
molecular mobility of the drug molecules in the given polymer matrix. 
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6.5.5 Drug release 
Drug release curves for both electrosprayed and spray dried particle samples prepared 
with a single solvent showed diffusion mediated release taking place over several hours. 
The electrosprayed samples showed different degrees of burst release depending on the 
preparation conditions while the spray dried samples generally showed less burst 
release. Figure 6.16 presents a comparison of drug release for particles prepared with 
ACE and ACN using electrospraying and spray drying. It is seen that the electrosprayed 
particles had a slightly higher drug release rate than the spray dried particles and that for 
both techniques, particles prepared using ACN had a quicker release than those 
prepared using ACE. The differences in release rate from these particle samples is 
attributed to their differences in porosity, particle size and drug distribution. Particle 
size is considered as one of the main determinants of drug release from microparticles 
and this was also observed from Figures (4.26-4.31). Large particles have a lower 
surface to volume ratio than small particles and also have a longer diffusion distance to 
travel for the drug, both of which lead to slower drug release.  
The spray dried samples were expected to release their drug quicker than the 
electrosprayed samples due to their smaller average size compared with electrosprayed 
particles prepared at similar conditions. Yet the spray dried samples showed slower 
drug release compared with the corresponding electrosprayed samples, which 
contradicts the theory. The electrosprayed particles were more porous than the spray 
dried counterparts and also had a higher surface drug concentration, which together 
could explain the results observed. An increase in particle porosity leads to an increase 
in surface to volume ratio as well as a reduction in the drug diffusion boundary, hence 
increasing the release rate. An increase in the surface drug concentration would result in 
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higher burst release and result in a general increase in release rate due to the shorter 
diffusion distances for drug molecules distributed near the particle surface.  
Further, although not measured, the density of the solid regions of the particles may 
have been lower for electrosprayed particles, with the PLGA network perhaps being less 
packed judging from the higher porosity and larger particles observed. This could also 
have had an influence on the drug release rate, but all in all the release rates and the 
shape of the curves were not that different when considering two separate techniques 
were used to prepared the particles. A greater difference could have been expected 
considering the differences in particle size distributions and particle characteristics. 
 
Figure 6.16 Drug release curves of electrosprayed and spray dried particles prepared 
with 5% solute concentration and 10% drug loading using ACN or ACE. 
When comparing the drug release from particles prepared with ACE-MeOH mixtures 
using electrospraying and spray drying (see Figures 5.8 and 6.14), the difference is seen 
more clearly. Here, all of the samples prepared using electrospraying had higher release 
rates than the spray dried samples, although the general trend between the samples was 
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similar. For both techniques samples prepared with high MeOH content had the highest 
release rates. Also here, larger particles were observed, on average, for electrosprayed 
samples (see Tables 5.5 and 6.3) but did not correlate with the drug release rates. In this 
case the electrosprayed particles were again more porous than the spray dried particles 
(see Figures 5.6 and 6.11) and the surface drug concentration was generally 
considerably higher for electrosprayed samples. Both of these characteristics support the 
higher release rates observed for electrosprayed particles.  
Moreover, the electrosprayed particles prepared with ACE:MeOH ratios, 90:10, 75:25 
and 69:31 had all disintegrated when observed after drug release whereas the spray 
dried particles seemed to be structurally intact. The disintegration of microparticles into 
nanoparticles would result in much higher surface area to volume ratio and higher 
release rates, which supports the differences observes in Figures 5.8 and 6.14. Particles 
prepared using the two techniques can thus lead to significant differences in the drug 
release kinetics due to differences in their particles formation process and resulting 
particle characteristics. Such differences could be used to optimize the release profile of 
drug formulations prepared with either of these two techniques. 
6.6 Additional remarks on electrospraying and spray drying 
The particle formation process in both spray drying and electrospraying is of high 
interest to those who wish to design and engineer particles with special characteristics 
and function. Although much effort has been made to better understand the mechanisms 
behind the particle formation process with spray drying, the seemingly similar 
mechanisms in electrospraying are less understood and still needs to be investigated 
[Park and Lee 2009]. Nevertheless, some aspects in the process are clear and can be 
used to compare the two techniques and further some things have been discovered 
during the present work. To the best knowledge of the author of this thesis, only one 
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review article has set the two techniques up against each other, comparing the processes 
and their application for producing drug nanoparticles [Peltonen et al. 2010]. In this 
review Peltonen et al. discusses the advantages and disadvantages of each technique 
with focus on the scalability of the techniques, the producible particle size range and the 
compatibility of the techniques with different classes of materials. However, they do not 
go into detail with respect to the differences in the actual processes and do not explain 
the mechanism behind their respective particle formation process.  
The advantages of electrospraying compared with spray drying is that it can fairly easily 
produce a near-monodisperse population of particles in the nano to micro range and can 
do this at ambient conditions with a large range of materials and solvents, given that the 
surface tension, electrical conductivity and viscosity of the liquid is kept within a 
certain window. Spray drying cannot produce particles with as narrow a size 
distribution and is further limited to non-thermolabile materials, but can still produce 
particles close to the nano range using a bench top system and is much easier to scale up 
than electrospraying. However, when scaled-up to commercial scale spray drying, 
currently, may not be able to produce particles with the same degree of control over 
their attributes as with a bench top system [Masters K 2002]. With electrospraying, a 
scale-up would likely involve having hundreds of parallel nozzles spraying 
simultaneously (see section 2.6.5) which would probably not affect the resulting particle 
characteristics.  
In terms of particle formation the two techniques are known to have differences as they 
first of all employ different forces to atomise the liquid into droplets. Whereas spray 
drying mainly uses the pressure of a gas to part the liquid, electrospraying uses a high 
electric potential. Further, with spray drying an active heat/mass transfer takes place 
after droplet formation, while with the present electrospraying setup the droplets are 
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exposed to an electric field until they are discharged at collection. The electrospraying 
device can, however, be customized to control the environment (temperature and 
humidity) and also possibly incorporate a drying system similar to that used in spray 
drying setups. But for the current time the electrospraying is associated with a passive 
drying process. For both techniques small liquid filaments are ejected from the nozzle 
and quickly develop into spherical droplets which go through an evaporation process, 
finally resulting in dry particles. However, in the steps in between there may be 
significant differences resulting from the exposure to heated air and the exposure to an 
electric field.  
A quantification of the typical time it takes for a droplet to form into a particle would be 
a useful measure to know for both techniques. Although this has not been measured, it 
can be speculated that the spray drying process should be quicker due to its active 
drying process. How much quicker it actually is, would need to be measured or 
extrapolated from indirect measurements and the influence of other factors on the 
particle formation and droplet evaporation processes should be elucidated. It has 
previously been reported that a liquid may evaporate at a higher rate when exposed to 
an electric field [Liu et al. 2005; Zheng et al. 2011]. Whether such an effect really takes 
place and plays a significant role during droplet evaporation in electrospraying is not 
currently known. The electric field in electrospraying may nevertheless have some 
influence at the droplet surface during particle formation. It is for instance plausible that 
a difference in electric charge between two materials suspended or dissolved in the 
droplet may lead to some sort of phase separation. Such a phenomenon would be 
interesting to look more into and may be useful to control the distribution of materials 
within the droplets.  
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7.1 Conclusions 
Developing an effective drug delivery system can be a complex and challenging task, 
but the opportunities and application of such systems are remarkable. Solid dispersion 
formulations have been widely studied and are promising for the development of oral 
dosages for poorly soluble drug compounds due to their dissolution enhancing ability. 
Moreover, extended release solid dispersions may further improve the performance of 
the formulations by providing less variation in the drug plasma concentration  and less 
frequent dosages. Microparticle based delivery systems have shown a great potential to 
improve current treatments by tailoring their physicochemical attributes to the specific 
needs. Electrospraying was chosen for this purpose and specifically to improve the 
performance of solid dispersion formulations of poorly soluble drugs. Unlike spray 
drying, a well-established technique for pharmaceutical development, electrospraying is 
still in an experimental stage but has proven an attractive technology.  
In the present study CEL-loaded PLGA microparticles were prepared with 
electrospraying with the aim to:  
 obtain small particles in the lower micro-range  
 the drug dispersed in the microparticles in a stable amorphous state  
 good control of particle characteristics, size, morphology and porosity  
 good control of drug release kinetics using the studied parameters.  
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With this in mind the influence of different processing parameters on the particle 
formation process, particle characteristics and drug release kinetics were investigated. 
This was done by studying a few different parameters which have previously been 
shown to have and important influence on the particle characteristics, including flow 
rate, solute concentration, drug loading and the composition of the solvent(s). The 
studies were focused on a single model drug, CEL, and the influence of different 
solvent mixtures on two drug-polymer combinations, CEL-PLGA and CEL-HPMCAS. 
7.1.1 Electrospraying of solid dispersions  
Solutions of CEL alone in different organic solvents demonstrated the sprayability of 
pure drug solution to form microparticles. CEL was then combined with PLGA, 
electrosprayed using a single nozzle setup and showed that they could be mixed and 
sprayed together in a single liquid phase to form microparticles with CEL molecules 
presumably dispersed within a PLGA matrix structure.  
Generally, high collection yields and entrapment efficiencies were observed with the 
electrospraying process compared with conventional particle preparation techniques 
such as emulsion-based techniques and laboratory scale spray drying. Due to the simple 
collection process most of the output (>81%) was retained at collection and could easily 
be optimised by coating the nozzle or collecting in a closed chamber. The entrapment 
efficiencies were generally very high mainly due to the collection method and the single 
nozzle setup used. The particles were collected dry and were not washed in any way and 
further the drug was fully mixed with the polymer before and after spraying and thus 
prevented excessive loss in drug entrapment in the process.   
7.1.2 Parametric study on particle characteristics 
For the parametric study using CEL and PLGA, the particle size generally ranged 
between 2-8 μm and the size distribution was relatively narrow (polydispersivity indices 
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mostly between 6-16%). The applied flow rate had the most dominant influence on 
particle size with particle size increasing as the flow rate was increased. Also, solute 
concentration, drug loading and type of solvent influenced the particles size, mainly by 
either increasing or decreasing the viscosity or the electrical conductivity of the 
solution. An increase in viscosity resulted in an increase in particle size while an 
increase in electrical conductivity resulted in a decrease in particle size. 
Particle morphology of drug-loaded PLGA particles ranged from being spherical with 
smooth or porous surface to raisin-like, grainy or collapsed. Elongated particles could 
also be produced by changing the viscosity of the solution to a higher range. Further, by 
using another polymer, HPMCAS, other types of surface morphologies were observed, 
mainly being collapsed with a shell or bowl shape or corrugated with different level of 
roughness. Particle surface morphology was influenced by the solvent(s) used and the 
presence of an anti-solvent to the polymer lead to significantly different morphologies. 
The results indicated that the evaporation rate and the solvent power of the solvents 
together had an important role in the particle formation process.  
Cross sectional images of the particles showed a porous inner structure for most of the 
electrosprayed particles except for some particles prepared with ACE. It was further 
observed that the porosity increased as the solute concentration was decreased, 
indicating that the excess solvent in the droplets resulted in pore formation. This effect 
was explained by the solvent evaporation mechanism and the relatively low solute 
concentrations used with electrospraying.  
XRPD and DSC analysis demonstrated that CEL was in an amorphous form for all 
PLGA-CEL particles studied, even at 30% drug loading, where no crystallinity was 
detected with XRPD. The absence of crystallinity indicated that CEL was molecularly 
dispersed in the PLGA matrix as a solid dispersion. Further, the physical stability of this 
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amorphous drug dispersion within the particles was measured over 8 months during 
storage in a desiccator. Yet, no signs of instability were observed both from XRPD 
measurements and visual inspection using SEM, indicating a relatively good physical 
stability of the prepared particle formulations.   
Drug release studies were performed to predict the intestinal in vivo release profile and 
showed that under sink conditions the drug release could be controlled over a 20-24 
hours period to provide either a rapid release over a short time or an extended release 
over the full 24 hours studied. Varying degrees of burst release was observed and is 
believed partly to be indicative of the surface CEL concentration. Further, particles that 
were either small or less compact also resulted in high burst release. Following the burst 
release a more sustained diffusion dependent release was observed until most of the 
drug had been released. Polymer erosion did not typically take place during the studied 
time span and thus did not affect the release. This was confirmed by taking SEM images 
of particles after dissolution and the release curves were fitted and correlated well with a 
standard Higuchi model for diffusion mediated release. 
The studied parameters were all found to have some influence on the drug release 
profile with size, porosity, drug loading and solubility of PLGA in the solvent being the 
most significant factors. All of the studied parameters had an influence on particle size 
and an increase in particle size resulted in slower release due to a reduced surface to 
volume ratio. Further, an increase in porosity is believed to have led to similar effect via 
a reduction in the effective surface to volume ratio and possibly a density reduction in 
solid areas of the particles. Finally, the drug distribution in the particles also seemed to 
have a significant influence on drug release with higher drug concentrations at the 
surface resulting in a shorter diffusion boundary for the drug molecules and hence 
quicker release. Better control of the drug distribution within the particles could 
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eliminate the burst release observed in these studies and have a desirable impact on the 
drug release curves. It would also be useful to achieve delayed release by distributing 
the drug more towards the core of the particles and this may also further increase the 
drug stability of more unstable drugs, such as proteins.  
Despite the fact that release mechanisms of PLGA-based controlled release systems 
have been extensively studied for over 20 years, the mechanism of drug release from 
PLGA microparticles is still not fully understood. This is partly due to the complexity of 
the processes and the interactions present in such a system but also because of the lack 
of full understanding on processes that govern drug release and the factors the influence 
the processes. In line with the Quality by Design (QbD) approach, the fundamental 
knowledge regarding these sophisticated processes and factors is necessary if we are to 
understand drug release in detail and gain better control of the drug release kinetics.  
7.1.3 Mixed solvent studies with electrospraying 
CEL-loaded PLGA and CEL-loaded HPMCAS microparticles were produced using 
mixed solvent systems at different solvent ratios using electrospraying to investigate the 
solvent interactions with the solutes and the influence of solvent compositions on the 
particle formation process. For the PLGA system mixtures of ACE and MeOH were 
used whereas for the HPMCAS system mixtures of ACE, EtOH and H2O were used. 
The studies demonstrated that particle formation in the electrospraying process 
depended markedly on the solubility of the solutes in the solvent(s), as well as on the 
evaporation rate of the solvents. By using an anti-solvent or a poorer solvent for the 
polymers during particles formation, the molecular conformation of the polymer chains 
became more compact and less entangled and further resulted in early precipitation of 
the polymer during solvent evaporation.  
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For CEL-loaded PLGA particles, depending on the amount of the anti-solvent, different 
degrees of roughness were observed in the surface morphology and this also influenced 
the accumulation of CEL at the particle surface. A clear correlation was observed 
between the concentration of the anti-solvent in the solvent mixture and the surface 
content of CEL, which was also evident from the release rates observed in the drug 
release studies. The effect was less obvious with the CEL-loaded HPMCAS particles. 
Although HPMCAS is supposedly soluble in aqueous solutions with a pH above 5.5-6 
as well as different organic solvents, there seems to be an unclear understanding 
whether a nano-suspension or an actual solution is formed. Further, it seems that a 
complex relationship exists between the solubility of HPMCAS in the solvent mixtures 
and the solubility during evaporation of the solvent. Here, CEL was less soluble than 
HPMCAS in some of the solvent mixtures and seemed to result in earlier precipitation 
of CEL and a lower surface drug concentration. Although there was some correlation 
between the solvent ratios, the particle morphologies, the surface CEL concentration 
and drug release, it was not as clear as for the PLGA-CEL system. The subtler 
differences in surface CEL concentration could also be explained by the lower 
molecular mobility of CEL in the HPMCAS matrix due to the higher viscosity of 
HPMCAS compared with PLGA. For these particles no crystallinity was measured 
despite the high surface CEL concentrations, which indicated that a phase separation is 
not likely to have happened. The mechanisms by which the different particle 
morphologies and drug distributions form different solvent mixtures are related to the 
balance between precipitation of solutes and evaporation of solvents.  
7.1.4 Spray dried microparticles and comparisons with electrospraying 
Spray dried particles were prepared at similar conditions as the electrosprayed particles 
to compare the two techniques. The spray dried particles appeared to be non-porous and 
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had a smooth surface under SEM observation making the different samples 
indistinguishable. The particles were generally smaller with a broader size distribution 
than the electrosprayed counterparts sprayed with the same solute concentration and 
drug loading. The drug was also highly dispersed in the polymeric matrix forming solid 
dispersions. For particles prepared with single solvents the release of CEL took place at 
slightly slower rates than with electrosprayed particles but not very differently, although 
the spray dried particles were smaller. This indicated that the spray dried particles were 
denser and therefore probably released their drug load slower than expected.  
Further, for the mixed solvent system with ACE and MeOH it was observed that the 
surface drug concentration was much lower for spray dried particles when compared 
with electrosprayed particles, although the same trends were observed, indicating that 
the active drying process allowed less diffusion of drug molecules towards the surface. 
This also explains the differences observed in drug release rate of the particles prepared 
with ACE-MeOH mixtures where much faster release rates were observed for 
electrosprayed particles when MeOH was added to the solvent. The difference observed 
here is also explained by the disintegration of grainy electrosprayed particles which is 
likely to have resulted in much quicker release, while the spray dried particles remained 
structurally intact. It is believed that the main differences observed between the particles 
prepared using spray drying and electrospraying can be explained by differences in the 
droplet formation and droplet drying process and the resulting particle characteristics. 
This, however, needs to be further elucidated by careful observation of the two 
techniques. 
At this point it is clear that there are certain differences between the electrospraying and 
spray drying processes for producing microparticles, mostly in the mechanisms 
involved in particle formation but also in the level of development of the technologies. 
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Whereas spray drying is a fully commercialized and optimized technology for 
pharmaceutical development and manufacturing, electrospraying is still at the 
experimental plan for formulation purposes, although the technology has become highly 
developed for mass spectrometer applications [Jaworek 2008; Takíts et al. 2004]. The 
difference in level of development makes it difficult to compare the two techniques due 
to the automated, commercial setups used for spray drying and the manual, customized 
setups available for electrospraying. In one way the automated functions and the 
convenient collection mechanisms of spray drying favour its use, and yet the high level 
of customization in electrospraying may also allow more flexibility with regards to 
experimentation and thereby favour the use of electrospraying. Also, although spray 
drying is automated and both humidity and temperature is controlled within the 
spraying chamber, it would still result in variation between the batches produced as it is 
not a continuous manufacturing process on its own.  
Although some steps are being taken towards commercialization of electrospraying for 
pharmaceutical formulations, there are still many aspects of the electrospraying process 
that are unknown. Better understanding on the particle formation process as well as the 
influence of different processing parameters may provide ways of optimizing the overall 
particle preparation and design. Nevertheless, both electrospraying and spray drying are 
useful techniques in preparing microparticles with control of particle size and 
morphology and are believed to be suitable for producing functional drug delivery 
carrier systems with superior performance. Currently, drug delivery systems such as 
microparticle based carriers and solid dispersion formulations are finding their way into 
the product pipelines of many pharmaceutical and biotech companies. Such drug 
delivery systems should have a superior performance over conventional drug 
formulations with better control of drug release kinetics and additional features making 
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them perform better. In order to prepare such drug delivery system, a suitable particle 
engineering technology enabling control of such particle characteristics and 
functionality is necessary. Electrospraying was demonstrated to provide considerable 
control of important particle attributes such as size, morphology, shape, porosity and 
drug distribution as well as the resulting drug release kinetics. In this study 
electrospraying showed more room for tuning and control of particle characteristics 
compared with spray drying and can be further optimized to provide better control for 
particle engineering purposes. Nevertheless, both techniques can be considered suitable 
for generating drug-loaded particles intended for use as drug delivery carriers, each 
technique with its own advantages and limitations to be overcome.   
7.2 Future work 
Based on the research done in this project and the results obtained, several aspects of 
future work are recommended as follows: 
7.2.1 Further investigation of the electrospraying particle formation process – A 
droplet study. 
In this work, the electrospraying particle formation process was investigated by looking 
at the properties of the spraying solutions and the characteristics and drug release profile 
of the particles. To further build on the results of this project, droplet formation and the 
initial droplet drying stage could be looked further into by visualization using a high 
speed camera. This high speed camera would be used to capture images of 
electrosprayed droplets immediately after detachment from the cone-jet further 
downstream of the spray. By capturing images at different distances from the cone-jet it 
would be interesting to study different stages of droplet formation as well as 
mechanisms such as Coulomb fission. The studies could for instance be done using a 
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high speed camera incorporated with a microscope lens, and adjusted to capture the 
droplets at different positions. This study may give interesting and important new 
information on the particle formation process with electrospraying and the results can be 
compared with similar spray drying studies done by other researchers. Initial studies 
were performed testing a high speed camera with a frame rate of 1000 frames per 
second. The rapid movements in the cone-jet could be nicely visualised, however as this 
point a high magnification lens was not incorporated in the camera setup and the 
droplets have therefore not yet been visualized.   
7.2.2 Electrospraying of protein drugs and control of drug distribution. 
Electrospraying of protein drugs – particle characteristics and stability 
Electrospraying of protein-based formulations could be studied using a model protein, 
such as lysozyme, to observe whether the protein remains stable and bioactive after 
being electrosprayed and also to examine the resulting particle characteristics. 
Lysozyme is a relatively stable protein with a net positive charge and a molecular 
weight of 14.3 kDa. Although a relatively common model protein it has not been used 
for electrospraying, to the best knowledge of the author, but provides a good protein for 
studying bioactivity and stability of proteins after electrospraying. The bioactivity can 
easily be measured using a standard kit with standard gram-negative bacteria, which 
should be lysed by the lysozyme if it is bioactive and the stability of the protein 
structure could be studied using spectroscopic techniques.  Since lysozyme is water-
soluble it could be electrosprayed either together with a water-soluble polymer such as 
HPMC or PVP or a sugar such as mannitol or trehalose using an aqueous and organic 
solvent mixture. Particles could also be prepared using electrospraying with a co-axial 
nozzle setup where proper encapsulation of the protein can be achieved. It is a common 
problem with spray drying of protein drugs that the proteins distribute towards the 
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surface of the particles due to their high surface activity and thus have a higher 
likelihood of denaturation caused by unfolding. By encapsulating the proteins within a 
polymer or sugar shell the protein molecules could be kept stable and bioactive for a 
longer time. This could perhaps also be done by controlling the drug distribution of 
particles to achieve higher drug concentration in the core of the particles.   
Control of drug distribution in electrosprayed particles for drug delivery. 
In the present project, CEL/PLGA and CEL/HPMCAS particles were prepared in binary 
solvent systems to study the influence of these solvents on the drug distribution in the 
particles. The study indicated solubility of the solutes in the solvents, molecular size of 
drug and polymer and the electrical charge of the solute may have had an influence on 
the drug distribution in electrosprayed particles. The influence of both the molecular 
size of solutes and their electrical charge would be interesting to further investigate by 
examining model proteins of similar molecular weight (14-17 kDa) with different net 
charge at a neutral pH. Lysozyme has a net positive charge (isoelectric point = 11), 
myoglobin has a net neutral charge (isoelectric point = 7.3) and alpha-lactalbumin has a 
net negative charge (isoelectric point = 4.2) and these proteins could be used and 
compared for this purpose. The differences in charge may result in different distribution 
of the proteins in the particles. These proteins could be electrosprayed using a polymer 
or sugar to study the distribution of the proteins in the resulting particles. In this case it 
may be advantageous to use a sugar such as trehalose, which has a molecular weight of 
342 Da and is much smaller than the proteins and typically has a higher solubility. 
There may then be a good chance that trehalose distributes towards the surface of the 
particles assuming their superior molecular mobility compared with the proteins. 
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7.2.3 Drug release kinetics from particles loaded with different drug molecules. 
In extension of the drug release studies performed in this project, where the influence of 
different particle characteristics on the drug release was studied, it would be interesting 
to examine the influence of drug molecular weight and drug water solubility on their 
drug release kinetics from PLGA particles. Although there are not many studies which 
report on the influence of drug properties on drug release from PLGA particles, it is 
believed that the molecular weight and solubility of the drug molecules have a great 
influence on drug release, provided that there are no strong interactions between the 
drug and the polymer. Since a large number of poorly water soluble drug compounds 
exist, some of these have similar molecular weight or similar aqueous solubility and can 
therefore be used to set up comparisons. The influence of the drug molecular weight on 
drug release rate could be established by looking at a few drugs compounds that are 
similar in solubility but different in molecular weight. The same could be done for the 
influence of drug solubility by studying drug compounds with similar molecular weight 
and different solubilities. It would be expected that diffusion mediated drug release 
from PLGA particles would take place at a higher rate for smaller molecules with a 
good solubility in the surrounding dissolution medium.    
7.2.4 Drug transport studies and cellular uptake from microparticles  
Caco-2 is a continuous cell line with origin from a human colon adenocarcinoma and is 
used extensively as a model of the intestinal barrier. These cells express many 
morphological and functional features that resemble that of intestinal enterocytes when 
grown in a monolayer [Pinto 1983]. Due to their similarity to small intestinal 
enterocytes Caco-2 cells are considered a representative model for the transport of drugs 
over the intestinal barrier. Caco-2 cells can be cultured on a permeable filter which 
allows them to act as a tight barrier between two compartments representing the apical 
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and basolateral sides of the cell monolayer (see Figure 7.1). Transport of different 
molecules across the monolayer can therefore be measured in both directions and the 
permeability of the cells to a specific substance can be determined [Sambuy et al. 2005]. 
It is of interest to test the drug release from electrosprayed microparticles and the 
transport of released drug by the Caco-2 intestinal cell model as this gives an indication 
of the in vivo performance of the drug formulations prepared. This drug transport model 
would then be used assess the permeability of the cells to drug molecules release from 
the microparticles in comparison to free drug crystals. Further, the differences in 
permeability between particles prepared with electrospraying and spray drying can be 
quantified to compare the performance of particles prepared with the two techniques. 
The particles would be suspended in the apical compartment of the system (see Figure 
7.1) and samples would be taken from the basolateral compartment at given time 
intervals to estimate the transported drug. It is believed that the drug transport from the 
particles would be slower than for drug crystals due to the slower release rate from the 
particles, yet the total percentage of drug transported may be higher for the particles due 
to the molecular form of the drug at release. Drug loaded HPMCAS particles could be 
tested to examine the effect of precipitation inhibition, which could give additional 
improvement to the drug transport.  
   
Figure 7.1 Caco-2 transwell plate (From Corning.com) (A) and sketch of components 
in a single well (B). 
A               B 
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